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Abstract 
 
There is considerable evidence that the lipid composition of cell and intracellular 
membranes, including those of mitochondria, is susceptible of being modulated by diet. 
It is also well known that lipids not only define membrane structure but also influence a 
multitude of signaling processes. Mitochondrial membrane lipids have been shown to 
play a critical role in physiological processes as diverse as protein biogenesis, energy 
production, membrane fusion and apoptosis. On the other hand, lipid-protein interplay 
assumes high importance in the mitochondrial inner membrane, which is highly 
vulnerable to membrane-active chemical agents. Although these findings have been 
extensively reported in literature, only a few studies are available specifically 
addressing diet potential to modulate the pharmacological/toxicological action of 
membrane-active drugs at the mitochondrial level. 
The experimental work in this thesis is divided into three main parts. In the first part, 
biophysical studies were carried out to unveil the membrane-mediated molecular 
mechanisms underlying the mitochondrial activity of three lipophilic compounds 
(FCCP, menadione and nimesulide). All three drugs showed to disturb membrane 
physical properties, although displaying dissimilar profiles of action. FCCP and 
menadione promoted the formation of different lipid domains in a mixed lipid system 
(DPPE:TOCL at 7:3 molar ratio) and favored inverted hexagonal (HII) lipid 
arrangements in a mitochondrial membrane mimicking model (DOPC:DOPE:TOCL, at 
1:1:1 molar ratio, in the presence of Ca2+). Despite disturbing membrane order similarly 
to the other two drugs, nimesulide was not efficient in promoting lateral lipid 
segregation and, unlike the others, stabilized the lamellar arrangement in detriment of 
the HII structure in the ternary lipid system. Therefore, these results indicated that the 
physico-chemical properties of drug molecules determine, as expected, the nature and 
severity of their effects on membrane structure and dynamics, and provided relevant 
information for understanding the effects exerted by the aforementioned drugs at the 
mitochondrial level. 
In the second part of the work, a suitable protocol inducing consistent and relevant 
changes in the lipid composition of rat liver mitochondria was established. A diet 
containing 20% rapeseed oil was selected for this purpose, and was administered over a 
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33 day period. In parallel with an exhaustive characterization of the lipid and protein 
composition of mitochondrial membranes from rats fed this diet as compared to a 
control group of rats fed a normal (calorically adjusted) diet, the mitochondrial 
alterations in terms of respiration, transmembrane electric potential and induction of the 
permeability transition were investigated, over several time-points (11, 22 and 33 days). 
The diet containing 20% rapeseed oil was shown to induce changes in the mitochondrial 
membrane lipid composition regarding the relative proportions of phospholipid classes 
(an increase in the PC/PE ratio and a decrease in cardiolipin content) and in the lipid 
fatty acid composition (incorporation of fatty acids from the diet and a decrease in the 
saturated/unsaturated ratio). Mitochondrial protein content remained mostly unchanged. 
The diet induced changes in respiratory parameters (inhibition of state 3 and uncoupled 
respiration, decrease of the respiratory control and ADP/O ratios and stimulation of 
state 4 respiration), reduced the transmembrane electric potential (∆Ψ), rendered 
mitochondria more susceptible to Ca2+-induced mitochondrial permeability transition, 
and reduced hydroperoxide generation at complex I.  
At the final time-point (33 days), the action of the compounds whose membrane 
physical interactions were studied in the precedent section was also investigated on 
hepatic mitochondrial fractions isolated from both modified diet and control diet-fed 
rats. Mitochondria from rats fed the rapeseed oil-containing diet were less affected by 
the action of the mitochondria-active drugs FCCP, menadione and nimesulide, namely 
in terms of meddling with respiratory parameters and ∆Ψ, but were more susceptible to 
MPT induction in the presence of nimesulide. 
The third part of the work regarded the influence of lipid composition on membrane 
binding and conformational behaviour of a typical mitochondrial protein (cytochrome 
c), using different membrane models, whose lipid composition was manipulated in 
order to reflect diet-induced changes in mitochondria lipid composition in vivo. The 
increase of PC/PE ratio as well as the decrease of the saturated/unsaturated fatty acid 
ratio, both simulating the major alterations induced by the modified diet in mitochondria 
membrane lipid composition in vivo, promoted a decrease of cyt c membrane binding 
and conformational changes upon the binding. Extrapolating these findings to other 
proteins, one can anticipate that diet-induced changes in mitochondrial membrane lipid 
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composition may modulate protein binding and conformational dynamics, with 
expectable consequences in physiology.  
Taken together, these results unequivocally show that diet can modulate mitochondria 
membrane lipid composition, thus influencing determinant physiological processes 
assured by those organelles. It was also shown that drug activity at the mitochondrial 
level may be modulated by the diet, opening new paths for research in the context of 
dietary interventions with therapeutic purposes or as chemiotherapy co-adjuvants in the 
treatment of a wide range of diseases. 
 
Keywords: apoptosis; attenuated total reflection Fourier transform infrared 
spectroscopy; cardiolipin; circular dichroism; cytochrome c; differential scanning 
calorimetry; FCCP; fluorescence anisotropy; lipid-protein interactions; liposomes; liver 
mitochondria; membrane biophysics; membrane lipid remodeling; menadione; 
mitochondrial membrane lipid composition; mitochondrial permeability transition; 
mitochondrial respiration; mitochondriotoxicity; nimesulide; NMR; oxidative stress; 
protein conformation.  
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Resumo 
 
Tem sido amplamente demonstrado que a composição lipídica das membranas celulares 
e intracelulares, incluindo as mitocondriais, é passível de ser regulada pela dieta. 
Também é hoje plenamente aceite que os lípidos não são meros componentes estruturais 
das membranas, mas estão envolvidos em inúmeros processos de sinalização. Os lípidos 
constituintes da membrana mitocondrial desempenham um papel fundamental em 
processos fisiológicos tão diversos como a biogénese de proteínas, produção de energia, 
fusão membranar e apoptose. Por outro lado, as interacções intermoleculares entre 
lípidos e proteínas assumem particular relevo ao nível da membrana mitocondrial 
interna, a qual é particularmente vulnerável à acção de agentes químicos que interferem 
com as propriedades físicas da membrana. Apesar de todos estes aspectos serem 
frequentemente debatidos na literatura, são escassos os estudos que investigam a 
regulação através da dieta da acção farmacológica/toxicológica exercida na mitocôndria 
por compostos com actividade membranar.  
O trabalho experimental a que se reporta a presente dissertação pode ser dividido em 
três partes. Na primeira, estudos biofísicos foram conduzidos com o intuito de 
esclarecer os mecanismos moleculares mediados pela membrana, subjacentes à 
actividade mitocondrial de três compostos lipofílicos (FCCP, menadiona e nimesulide). 
Os três compostos revelaram a capacidade de perturbar as propriedades físicas de 
membranas-modelo, embora apresentando diferentes perfis de acção. FCCP e 
menadiona promoveram uma separação lateral de fases numa mistura ideal de lípidos 
(DPPE:TOCL, na razão molar de 7:3) e favoreceram a transição para a fase hexagonal 
invertida (HII) num modelo membranar que simulava a composição lipídica da 
membrana mitocondrial (DOPC:DOPE: TOCL, nas proporções de 1:1:1, na presença de 
Ca2+). O fármaco nimesulide, ao contrário dos outros dois compostos, não induziu 
segregação dos componentes da mistura lipídica binária e estabilizou a fase lamelar em 
detrimento da HII, na mistura ternária. Estes resultados, além de terem mostrado que 
compostos com propriedades físico-químicas moleculares diferentes produzem, como 
seria de esperar, efeitos distintos na estrutura e dinâmica membranares, forneceram 
informação relevante à compreensão dos mecanismos moleculares de acção dos 
compostos acima mencionados na mitocôndria. 
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Na segunda parte do trabalho, foi estabelecido um protocolo capaz de induzir alterações 
consistentes e significativas da composição lipídica membranar de mitocôndrias de 
fígado de rato. Para esse efeito, foi selecionada uma dieta contendo 20% de óleo de 
colza, administrada aos ratos ao longo de um período de 33 dias. Em paralelo com uma 
caracterização detalhada da composição lipídica e proteica das membranas 
mitocondriais de ratos alimentados com esta dieta, comparativamente a um grupo 
controlo de animais com uma dieta comum (ajustada caloricamente), foram investigadas 
as alterações ao nível da mitocôndria em termos de respiração, potencial eléctrico 
transmembranar e indução da permeabilidade transitória, a diferentes intervalos de 
tempo (11, 22 e 33 dias). A dieta contendo 20% de óleo de colza induziu alterações na 
composição lipídica da membrana mitocondrial com respeito às proporções relativas das 
classes de fosfolípidos (um aumento da razão PC/PE e um decréscimo da cardiolipina) e 
à composição em ácidos gordos (incorporação de ácidos gordos da dieta e um 
decréscimo da razão entre ácidos gordos saturados e insaturados). O conteúdo 
mitocondrial em proteínas permaneceu praticamente inalterado. Esta dieta induziu 
alterações nos parâmetros respiratórios (inibição do estado respiratório 3 e da respiração 
dissociada da fosforilação, decréscimo do índice de controlo respiratório e da razão 
ADP/O e estimulação do estado respiratório 4), reduziu o potencial eléctrico 
transmembranar (∆Ψ), tornou as mitocôndrias mais susceptíveis à permeabilidade 
transitória mitocondrial induzida por Ca2+ e diminuiu a geração de hidroperóxido ao 
nível do complexo I. 
No último tempo experimental (33 dias), a acção dos compostos, cujas interacções 
físicas com membranas-modelo tinham sido estudadas na secção precedente, foi 
avaliada em fracções mitocondriais hepáticas isoladas de ambos os grupos, ratos 
nutridos com a dieta modificada e com a dieta controlo. As mitocôndrias de ratos 
alimentados com a dieta contendo o óleo de colza foram menos afectadas pela acção dos 
compostos FCCP, menadiona e nimesulide, em termos de parâmetros respiratórios e 
∆Ψ, mas mostraram ser mais susceptíveis à indução de permeabilidade transitória 
mitocondrial na presença de nimesulide. 
A terceira parte do trabalho foi consagrada ao estudo da influência da composição 
lipídica na ligação à membrana e no comportamento conformacional de uma proteína 
mitocondrial típica (citocromo c), usando diferentes modelos membranares, cuja 
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composição lipídica foi manipulada no sentido de reflectir as alterações induzidas pela 
dieta modificada na composição lipídica mitocondrial, in vivo. Um aumento da razão 
PC/PE, bem como uma diminuição da razão entre ácidos gordos saturados e 
insaturados, reflectindo as principais alterações induzidas pela dieta modificada na 
composição lipídica das membranas mitocondriais in vivo, promoveram uma 
diminuição na ligação do citocromo c às membranas bem como diferenças 
conformacionais após essa ligação. Extrapolando estes resultados para outras proteínas, 
pode suspeitar-se que modificações induzidas pela dieta na composição lipídica da 
membrana mitocondrial possam afectar a ligação de proteínas à membrana bem como a 
sua dinâmica conformacional, com previsíveis consequências fisiológicas. 
No seu conjunto, estes resultados mostraram inequivocamente que a dieta pode regular 
a composição lipídica membranar da mitocôndria, influenciando assim importantes 
processos fisiológicos assegurados por este organelo. Também ficou demonstrado que a 
actividade de compostos ao nível mitocondrial pode ser influenciada pela dieta, abrindo 
novos caminhos de pesquisa no contexto de intervenções nutricionais com propósitos 
terapêuticos ou como coadjuvantes de fármacos para um largo espectro de doenças. 
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1.1. Mitochondria: an overview 
 
The traditional view of mitochondria has significantly evolved in the last decades. On 
one hand, technological developments in microscopy have substantially changed the 
structural view of these organelles and, on the other hand, mitochondria are now 
recognized as playing an important role in many cellular processes and directly 
intervening in a number of relevant signaling pathways. Mitochondria function as cell 
powerhouses is a matter of common knowledge. However, mitochondria, as highly 
specialized cell compartments with an intricate structure where diverse processes take 
place, play other roles in the cellular context, which clearly surpass the energy 
production realm. In fact, mitochondria have been implied in a network of pathways, 
which contribute to the proper cell function, and also play a central role in all major 
pathways of cell death. The entangled physiology of mitochondria, to which many of 
cell processes and homeostatic requirements converge, makes them extremely 
susceptible to toxic action. Numerous proteins, especially in the notoriously protein-rich 
inner mitochondrial membrane (IMM), guarantee the fulfillment of the mitochondria 
intervention in a wide range of physiological processes, and their action and 
toxicological susceptibility have been well characterized. However, mitochondrial lipids 
have also been pointed as a target for a number of drugs. 
Issues regarding the lipid part of the mitochondrial membrane, such as lipid involvement 
in processes taking place in mitochondria and manifestations of lipid moiety influence 
on membrane protein function, constitute a field which has recently deserved increasing 
attention. The mitochondrial membrane system contains a wide variety of lipids and 
exquisite asymmetries. Some of these lipids are synthesized inside mitochondria, while 
others have to be imported or acquired in the form of precursors. This variety in lipid 
content should indicate specific lipid requirements from mitochondrial physiology. In 
fact, evidence is emerging pointing that the integration and biological outcome of all 
pathways converging in mitochondria are critically dependent on the unique lipid 
composition of mitochondrial membranes. Therefore, modulation of mitochondrial lipid 
content may hold relevant physiological implications. Processes that may result in 
alterations of mitochondrial lipid content include external interventions (e.g. diet, 
genetic) and a range of biological processes (apoptosis, disease and aging). 
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Although the lipid content of the mitochondrial membrane has often been disregarded in 
the context of “Mitochondrial Medicine”, which targets mitochondrial function with 
biologically active molecules in order to manipulate mitochondrial functions, recent 
advances in membrane lipid therapies allow us to predict that membrane mitochondrial 
lipids should be a critical target for new pharmacological drugs. The possibility of 
modulating the mitochondrial membrane lipid composition, promoting predictable 
repercussions in functioning may represent an opportunity in the treatment of some 
pathologies. Therefore, valuable interventions with therapeutic application may arise in 
this context, taking the lipid part of the mitochondrial membrane as a target and 
attempting to counteract functional changes brought by disease or to potentiate/attenuate 
mitochondrial-dependent apoptosis. 
In this introduction, the influence of mitochondria membrane lipid moiety on the 
physiological processes taking place in these organelles will be highlighted. 
Mitochondrial pharmacology and toxicology will be also addressed, with special focus 
on drug action exerted on the lipidic part of mitochondrial membranes. 
 
1.2. Mitochondria: a paradigmatic example of how structure 
fits function in biological systems 
 
Mitochondria structure comprises an outer mitochondrial membrane (OMM), an 
internal mitochondrial membrane (IMM), an intermembrane space (IMS) between the 
former two, and a gel-like internal space, the mitochondrial matrix. The presence of a 
double-membrane system in mitochondria (as in chloroplasts) has been explained by the 
endosymbiotic theory, which postulates that mitochondria originated from an alpha-
proteobacterium endosymbiont, as has been strongly supported by molecular phylogeny 
[1]. 
The OMM, which delimits the outer contour of mitochondria has been assumed as 
permeable to small metabolites and solutes up to around 5 kDa, mainly due to the 
presence of an abundant protein, the voltage-dependent anion channel (VDAC) [2]. The 
IMM convolutes in structures called cristae, which lead to a substantial increase of the 
membrane surface area, being IMM hence able to accommodate a considerable amount 
of catalytic proteins, such as those involved in the respiratory process. The great 
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abundance of membrane proteins in the IMM favors the association of respiratory 
complexes into the so-called respirasomes, i.e. multisubunit supercomplexes composed 
of several individual respiratory complexes [3], which significantly potentiates 
mitochondrial respiration efficiency. This membrane is impermeable to all ions, 
including protons, contributing to building up a proton motive force (∆µH+) generated by 
the mitochondrial respiratory system [4, 5]. 
Recent advances in microscopic and tomographic techniques allowed refining the view 
of the mitochondrial interior, with the definition of tiny junctions that separate the cristae 
from the inner boundary membrane [6]. These advances also altered the perception of 
how mitochondria look like. As opposed to the way mitochondria are traditionally 
pictured, resembling ellipsoid–shaped organelles, a wide network of long tubules is now 
considered to be a more realistic conception of mitochondria in the cell. Efforts towards 
defining an accurate three-dimensional reticular architecture of mitochondria resulted in 
important progress in mitochondrial research, and the term “mitochondrial network” 
started to replace, in some contexts, the traditional name “mitochondria” [7]. 
 
1.3. Mitochondria in the cell metabolism network and 
signaling pathways 
 
Mitochondrial oxidative phosphorylation accounts for about 90% of cellular demands in 
terms of oxygen uptake and provides more than 80% of the energy requested for cellular 
activity [8]. The mitochondrial matrix contains all the enzymes involved in fuel 
oxidation, except those participating in glycolisis, which reside in the cytosol. Therefore 
the conversion of pyruvate (the final product of glycolisis) to acetyl-CoA by the 
pyruvate dehydrogenase complex, the citric acid cycle (Krebs cycle or tricarboxylic 
acid- TCA, cycle), representing the universal catabolic pathway by which compounds 
derived from carbohydrates, fat and proteins are oxidized to CO2 in aerobiosis, as well 
as the fatty acid β-oxidation and aminoacid oxidation pathways, all take place within 
mitochondria. The TCA cycle also serves anabolic processes in aerobic organisms 
(amphibolic pathway) and thus, its set of reactions holds a relevant place in cell 
metabolism network, offering three important advantages to the aerobic cell: increased 
generation of ATP, reduction of the coenzyme NAD+ to NADH and production of 
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FADH2 in the succinate dehydrogenase complex, and source of precursors for many 
biosynthetic pathways [9]. 
The oxidative phosphorylation, taking place at the IMM, is the point of convergence of 
all oxidative processes involved in the energy-yielding aerobic metabolism. This 
process, which involves oxygen reduction to water with the electrons donated by 
NADH and FADH2 and flowed through a system consisting of four membrane-bound 
protein complexes numbered from I to IV (see Fig. 1A, below) and two mobile 
electron-carriers, the quinone coenzyme Q (CoQ) and the cytochrome c (cyt c), leads to 
the synthesis of ATP by a chemiosmotic mechanism, according to the hypothesis firstly 
introduced by Peter Mitchell, fifty years ago [10]. 
The sequential action of the enzymes of the respiratory system results in the generation 
of an electrochemical gradient, as respiratory complexes (I, III and IV) pump electrons 
from the matrix to the IMS. This difference in proton concentration and separation of 
charge between these two mitochondrial subcompartments (matrix and IMS) represents 
a temporary conservation of the energy derived from electron transfer. This proton-
motive force (∆µH+) has two components: the chemical potential energy derived from 
the difference in concentration of H+ (∆pH), and the electrical potential energy (∆Ψ) 
resulting from the separation of charge associated to proton migration between the 
subcompartments [9]. The energy produced and stored in this manner will be ultimately 
used by ATP synthase (respiratory complex V) to drive ATP synthesis (Fig. 1A). The 
model proposed by Peter Mitchell in 1961 implied the generation of a delocalized 
proton pathway within the two bulk aqueous phases on each side of the membrane 
(delocalized chemiosmotic theory), but more recent evidences strongly supported a 
semi-localized hypothesis, namely those provided by the observation that phospholipid–
water interface can act as an efficient proton conductor [11]. On the other hand, both the 
export of protons and the synthesis of ATP were seen by Peter Mitchell as being a direct 
consequence of the orientation of chemical reactions. In more recent models, protons 
are pumped through the IMM as a consequence of dynamic conformational 
transformation of the proteins involved in electron transport, namely cyt c oxidase [12]. 
Similarly, protons do not directly displace the ADP-ATP equilibrium, but rather alter 
the binding of ATP through a complex conformation transition of the catalytic F1 part of 
ATPase in a process called rotational catalysis [13]. This should be the final step 
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towards the release of ATP in the mitochondrial matrix. F-ATPases consist of a 
catalytic part (F1) and a proton channel (F0) formed from the α3β3γδϵ and ab2c10-14 
subunit complexes, respectively. The electrochemical gradient rotates the γϵc10 in 
ATPase, resulting in ATP synthesis at the β subunit catalytic site [14]. It has been 
theorized that the γ subunit should rotate in one direction when FoFl is synthesizing ATP 
and in the opposite direction for ATP hydrolysis. 
The whole respiratory chain of higher eukaryotes contains about 90 protein subunits, 
which are both nuclear and mitochondrial DNA-encoded (with the exception of 
complex II, which is nuclear-encoded only), combined to form the active respiratory 
complexes [15]. As noted before, the multisubunit proteins in the respiratory system, 
complex I (NADH-ubiquinone:oxidoreductase), complex II (succinate dehydrogenase), 
complex III (ubiquinone-cyt c oxidoreductase), and complex IV (cyt c oxidase), can 
form supramolecular assemblies, which modulate the thermodynamic and kinetic 
properties of the components of the chain. Negative contrasting electron microscopy 
studies allowed detecting complex I1III2IV1 preparations as triangular particles with a 
long side of 30-33 nm [16], and the occurrence of large supramolecular structures 
consisting of respirasomes was proposed on the basis of these observations [17]. 
Generation of reactive oxygen species (ROS) during several steps in the respiratory path 
is a functional consequence of mitochondrial respiration [18]. The superoxide anion 
radical generated specially at the complex I and III levels [19] is highly reactive and 
may be subsequently transformed in hydroxyl radical, which is even more reactive. 
Mitochondrial mediated oxidative stress, consequence of the establishment of an 
unbalance between the generation of ROS and the available protection afforded by 
antioxidant defenses, may result in damage to membrane lipids, ultimately also 
affecting the activity of mitochondrial enzymes, and possibly impairing mitochondrial 
function [20-24]. It has been described that 1-2% of the molecular oxygen consumed in 
mitochondria during normal physiological respiration is converted into superoxide 
anion radical [25]. In normal conditions, the most part of these mitochondrially-
produced ROS is detoxified by natural antioxidant defense and only a small amount of 
residual ROS persists, serving as signaling molecules [26]. However, when ROS are 
generated in excess and/or the level of antioxidant defenses is low, oxidation of 
mitochondrial proteins, lipids and DNA may occur due to a direct interaction with ROS. 
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The overall performance of mitochondria may then be affected, influencing cell 
viability and triggering cell death [25]. Reactive aldheydes such as malondialdehyde 
(MDA) and 4-hydroxynonenal (4-HNE) are produced during lipid peroxidation [27, 
28]. Another consequence may be cytokine overproduction (transforming growth factor-
β - TGF-β, interleukin-8 - IL-8, tumor necrosis factor-α - TNF-α - and Fas ligand) [27, 
29]. ROS can also be part of intricate signaling mechanisms [30]. Superoxide anion 
interferes with cellular signaling through activation of Ras/Rac-Raf-1-MAPK pathway 
[30] and induction of ERK (extracellular signal-regulated kinase) phosphorylation and 
activation [31], which regulates the transcriptional activity of activator protein 1 (AP-1), 
c-Myc and Bcl-2 [32]. In fact, ERK, JNK (c-Jun N-terminal kinase) and p38 mitogen-
activated protein kinase (p38 MAPK) have all been shown to be activated by oxidative 
stress [33]. Several important transcription factors, including p53, NF-kB and activating 
transcription factor 2 (ATF-2) are p38 MAPK phosphorylation targets [33], and JNK 
has as specific targets the transcription factors AP-1, p53 and c-Myc and many other 
proteins, such as Bcl-2 family members [33]. ROS-induced activation of p38 and/or 
JNK may play important roles in the redox signaling cascade, leading to caspase-3 
activation [33]. In addition, phosphatases, such as calcineurin [34-36] and the 
phosphoinositide-3-phosphatase (PTEN) [37] are also redox sensitive. 
Mitochondria hold an important and efficient role in cytosolic Ca2+ buffering and 
regulation, being able to accumulate this cation in the matrix, a process favored by the 
existing mitochondrial ∆Ψ [38]. Calcium is a highly versatile intracellular signaling 
molecule involved in the regulation of a great number of cellular functions [39-41], such 
as gene transcription, metabolism, proliferation and apoptosis, but also, fertilization, 
migration, exocytosis or muscle cell contraction [42].  In intracellular stores, calcium 
ions reach concentrations in the micromolar range, while the normal Ca2+ concentration 
in cytoplasm is around 100 nM [42]. Calcium signaling may involve different spatial 
and temporal patterns of calcium concentration increase [42]. Calcium can be locally 
released, and local Ca2+ concentration increments are defined as Ca2+ sparks or Ca2+ 
puffs, while an overall Ca2+ concentration increase throughout the cell is described as a 
Ca2+ wave [42]. Calcium elevation can persist from microseconds to hours. Therefore, 
calcium signaling can be transitory (Ca2+ transients), recurring (Ca2+ oscillations), or can 
occur as a sustained Ca2+ increase, referred to as a Ca2+ plateau [42]. The variety of both 
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spatial and temporal features of calcium elevation determines its cellular consequences. 
Within the cell, calcium can be specially accumulated in the endoplasmic reticulum 
(ER) but also in mitochondria, Golgi complex cisternae and nucleus. Mitochondria may 
modulate the amplitude and profile of cytosolic Ca2+ transients, shaping up several 
signaling processes [43]. The pathways of Ca2+ entry to the mitochondrial matrix 
include the mitochondrial calcium uniporter (MCU) [44], rapid uptake mechanism 
(RaM) [45], and the still ill-characterized mitochondrial ryanodine receptor (mRyR) 
[46]. Mitochondrial calcium efflux mechanisms, not related with the mitochondrial 
permeability transition (MPT), exist in excitable cells such as heart, brain and skeletal 
muscle cells through a Na+ dependent 2Na+/Ca2+ exchanger [38], while an alternative 
mechanism involving the 2H+/Ca2+ exchanger occurs predominantly in liver, kidney, 
lung, and smooth muscle [43, 47]. Both exchangers have been found in mitochondria 
from all tissues examined, indicating that Ca2+ efflux is not mediated by a single 
mechanism in any given cell type [38]. The mitochondrial permeability transition pore 
(MPTP) has also been suggested to act as a Ca2+ release mechanism by transiently 
opening and releasing Ca2+ to the cytoplasm in a redox and calcium-sensitive manner 
[48, 49]. As consequence of excessive Ca2+ uptake, mitochondria may undergo 
sustained MPTP opening, which may result in cyt c release from the IMS into the 
cytoplasm, with consequences for cell viability. 
In addition to the more classically established roles of mitochondria, namely regarding 
energy metabolism, regulation of cell death has also emerged as another characteristic 
function of these organelles [50]. Apoptosis is a form of programmed cell death in 
which a variety of triggering stimuli lead to a form of “cell suicide” [51]. During 
apoptosis, a succession of structural changes normally takes places, which includes 
condensation and fragmentation of nuclear chromatin, compaction of cytoplasmic 
organelles, dilation of the ER and a decrease in cell volume – cell shrinkage [52, 53]. 
These changes ultimately lead to plasma membrane alterations, resulting in the 
recognition and phagocytosis of apoptotic cells, hence preventing an inflammatory 
response [52, 54], which normally occurs in the case of necrotic cell death. During 
apoptosis, cells require the maintenance of a steady supply of energy (ATP) [55, 56] in 
order to sustain and regulate several of the steps that are hallmarks of this process. 
When cellular ATP levels become abnormally low, which may result from 
10 
João P. Monteiro, 2012 
 
mitochondrial dysfunction, classical apoptotic triggers typically cause necrotic demise, 
showing that sustained ATP production is required for the cells to engage the apoptotic 
program [57]. Necrosis results in the swelling of the cell and the disruption of the 
plasma membrane, with resulting release of cellular content to the extracellular space. 
As opposed to apoptosis, necrosis triggers an inflammatory response, which can cause 
further damage to surrounding cells [58]. 
Apoptosis is involved in numerous physiological cellular events, including normal cell 
turnover, immune system function, embryonic development, metamorphosis and 
hormone-dependent atrophy, and also in chemically-induced cell death [52, 59, 60]. A 
variety of pathological conditions result from apoptotic program deregulation. When 
apoptosis in the tissue is compromised, cancer, rheumatoid arthritis or auto-immune 
diseases may occur; conversely, excessive apoptosis is involved in neurodegenerative 
disorders (e.g. Alzheimer’s disease and Huntington’s disease), acquired immune 
deficiency syndrome (AIDS) and other manifestations of auto-immune diseases, several 
forms of myopathies and tissue damage resulting from ischaemia and reperfusion [61, 
62]. 
Apoptosis occurs via two interconnected pathways: the extrinsic pathway, which is 
death receptor-dependent, and the intrinsic pathway, which is mitochondria-dependent 
[53], and which leads to the activation of effector caspases (caspases-3, -6, -7), the 
ultimate mediators of apoptotic cell death [63]. Both intrinsic and extrinsic apoptotic 
pathways engage this family of cysteine proteases, which cleave specific cellular 
substrates leading to the dismantlement of the cell characteristic of apoptosis [64]. 
Caspase-independent cell death involving mitochondria has also been identified; this 
process is mediated by the release and nuclear translocation of the mitochondrial 
apoptosis-inducing factor (AIF) followed by DNA strand breaks, which differ from the 
DNA internucleosomal cleavage [65], recognized as a “DNA ladder” on conventional 
agarose gel electrophoresis and long considered as a biochemical hallmark of apoptosis 
[66]. 
The intrinsic pathway of apoptosis may be activated in response to a variety of 
apoptogenic stimuli, such as growth factor deprivation, hypoxia, cell detachment, and 
DNA damage [67, 68]. These stimuli result in the activation of the pro-apoptotic 
members of the Bcl-2 superfamily, leading to mitochondrial membrane 
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permeabilization and release of cyt c, which then forms a complex with apoptotic 
protease activating factor 1 (Apaf-1) and ATP, the apoptosome, leading to the 
subsequent activation of the effector caspases [53]. 
Mediating the critical balance between cell life and death processes, there is a family of 
anti- and pro-apoptotic proteins that regulate and execute the core of the mitochondrial 
pathway of apoptosis, the so-called Bcl-2 family of proteins [68]. Proper regulation 
requires a delicate balance between pro-apoptotic members of the Bcl-2 family (for 
example, Bax, Bak, Bad, Bid, Bim, Noxa, Puma) and the anti-apoptotic members (Bcl-
2, Bcl-XL, Mcl-1, among others) [69]. The Bcl-2 protein family may be divided into 
three different groups – two pro-apoptotic groups and one anti-apoptotic – based on 
their conserved regions, termed Bcl-2 homology (BH) domains [69]. The pro-apoptotic 
groups include ‘‘multidomain’’ members that possess BH1-3 domains (Bax, Bak), or 
‘‘BH3-only’’ members (Bad, Bid, Bim, Noxa, Puma) [69]. The “BH3-only members” 
are upstream signal detectors that become activated by a variety of pro-apoptotic stimuli 
[69]. Once activated, the “BH3-only members” activate the “multidomain” pro-
apoptotic members, Bax and Bak, which are ultimately responsible for inducing OMM 
permeabilization, cyt c release and apoptosis [70]. The anti-apoptotic Bcl-2 family 
members possess conserved BH1-3 domains, which come together to form a 
hydrophobic pocket that is capable of binding the BH3 domain of pro-apoptotic 
members [70]. It is believed that the anti-apoptotic members primarily function by 
binding and sequestering the BH3-only members [71]. 
Mitochondrial membrane permeabilization may occur at the IMM and OMM levels. 
IMM permeabilization by formation of pores leads to the dissipation of the ∆Ψ 
established by mitochondrial respiration [2]. Following IMM permeabilization, an 
increase in mitochondrial matrix volume – swelling – can occur due to a massive 
internalization of solutes and, consequently, water; mitochondrial swelling gives rise to 
a distension and disorganization of the cristae, as well as to a decrease of the electron 
density of the matrix, which is commonly observed by electron microscopy in isolated 
mitochondrial fractions [2]. The main mechanism proposed as leading to IMM 
permeabilization involves the formation and opening of the MPTP (Fig. 1B) [2], whose 
exact molecular composition is still controversial. Nevertheless, in light of recent 
reports, the IMM phosphate carrier (PiC) seems to be involved while the adenine 
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nucleotide translocator (ANT) and the matricial protein cyclophilin-D (CypD) seem to 
hold a regulatory function (Fig. 1B). It appears that an OMM component may not be 
necessary for this process [72]. It has indeed been described that more than an in vitro-
only effect, the MPT is a common phenomenon in tissue injury [73]. In fact, in intact 
healthy cells, the MPTP likely fluctuates between the open and closed states with a 
rapid kinetics [74]. Large and long-lasting openings can lead to cell death induction by 
excessive calcium accumulation [2].  
 
Fig. 1: Mitochondrial respiratory chain and oxidative phosphorylation (A) and 
mechanisms of OMM permeabilization (B). A) Mitochondria main function is the synthesis 
of ATP through oxidative phosphorylation, being these organelles the major cellular source of 
energy. However, when mitochondria are affected by a wide range of stress signals, oxidative 
phosphorylation can be impaired, leading to ROS formation and oxidative stress (in dashed 
line); in parallel, a loss of ∆Ψ will occur. All these events culminate in the opening of the 
MPTP, ATP depletion, mitochondria fragmentation, matrix disorganization, cristae disruption, 
and lipid peroxidation of cellular membranes. B) OMM permeabilization may occur through 
several mechanisms, such as activated Bax-Bak proteins which may assemble into large 
multimers, allowing for the release of IMS proteins (e.g., cyt c, Smac/DIABLO, AIF); 
alternatively, long-lasting opening of the MPTP may lead to the dissipation of ∆Ψ, efflux of 
IMS proteins, followed by an osmotic imbalance that induces swelling of the mitochondrial 
matrix, and eventually cell death. 
 
The role of MPTP in cell death is further reinforced by the fact that pro-apoptotic Bcl-2 
family members (for instance, Bax, Bak and Bid) regulate its opening [2]. The calcium 
threshold for MPTP opening is altered in the presence of pro-oxidant agents [75, 76], 
including some chemotherapeutic drugs [2], and is inhibited by CypD ligands, such as 
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cyclosporin A (CsA) [77], ANT ligands such as bongkrekic acid (BA) [78] and anti-
apoptotic members of the Bcl-2 family, including Bcl-2 and Bcl-XL [79-82]. On the 
other hand, pro-apoptotic proteins including truncated Bid (tBid), Bad or Bax, can 
cooperate to increase the permeability of the OMM, promoting the release of 
mitochondrial pro-apoptotic factors that activate the apoptotic cascade (Fig. 1B). OMM 
permeabilization is generally evaluated by determining the subcellular localization of 
proteins, which are normally retained within the IMS by the protein-impermeable 
OMM. The occurrence of these proteins in an extra-mitochondrial compartment 
(cytosol or nucleus) is indicative of OMM permeabilization (Fig. 1B) [2]. Among the 
proteins released from mitochondria upon apoptotic stimuli, the most extensively 
studied are cyt c, AIF, Smac/DIABLO, Omi/HtrA2 and endonuclease G. The release of 
these mitochondrial proteins into the cytosol compromises cell survival and apparently 
represents a point of no return to cell death [83]. 
 
1.4. Mitochondrial membrane lipid composition and 
organization 
 
The mitochondrial phospholipid composition is roughly maintained similar among 
different cells in different organisms, which suggests that major lipid changes cannot be 
tolerated in this organelles and that lipids serve functional purposes [84]. This is 
illustrated by the relative abundance of different phospholipids in mitochondrial 
membranes of yeast and mammalian cells, which shows slight variations. In mammals, 
the mitochondrial membrane lipid composition shows sensible changes between tissues 
(Fig. 2). The most abundant phospholipids in mitochondrial membranes are 
phosphatidylcholine (PC) and phosphatidylethanolamine (PE), representing about 40-
55% and 30-45% of total mitochondrial phospholipids, respectively. Cardiolipin (CL), a 
tetraacyl phospholipid, accounts to up to 15% of mitochondrial phospholipid content 
[85].  Phosphatidylinositol (PI), phosphatidic acid (PA) and phosphatidylserine (PS) are 
also present, but at more modest amounts [86, 87]. The presence of PS in mitochondria 
is thought to be related with its role as a PE precursor [88]. The lipids cytidine 
diphosphate-diacylglycerol (CDP-DAG), phosphatidylglycerol-phosphate (PGP), and 
phosphatidylglycerol (PG) are important intermediates for the synthesis of the most 
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abundant phospholipid species but do not accumulate in mitochondria under normal 
conditions. Other membrane lipids, such as sphingolipids and sterols, important 
structural lipids in other membrane structures, are only found in trace amounts in 
mitochondrial membranes [89]. The low mitochondrial content in cholesterol (chol) 
originates from import mediated by the action of specialized proteins involved in the 
uptake from extramitochondrial sources and trafficking within the mitochondrial 
membranes [90]. 
 
Fig. 2: Diagram illustrating the lipid composition of mitochondrial membranes from 
different rat organs according to data provided by Klaus Urich (In: “Comparative animal 
biochemistry”, 1994, Springer-Verlag, New York, pp. 597) [91]. For illustration purposes, 
averages were calculated when value ranges were available. 
 
The diversity of mitochondrial membrane lipids is also a consequence of the variation in 
hydrocarbon chain length and degree of fatty acid unsaturation within each class of 
phospholipid. Phospholipid fatty acid composition has a determinant influence on the 
biophysical properties of cellular membranes. With the exception of the acyl chain 
remodeling of CL, which has been studied in some detail [92], the regulation of the acyl 
chain composition of mitochondrial lipids and its repercussion on mitochondrial 
processes are poorly understood. 
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The most significant difference in the relative abundance of phospholipids between the 
IMM and OMM is observed for CL [84], which was thought for a long time to be 
confined to the IMM. However, a recent study in yeast has convincingly demonstrated 
that a purified OMM fraction from yeast contains 25% of the total CL content in 
mitochondrial membranes [93]. A mitochondrial phospholipid scramblase (PLS3) has 
been described as being involved in the translocation of CL from the IMM to the OMM, 
a process which is important in the earliest phase of mitochondrial apoptosis [94]. PC 
content was reported to be higher in the OMM, while PE content seems to be similar in 
both membranes [88]. Regarding chol, its presence is detected mostly in the OMM [95]. 
Regardless of its higher chol content, the OMM was proposed to be more fluid than the 
IMM [96], which may have functional implications. Mitochondrial contact sites 
(MCS’s) between the IMM and OMM appear to be specialized structures, also 
displaying a particular composition. Isolated fractions from MCS’s were reported as 
having a lower concentration in PC than the OMM or IMM, but higher content in CL as 
compared to the IMM [97]. 
Specific lipid distribution between the inner and outer leaflets has been found in both 
mitochondrial membranes. Lipid asymmetry in membranes is a consequence of multiple 
factors, including the biophysical properties of lipids, which dictate their ability to 
spontaneously “flip” their polar headgroups through the hydrophobic membrane 
interior, and the presence of transporters (enzymes) that cooperate in active lipid 
translocation across the bilayer [89]. Asymmetric distribution of phospholipids in rat 
liver OMM is well known [98]. The outer leaflet of this membrane, exposed on the 
cytosolic surface, was reported to have more PC (55%), PE (77%) and interestingly 
almost all the CL, while PI and PS are preferentially confined to the inner leaflet. Also 
the major phospholipids of the IMM of beef heart mitochondria were reported to be 
asymmetrically distributed in the transversal plane of the membrane [99]: PC is 
preferentially located on the external side, while PE and particularly CL are 
preferentially located on the inner (matrix) side. Regarding CL, a distribution of roughly 
60:40 between the inner and the outer leaflets was reported [98, 100]. Since a significant 
portion of CL is associated with proteins [101], which are themselves asymmetrically 
localized in the IMM [102], CL distribution is likely to be critically dependent on 
membrane protein topology. 
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The IMM has an unusually high protein:lipid molar ratio (between 3:1 and 4:1), which 
makes it one of the most protein-rich membrane systems. Many abundant IMM peptides 
are components from the respiratory chain complexes or the F1F0-ATP synthase, which 
accumulate in cristae membranes [103]. In contrast, the protein:lipid molar ratio of the 
OMM is about 1:1 or 1.6:1 [96, 97, 104]. 
Another relevant aspect of mitochondrial membrane structure, which has been recently 
unveiled, regards the occurrence of raft-like lipid domains enriched in CL and 
containing the ganglioside GD3 and chol, though at substantially lower amounts than in 
plasma membrane lipid rafts [105]. During apoptosis, these raft like domains act as 
active “platforms” recruiting a large number of mitochondrial proteins which are 
involved in the modulation of mitochondrial functions and cell fate [106]. 
In summary, it can generally stated that mitochondrial membranes (i) exhibit a lower 
phospholipid to protein ratio as compared to other organelle membranes; (ii) contain PC 
and PE as major phospholipid classes similarly to other organelle membranes; (iii) 
present CL as a peculiar phospholipid, which is absent in all other membrane systems; 
(iv) show a negligible content in sphingomyelin, glycosphingolipids and sterols as 
compared to other membranes. In conclusion, mitochondria hold a highly structured 
membrane system, reflected in differences taking place between the IMM and the 
OMM, lipid asymmetry within each membrane and presence of different lipid 
microdomains in the plane of the IMM bilayer. All these particular properties of 
mitochondrial membranes should not result from chance, and many of them have in fact 
been implied in mitochondrial function. 
 
1.5. Origin of mitochondrial membrane lipids and proteins 
 
Mitochondria do not have the capacity to synthesize all lipid constituents; most 
mitochondrial lipids are imported [85]. The maintenance of a defined lipid composition 
within mitochondria depends on their capacity to synthesize phospholipids such as CL, 
PE, PG, CDP-DAG, and PA, whereas PI, PC and PS are primarily synthesized in the 
smooth endoplasmic reticulum (sER) and imported into mitochondria as end products or 
as precursors for other lipids (Fig. 3) [85]. Sterols are also synthesised in sER and 
transported to mitochondria [89]. 
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Most lipids of eukaryotic cells are synthesized in the sER, with the synthesis of some of 
them, including sphingolipids, being completed in the Golgi system [85]. Phospholipid 
translocation between membranes of the ER and mitochondria was proposed to occur at 
specialized fractions of the ER that are tightly associated with mitochondria, and which 
are called mitochondria-associated membranes (MAMs; Fig. 3) [107-109]. After being 
imported (or synthesized in situ), phospholipids are redistributed through the 
mitochondrial membranes, giving rise to the aforementioned lipid asymmetry. Lipid 
transfer from one leaflet to the other is energetically unfavourable because of the 
presence of polar headgroups, and is generally facilitated by dedicated enzymes 
commonly named flippases. However, the only known mitochondrial flippase is PLS3, 
which was shown to catalyze trans-bilayer flipping of CL in vitro [110]. Phospholipid 
translocation between the two mitochondrial membranes has been proposed to occur at 
the MCS’s [104, 111]. The recent identification of a set of conserved proteins in the 
IMS, appearing to regulate the distribution of CL and PE in mitochondria, may originate 
new insights regarding the mechanism of phospholipid transport across this 
mitochondrial compartment [84]. 
De novo CL biosynthesis in mitochondria is catalyzed by a multi-enzyme cascade in the 
IMM [112, 113]. Synthesis of CL from CDP-DAG was shown to occur by the stepwise 
formation of PGP catalyzed by phosphatidylglycerolphosphate synthase 1 (PGS1) in 
yeast [114, 115] and its subsequent dephosphorylation. This step is catalyzed by the 
recently identified PGP phosphatase Gep4 [116]. CL synthase-mediated generation of 
CL from PG and CDP-DAG is the rate-limiting step of CL synthesis, taking place at the 
matrix side of the membrane [117], but subsequent acyl chain remodeling steps occur at 
the outer leaflet of the IMM [118]. Newly synthesized CL undergoes a remodeling 
process in which saturated acyl chains are replaced with more unsaturated chains, 
thereby establishing a high degree of structural uniformity and molecular symmetry 
[117]. It has been proposed that de novo synthesis predominantly contributes to the 
diversity of CL molecular species, whereas acyl-specific remodeling yields a limited 
number of CL molecular species [119].  
Extramitochondrial PS is imported from the ER as a precursor for mitochondrial PE in 
both yeast and mammalian cells. Decarboxylation of PS by Psd1 (PS decarboxylase 1) 
takes place at the outer leaflet of the IMM [120, 121]. PC, a major phospholipid in 
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mitochondrial membranes, is synthesized by the CDP-choline pathway in the ER [85]. 
Therefore, all mitochondrial content in this phospholipid must be imported, as 
mitochondria do not contain enzymes capable of PC biosynthesis.  
Mitochondria have their own fatty acid synthesis pathway, which is composed of a set 
of monofunctional enzymes resembling the bacterial fatty acid synthase II (FAS II) 
system and which contrasts with the eukaryotic cytosolic multifunctional complex 
[122]. Therefore, mitochondrial fatty acids can be either imported or biosynthesised in 
situ.  
 
 
Fig. 3: Schematic representation of the origin of mitochondrial membrane phospholipids, 
emphasizing the interplay with the ER, trough MAMs. CL synthesis is given special 
attention and the prohibition signs indicate steps where the process may be genetically 
manipulated (namely by the production of crd1∆ mutants, which lacks the enzyme CL synthase, 
being CL production from PG and CDP-DAG compromised, and ∆taz1 mutants with defective 
CL transacylase, preventing the production of mature CL from immature precursors, CLim). 
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Other lipids occurring at low amounts in mitochondria, such as ganglioside GD3 (or 
simply GD3) and ceramide, which have been reported to be involved in mitochondria-
mediated apoptosis, are imported to mitochondria. GD3 found in mitochondrial raft-like 
domains is translocated from the plasma membrane, upon pro-apoptotic stimuli [123]. 
Ceramide is imported from the ER [124], although may be also generated in 
mitochondria [125]. 
The vast majority of mitochondrial proteins are nuclear encoded, although the 
complexes of the respiratory chain incorporated in the IMM contain several subunits 
that are encoded by the mitochondrial DNA, including subunits of complexes I, III, IV 
and V. All other mitochondrial membrane proteins are encoded in the nucleus and 
synthesized on cytosolic ribosomes as precursor proteins [103]. The classical 
mitochondrial signal that targets proteins to mitochondria is a cleavable N-terminal 
positively charged sequence (presequence). However, the greater part of mitochondrial 
proteins residing in the OMM, IMS and IMM lack the classical presequence, but rather 
contain internal cryptic targeting sequences within the mature protein [126].  All 
nuclear-encoded proteins occurring in the inner mitochondrial compartments cross the 
OMM through a specific translocase of the outer mitochondrial membrane (TOM 
complex). Additionally, the OMM contains the sorting and assembly machinery (SAM 
complex), which is required for the biogenesis of OMM proteins [103]. 
 
1.6. Remodeling of lipid content in mitochondrial 
membranes 
 
The phospholipid composition of membranes is supposed to be under tight genetic 
control, and varies markedly between different tissues and organs within an individual 
animal, representing a specific feature of each given membrane [127]. For the same 
tissues and organs, membrane phospholipid composition also changes between different 
species. Regarding mitochondrial membranes, their lipid composition has been reported 
as being susceptible of undergoing changes induced by external factors (through diet or 
knockout genetic manipulation) or in the context of physiological processes (apoptosis 
and aging) and disease. Mitochondrial membrane lipid changes promoted by these 
processes will be discussed hereafter. 
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1.6.1. Diet-induced alterations in mitochondrial membrane lipid 
composition 
 
Many studies have reported the influence of diet on mitochondrial membrane lipid 
composition [128-130]. It is well accepted that the dietary fat source deeply influences 
not only the lipid composition, but also several biochemical parameters in 
mitochondrial membranes [130, 131]. Evidences of the influence of lipid content on 
mitochondrial function have been gathered from a number of studies where dietary fat 
manipulations induced changes of mitochondrial membrane lipid composition. Some of 
these studies suggest that alterations of mitochondrial membrane lipids promote 
changes on the physical properties of mitochondrial membranes [132-136] as well as 
alterations on mitochondrial respiration [129, 137-141], ROS production [142] and 
Ca2+-induced MPT [143]. 
A substantial amount of these studies shows how diet manipulation can affect 
mitochondrial membrane fatty acid composition in a number of tissues from a variety of 
animals [129, 134, 144-148]. Indeed, changes of the fatty acid composition of 
mitochondrial membranes are easily induced by diet manipulation, although those 
changes could be counteracted by endogenous control. For example, when no 
polyunsaturated fatty acid (PUFA)-containing diets are consumed, changes in 
unsaturation of tissue lipids are buffered by the incorporation of endogenously 
synthesized PUFA [149]. 
The promptness with which dietary treatment can influence mitochondrial membrane 
lipid composition has been reported. A period of 3 days was shown to be enough to 
achieve changes on mitochondrial lipid composition by dietary manipulation [150]. 
Some studies reported that the changes promoted in the fatty acid composition of 
phospholipids are rapid but also reversible [134, 135]. 
Early works on the impact of diet on mitochondrial membrane lipid composition and 
function were performed in the context of dietary fat deficiency. Some of these studies 
reported a significant decrease in essential fatty acid content in mitochondria isolated 
from rats fed a fat-free diet [151]. Johnson and Ito [152] determined the fatty acid 
composition of liver mitochondrial phospholipids from rats rendered deficient in 
essential unsaturated fatty acids and found marked reductions in the amounts of linoleic 
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and arachidonic acids esterified at the β-position of ethanolamine-, inositol-, and choline 
glycerophosphatides. Both cyt c oxidase activity and endogenous respiration in liver 
mitochondria of rats fed a fat-deficient diet were shown to be significantly higher than 
those of mitochondria from control animals [153]. Increased substrate oxidation [154, 
155] and partial uncoupling of oxidative phosphorylation [156-158], were also found in 
liver homogenates and isolated liver mitochondria from rats fed lipid-free diets. In this 
context, it has also been reported that long-term calorie restriction (an intervention that 
has consistently been shown to increase maximum lifespan) increases mitochondrial 
linoleic acid content [142, 159, 160] and decreases the content in docosahexaenoic acid 
[159, 160]. 
A significant amount of studies also reported the specific susceptibility of CL, the 
characteristic phospholipid of mitochondria, to undergo changes in terms of fatty acid 
components [129, 161-165]. Decrease of CL susceptibility to peroxidation has been 
proposed as a primary target for the discovery of antiapoptotic drugs acting before the 
point of no return, whose mode of action consists of inhibiting the activity of cyt c/CL 
peroxidase complexes [166]. Therefore, dietary approaches may prove useful when 
attempting to regulate apoptosis, via alterations in CL acyl chain composition. 
Another topic that has deserved a significant amount of interest is the dietary effects of 
PUFA. PUFA-enriched diets were shown to increase the content of these fatty acids in a 
variety of membranes, including mitochondrial membranes [132-135, 142]. On the 
other hand, a consequence of PUFA deficiency in diet is a large rise in the content of  
palmitoleic and oleic acids (monounsaturated fatty acids), concomitant with a decrease 
in the linoleic acid found in total phospholids and in CLs [158, 167]. 
There is some controversy regarding the susceptibility of cellular and subcellular 
membranes from different tissues to diet-induced changes in terms of the fatty acid 
content. Some studies point the liver and heart as organs whose cell membranes are 
more susceptible to diet-induced fatty acid composition changes than those from the 
brain [129, 146], whereas other studies consider the liver and skeletal muscle cell 
membranes as being more susceptible to changes than those from the heart [131]. The 
liver has also been reported as being more resistant to dietary changes and ageing than 
the heart and skeletal muscle [168]. 
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Reports of diet-induced changes in the relative proportions of phospholipids of 
mitochondrial membranes are much scarcer than those reporting changes in fatty acid 
composition. However, some studies reported changes in the PC/PE molar ratio [161] 
and an increase of the content of PC and CL in mitochondrial membranes [135, 169]. A 
diet containing 20% high-erucic acid rapeseed oil showed to modify the relative 
proportions of phospholipid classes, in rat heart mitochondria [135]. Rats fed this diet 
for 12 or 23 days showed a significant PC enrichment in heart mitochondrial 
membranes. 
 
1.6.2. Apoptosis-induced alterations in mitochondrial membrane lipids  
 
Changes in mitochondrial lipids during apoptosis have also been reported (Fig. 4). The 
increase in DAG, monolysocardiolipin (MLCL), and phosphorylated PI contents was 
reported in mouse liver mitochondria. On the other hand, CL and linoleic acid-
containing PC (LPC) were found to decrease, with the same trend observed in 
mitochondria from other origins [170]. 
After apoptosis induction, the earlier lipid changes observed appear to reflect a 
deficiency in the biosynthesis of PC, with impact in the remodeling of CL, since it 
primarily requires PC species as acyl donors. An increase in MLCL is often 
concomitantly found with the initial loss of CL [171]. The content in lysolipids (C16:0 
and C18:1 lysoPC) increases during these early stages of the apoptotic process [172] 
and may play a crucial, yet largely unexplored role in facilitating the action of the pro-
apoptotic proteins Bax and Bak and the onset of OMM permeabilization [170]. CL 
peroxidation and other lipid changes are observed in mitochondria upon apoptotic 
stimuli. Those changes were proposed to favour the OMM permeabilization and the 
subsequent release of apoptogenic factors into the cytoplasm. During apoptosis, there is 
a decrease in CL content in the IMM accompanied by an increase in the OMM, where 
CL can reach up to 40% of its total content [166]. The remaining 60% of CL becomes 
almost symmetrically distributed between the two leaflets of the IMM [173]. CL 
translocation to the OMM will result in increased association with cyt c. The complex 
cyt c/CL holds a catalytic peroxidase activity selectively targeted towards CL, and this 
oxidation process mediates mitochondrial release of pro-apoptotic factors [166]. 
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Fig. 4: Membrane lipid alterations taking place during apoptosis (CLim: immature CL; 
MLCL: MLCL: monolyso-CL; CLper: peroxidized CL). Prohibition sign indicates a step 
putatively compromised during the development of the apoptotic process. 
 
GD3, a ceramide-based glycolipid, has been reported to accumulate during apoptosis in 
mitochondria, where it is supposed to trigger specific events involved in the 
apoptogenic program by interacting with mitochondrial raft-like microdomains [174]. In 
fact, GD3 was shown to be more abundant in mitochondrial lipid rafts upon Fas/CD95-
mediated apoptotic signals, forming well-ordered structures connected to the internal 
mitochondrial cristae in mitochondria [175]. Upon pro-apoptotic stimuli, a number of 
mitochondrial proteins has been shown to converge to lipid rafts, such as ATP synthase, 
VDAC-1, VDAC-2 [176] and hFis [177], and raft-like mitochondrial microdomains 
have been proposed as contributing to apoptosis-associated modifications and late 
apoptogenic events [178]. GD3 was considered as an actual structural component 
involved in the formation of the MPTP, by contributing to the formation of a 
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multimolecular complex that includes VDAC-1, Bcl-2 family and fission proteins, such 
as hFis [177]. On the other hand, upon CD95/Fas crosslinking, Bax, Bak, caspase-8 and 
tBid are also recruited to GD3-enriched mitochondrial raft-like microdomains [105, 
175]. Therefore, GD3 has been proposed as playing a crucial role in the context of MPT 
induction and cyt c release and subsequent cell death promotion [175].  
Finally, the levels of mitochondrial ceramide have been shown to increase prior to the 
onset of apoptosis, leading to increased permeability of the OMM as consequence of 
formation of ceramide channels in this membrane [125]. Moreover, the ceramide 
generated in the OMM of mammalian cells was suggested to form functional platforms 
into which Bax inserts, and subsequently oligomerizes and forms pores itself [179]. 
Therefore, ceramide was proposed to act as a membrane-based stress calibrator, 
mediating membrane macrodomain organization across the plane of OMM. 
 
1.6.3. Disease-induced alterations in mitochondrial membrane lipids 
 
Several pathological conditions have been proposed to promote changes in 
mitochondrial lipid composition, which may be implicated in disease progression. 
Adjuvant arthritis was found to induce alterations in phospholipid and fatty acid 
composition of rat heart mitochondrial membranes as well as in their membrane fluidity 
[180]. Accumulation of chol in mitochondria may be a key step in the progression of 
some conditions, including steatohepatitis, carcinogenesis and Alzheimer disease [90]. 
Alterations associated with CL content also play an important role in a disease context. 
Reduced CL levels (the most frequently reported pathological alteration regarding this 
lipid) [181], CL oxidation and/or alteration of its molecular composition have been 
associated with mitochondrial dysfunction in multiple tissues in several 
physiopathological conditions, including ischaemia/reperfusion, different thyroid states, 
diabetes, heart failure and Barth syndrome [182-186]. A loss of CL in heart 
mitochondria following ischaemia and reperfusion has been described in the early 1980s 
[187, 188], and has since been well documented in a variety of tissues. Regarding 
thyroid hormone behaviour, an increase in mitochondrial CL content in rat heart [189-
191] and liver mitochondria [192] was found to be induced by hyperthyroidism as well 
as an increase in the activity of multiple CL-dependent mitochondrial proteins and 
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processes. Conversely, drug-induced hypothyroidism results in a marked loss of CL 
content and CL-dependent protein function [193].  Recent reports indicate a reduction 
of mitochondrial CL levels and alterations of CL acyl chain remodeling, resulting in 
increased incorporation of the highly unsaturated docosahexaenoic acid in the hearts of 
streptozotocin-treated diabetic mice [194, 195]. Whether these specific CL alterations 
influence the development or progression of diabetic cardiomyopathy remains 
unknown.  CL alterations have also been reported as being implicated in heart failure. A 
reduction in the linoleoyl content of CL extracted from heart mitochondria was reported 
in rats which underwent a rapid pressure-overload hypertrophy and failure by chronic 
aortic banding [196, 197]. A reduction of heart CL content was also reported during the 
progression of heart failure in cardiomyopathic hamsters. The authors of this report 
ascribed this event to a reduction of the diacylglycerol content in heart and impaired 
phospholipid biosynthesis [198]. Barth syndrome is a cardioskeletal myopathy in which 
patients exhibit not only a decrease of CL content [199], but also alterations in CL 
remodeling/maturation, as reflected in impaired incorporation of linoleic acid into CL 
[200], and a specific decrease in tetralinoleoyl-CL [201] in a variety of tissues. 
A recent study also provides intriguing evidence for a potential role of CL alterations in 
Parkinson’s disease [202]. Mice lacking α-synuclein exhibited a 22% reduction in CL 
mass in the brain, a 25% reduction in CL content in n-6 PUFAs (including 18:2) and a 
51% increase in the CL content in saturated fatty acids. A 23% reduction in PG (a CL 
precursor) was also detected, without any changes in the content of other brain 
phospholipids or mitochondrial density, suggesting that the CL biosynthesis pathway 
should have been selectively impaired. 
A significant decrease of CL mitochondrial content and a relevant increase in the level 
of peroxidized CL was reported in non-alcoholic fatty liver disease. These changes in 
CL content were related to the decrease in complex I activity found in liver 
mitochondria from rats to which this disease was diet-induced, since the activity of 
complex I was completely restored to the level of control livers by exogenously added 
CL. Moreover, the effect of exogenous CL was not reproduced by other phospholipids 
nor by peroxidized CL [203]. 
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1.6.4. Aging-induced alterations in mitochondrial membrane lipids  
 
A decrease of CL content has been hypothesized to contribute to age-related decline in 
mitochondrial function reported in a variety of tissues [204]. A selective reduction of 
CL content with aging is however controversial, some studies reporting this event in rat 
heart and liver mitochondria [205, 206], while others report no age-related decline in 
CL in rat heart mitochondria [207]. However, CL remodeling seems to occur with 
aging, leading specifically to an increase in the content of highly unsaturated fatty acids, 
namely arachidonic and docosahexaenoic acids, and a decrease in linoleic acid content 
[208]. Similar changes were not observed in PE or plasma unesterified fatty acids, 
suggesting specificity of these effects to CL. 
 
1.6.5. Alteration of mitochondrial membrane lipids by genetic 
manipulation 
 
A group of experiments have been performed, modifying mitochondrial membrane 
composition by genetic manipulation (Fig. 3). CL has represented a common target for 
these manipulations, given its involvement in a substantial amount of physiological 
processes taking place at mitochondria. 
The topic of the importance of CL in mitochondrial function was given a boost when a 
yeast strain lacking the enzyme CL synthase was successfully produced [209]. Initial 
work with this mutant showed reduced activities at different mitochondrial levels, such 
as oxidative phosphorylation and protein import. Also, mitochondria isolated from a 
crd1∆ yeast strain, which lacks the enzyme CL synthase (Crd1) and thus CL, were 
shown to display reduced supercomplex stability [210], implying CL as a crucial player 
in the dynamic association of these molecular assemblies. Another study involving 
∆taz1 yeast mutants with defective CL transacylase (taffazin) showed the presence of 
modified CL containing fatty acids with altered chain length and a different degree of 
unsaturation on position C2 [211], resulting in a reduced stability of yeast respirasomes. 
Some genetic studies were also conducted in mammalian cells showing for example that 
mutations in PGP synthase depleting PG and CL pools, resulted in altered mitochondrial 
structure and function [212, 213]. Another study showed that mice null for calcium-
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independent phospholipase A2γ (iPLA2γ) display a reduction in myocardial CL content 
accompanied by alteration of the relative proportions of CL molecular species, with a 
decrease in tetralinoleoyl-CL content [183]. The alterations in mitochondrial CL taking 
place in mice lacking α-synuclein have already been discussed in the context of 
Parkinson’s disease [202]. 
Finally, a study where CL levels were manipulated in HeLa cells by knocking down CL 
synthase using RNA interference showed that the decrease in CL content was 
accompanied by a significant increase in the presence of its precursor, PG [214]. The 
decrease of CL content would result in an increased resistance of cells to apoptosis, by 
limiting CL oxidation [214]. 
 
1.7. Mitochondrial membrane lipid composition and 
structure as a sensor of cell health or disease 
 
A great part of cell physiological processes depends, fully or at a given step, on 
membranes, where an important interplay between membrane lipids and proteins takes 
place [215]. The concept of biological membranes as passive entities just assuring a 
permeability barrier and constituting a support for proteins, which would diffuse freely 
in the plane of the lipid bilayer, has been progressively abandoned. In vitro assays have 
shown that a single phospholipid species would be sufficient to define a permeability 
barrier for the cell; also, a mixture of a few lipids could provide an adequate milieu for 
protein assembly and function in a variety of catalytic processes [216]. On the other 
hand, evidences have been accumulated highlighting membrane lipids as being 
heterogeneously distributed in cell membranes and as participating actively in cell 
physiology [215, 217, 218]. Such evidences are also valid for mitochondrial 
membranes. The performance of the IMM and the activity of proteins associated with 
this membrane are largely influenced by IMM lipid composition and structure, 
ultimately depending on dynamic interactions between IMM lipids and proteins [126], 
as will be described in more detail in the following section. Therefore, local adjustments 
of membrane lipid composition (including alterations in the content of chol, PUFAs, or 
lipid metabolites such as ceramides) may constitute an economic way by which cells 
control the activity of a wide range of membrane proteins in a seemingly non-specific 
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manner [219]. On the other hand, lipids may play a crucial role in a 
toxicological/pharmacological context. For full appreciation of these issues, it is 
necessary to have in mind how lipids or membrane lipid domains of different 
composition and phase regulate protein function. Two interdependent aspects should be 
considered when approaching lipid-protein interactions and their repercussions in cell 
physiology: a) how the lateral and transverse asymmetries of the lipid bilayer affect 
protein association to the membrane system; b) how the physical properties of the lipid 
bilayer in specific domains modulate, and are in turn modulated by the conformational 
dynamics of membrane-embedded proteins, and which consequences this dynamic 
interplay holds in membrane-associated cell processes. 
Regarding the first aspect, accumulating knowledge about the role of protein-lipid 
interactions in determining membrane protein topology derives greatly from the 
identification of an increasing number of proteins, which show different preferences for 
being localized in rafts or non-raft lipid domains. Protein-lipid charge interactions have 
also been considered to explain protein topology in membrane systems. A review 
regarding this issue and its implications in a disease context can be found in an 
interesting work by Bogdanov and colleagues [220]. 
Concerning the influence that the physical state of the membrane exerts on the activity 
of integral proteins, numerous examples can be found in literature and various 
conceptual models have been proposed to explain it. Although fluidity has been, and 
remains being, the most evoked membrane property affecting the activity of a great deal 
of membrane proteins, including enzymes [221, 222], channels [223] and receptors 
[224], in the last two decades the focus has been shifted to other collective physical 
properties, such as bilayer thickness or intrinsic lipid curvature [225]. A review of 
Lundbaek et al. [219] provides an exhaustive list of lipid bilayer properties which have 
been used to describe the role of lipids in protein function regulation. Extensive research 
efforts have been recently expended to select proteins, which could be easily used as 
probes for studying and discriminating the lipid-mediated mechanisms underlying 
protein activity regulation. Gramicidin channels have been used with this purpose, 
allowing to discriminate the influence of monolayer curvature and bilayer elastic moduli 
on the functioning of bilayer-spanning proteins [219]. Bilayer-incorporated gramicidin A 
channels constitute an example of a bilayer-spanning protein (generated by trans-bilayer 
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association of two β6.3–helical subunits) whose function (ion-conducting channel) has 
been considered to be regulated by hydrophobic coupling between the protein 
transmembrane segments and the bilayer hydrophobic core. According to the 
“hydrophobic coupling model”, the thickness of the bilayer constitutes an allosteric 
regulator of membrane protein function [225]. This model postulates that a mismatch 
between the length of the transmembrane segments of the protein and the hydrophobic 
thickness of the bilayer is energetically unfavourable and can therefore have a strong 
influence on the conformational equilibrium of membrane proteins. However, 
hydrophobic mismatch has also repercussions in the physical properties of lipids, 
especially those in the immediate vicinity of protein membrane-spanning segments. 
Thus, lipids may adopt non-equilibrium conformations, stretching or disordering (and 
then shortening) their acyl chains, in order to closely match the hydrophobic segments of 
proteins, an event that does not occur without an energetic penalty. Therefore, any 
condition contributing to attenuate or exacerbate the energetic cost of bilayer 
deformations may promote alterations of the conformational behaviour of membrane-
embedded proteins. Such conditions include those resulting from lipid composition 
changes or from incorporation of foreign compounds that may induce alterations of 
bilayer physical properties (e.g. thickness, elastic compression and bending moduli). 
Changes in lipid composition with repercussion in bilayer physical properties include 
chol or PUFA contents, which have been shown to regulate a wide range of membrane 
proteins by the aforementioned mechanism [219]. Among the amphiphiles whose 
toxicological/pharmacological effects have been related with the induction of 
hydrophobic mismatch are anaesthetics [226, 227]. The role of lipids in the mechanisms 
through which alcohols and anaesthetics exert their action in the central nervous system 
(CNS) has been the focus of a long-standing debate. Recent hypotheses propose that 
alterations in the lateral pressure profile of the lipid bilayer [228, 229], interference with 
the hydrogen bond network in the water-lipid interface [230] and/or hydrophobic 
mismatch [226] could interfere with the conformational flexibility of membrane-
spanning critical proteins of neuronal cells, ultimately leading to the effects of those 
compounds on CNS. Hydrophobic mismatch can also mediate protein-protein 
interactions, with predictable functional implications. Proteins exhibiting a hydrophobic 
mismatch of the same sense, hence imposing the same kind of deformation to the 
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adjacent lipids, are prone to aggregation [231], whereas proteins having hydrophobic 
mismatch of opposite sense may repel each other [232]. Hydrophobic matching issues 
may also be relevant for the distribution of transmembrane proteins between raft and 
non-raft domains [233], since the bilayer in those domains shows significant thickness 
differences due to the conformational order of lipid acyl chains (ordered versus 
disordered, respectively). 
Another important membrane property is the propensity to form non-lamellar phases 
(particularly, cubic and inverted hexagonal phases), since these structures or their 
intermediates have been shown to play a role in fusion and fission processes that take 
place in cells [234], as well as in the recruitment of proteins involved in signal 
transduction [217, 235]. Phenomena such as the insertion of peptides or binding of 
peripheral proteins and the translocation of molecules across the lipid bilayer or from a 
leaflet to the other have been suggested to be driven by a transient and localized 
destabilization of bilayer structure [236]. 
Non-bilayer phases have been proposed to be present at the MCS’s, where the MPTP is 
thought to be formed [237]. Prominent examples of mitochondrial non-bilayer lipids 
include CL (which forms HII phases in the presence of Ca2+) [238-240] and unsaturated 
PE [241]. Decreases in mitochondrial PE and CL contents were reported to result in 
abnormal mitochondrial morphology [242-245] and frequent generation of respiratory 
deficient mitochondria [246, 247]. 
Studies with reconstituted systems have shown that the activity of a great diversity of 
proteins (Ca2+-ATPase, manosyltransferase II, protein kinase C) are favoured by the 
presence of lipids displaying propensity to form non-lamellar phases such as hexagonal 
and cubic phases [248-250]. The same studies have evidenced that, rather than the global 
formation of non-lamellar phases, the increased propensity for the generation of these 
phases associated with an intrinsic curvature-stress field in the bilayer is the responsible 
for favouring protein activity [251]. Regarding mitochondrial function, VDAC gating 
was proposed to be regulated by changes in the presence of non-lamellar lipids [252], PE 
and CL, which were found to alter VDAC conformational equilibrium, promoting 
shorter closed states. This fact suggests a coupling between the mechanical pressure 
exerted in the hydrocarbon lipid region by non-bilayer lipids and VDAC channel gating. 
Interestingly, VDAC is believed to be more concentrated at the MCS’s [253, 254], 
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which are enriched in CL [97, 104].  Therefore it has been proposed that specific lipid 
composition of the OMM and/or MCS’s might influence mitochondrial OMM 
permeability by regulating VDAC gating. ATP-induced membrane potential generated 
by inverse activity of the H+-ATP synthase was also shown to be enhanced by increasing 
the content in the non-bilayer phospholipid PE [251]. 
For certain proteins and associated functions, more important than a specific lipid phase 
(lamellar or non-lamellar, ordered or disordered) is the membrane microstructure, i.e. the 
maintenance of a dynamic equilibrium between lipid domains with different composition 
and phases accompanied by a network of interfacial regions. A paradigmatic example of 
a protein whose function depends on these circumstances is the phospholipase A2 [255-
257]. Both experimental and simulation studies have shown that the catalytic activity of 
this enzyme requires a dynamic membrane structure displaying a high level of lateral 
heterogeneity. Therefore, this enzyme has been proposed, similarly to gramicidin A, as a 
molecular probe of a membrane lipid-driven mechanism of protein activity regulation 
[219]. Phospholipase A2 would constitute a sensitive probe for membrane micro-
heterogeneities allowing identifying membrane-active compounds whose 
pharmacological/toxicological action is mediated by promotion of lipid rearrangements 
in the bilayer and the creation of lateral phase separation. 
On the basis of these considerations and in respect to mitochondrial membranes, we 
emphasize that, although many studies have proposed an adequate level of membrane 
fluidity as being essential for mitochondrial processes, such as oxidative 
phosphorylation involving IMM enzymes, ion pumps and electron transporters [133, 
258-260], the current state of knowledge allows us to state that other physical 
mechanisms should modulate those events. Fluidity is a very ill-defined property, whose 
operational meaning depends on the technique used for its determination. Very often, the 
influence of membrane fluidity on protein function is deduced on the basis of alterations 
of membrane lipid composition (frequently regarding the chol content and the 
unsaturation level in phospholipid fatty acid composition) and evaluation of the phase 
behaviour of artificial membrane models mimicking the lipid composition of native 
membranes. Techniques such as differential scanning calorimetry (DSC), 
spectrofluorimetry (e.g. fluorescence anisotropy) and electron spin resonance (EPR) 
have been widely used.  The thermodynamic properties of phase transitions (provided by 
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calorimetric techniques) and fluidity related spectroscopic parameters (provided by 
fluorescence or EPR probes), as evaluated in aqueous suspensions of synthetic lipids or 
membrane lipid extracts, have been used to deduce the physical behaviour of native 
membranes. Two aspects should be taken into consideration in this type of rational 
reasoning. Firstly, we have to be aware that membrane models cannot reproduce the real 
structure of biomembranes, and fluidity probes as well as calorimetric approaches only 
report the average behaviour of the membrane lipid population; secondly, slight fluidity 
changes or subtle shifts of phase transition temperatures may not have significant 
functional repercussions by themselves, at least when affecting the bulk lipid phase. 
However, the emergence of membrane lipid heterogeneities, alterations of the 
hydrophobic coupling between specific proteins and their lipid environment (for instance 
as a result of trans-gauche isomerisation increase), or alterations of the pressure profile 
across the bilayer in limited membrane domains, could be the basis of functional effects 
hardly assigned to the fluidity alterations detected by conventional techniques. 
Overall, data regarding alterations of membrane lipid organization and structure 
constitute the most extensively used way to identify membrane lipid-mediated 
toxicological/pharmacological effects exerted by foreign molecules. The best 
experimental approach will be the one based on data provided by a wide range of 
biophysical techniques and membrane models. In this regard, complementary 
information could be gathered to support hypothesis concerning the complex 
mechanisms by which drug-membrane lipid interactions modulate cell function. 
Theoretical models, such as those provided by computer-simulation techniques, could 
also reinforce experimental data and help in their interpretation. 
 
1.7.1. Mitochondrial membrane lipids in cell life 
 
Mitochondrial membrane lipids have been involved in a number of processes as diverse 
as protein biogenesis, energy production, membrane fusion and apoptosis [84]. Ever 
since the finding of a large concentration of lipid associated with respiratory enzymes 
[261] attention has been paid to the role of lipid-protein interactions in mitochondrial 
membranes. PC, PE and CL were found to be required for the assembly of the 
mitochondrial respiratory system [262, 263]. In fact, purified preparations of 
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mitochondrial electron transfer complexes were isolated as lipoprotein complexes and 
the extraction of phospholipids from the lipoprotein complexes revealed an overall 
phospholipid composition reflecting that of the IMM. The phospholipids found were 
predominantly CL, PC, PE, but lower amounts of neutral lipids and PI were also found 
[263]. 
In vitro assays showed that PE was specifically required for reconstituting complex III 
into vesicles capable of respiratory activity [264] and optimal respiratory control of cyt 
c oxidase is only achieved in vesicles containing negatively charged lipids [265, 266]. 
CL is required for the structural integrity of NADH:ubiquinone oxidoreductase 
(complex I), playing a crucial role in its functionality [267]. PC and PE also seem to 
determine the catalytic activity of this complex [267]. These phospholipids are more 
weakly bound to complex I than CL, being able to exchange with PC and PE in ion-
exchange buffers, and also to substitute each other, although a non-transitory loss of 
these phospholipids leads to irreversible functional impairment. 
Additional evidence of the influence that mitochondrial membrane lipids hold on energy 
production have been provided by studies addressing dietary fat manipulations of the 
lipid content of mitochondria. Dietary-induced changes in mitochondrial membrane lipid 
composition were reported to alter the activities of complexes III [138], IV [129, 138], 
and V [138, 140] as well as the amount of CoQ in mitochondrial membranes [268, 269]. 
Diet fat content, as well as the ratio of dietary polyunsaturated/saturated fatty acids, and 
the fatty acid chain length have all been shown to alter H+-ATPase activity [140]. Cyt c 
oxidase and succinate-, butyrate-, and glutamate-dehydrogenase activities were reported 
to be perturbed by fat deficiency in rats [270, 271]. 
CL, the trademark phospholipid of mitochondria, has been implicated in numerous 
physiological processes taking place in this organelle. CL molecules have been found in 
the crystal structures of ANT and the respiratory complexes III and IV, where that lipid 
has been proposed to fulfill important structural roles [272-274]. CL, which is 
preferentially located in the IMM, has been shown to be essential for fundamental 
processes mediated by a number of IMM proteins [275]. Although not strictly required 
for oxidative phosphorylation, CL favours optimal activity of respiratory complexes I 
[267, 276], III [272, 276, 277], IV [278, 279] and V (ATP synthase) [280]. Furthermore, 
CL seems to facilitate the association and stabilization of respiratory chain complexes 
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into large supercomplexes [281, 282], the association between complexes III and IV 
being destabilized in mitochondria lacking this phospholipid [283, 284]. Moreover, CL 
is suggested to function as a proton sink, restricting pumped protons to CL-enriched 
domains in the outer leaflet of the IMM, thus providing the structural basis for the ∆Ψ 
and supplying protons for ATP synthase activity [285]. CL has been shown to have two 
pK’s. A low pK1 (1.04), was known for a long time [286]. A second pK was later shown 
to exist [287] which required the presence of a free hydroxyl group on the connecting 
glycerol. The determination of this pK2 required the headgroup to be stabilized by two 
high-energy H-bonds between the phosphate groups and that free hydroxyl group. In 
order to establish the so-called bicyclic headgroup conformation, one phosphate group 
must pick up a proton from solution which remains delocalized between the two 
phosphates, forming a “resonance-stabilized structure”. When in solution, CL is thought 
to have a different conformation in the phosphate region than it has in bilayers, which 
does not favor the formation of the byciclic conformation, which made it impossible to 
detect the pK2, until experiments in bilayers were conducted. Therefore, in a 
physiological mitochondrial context, CL should be able to promote a high concentration 
of protons in the headgroup surface, while decreasing ∆pH as a component of the energy 
in the ∆µH+, by sequestering protons. In fact, it was shown that proton movement along 
F0 during the ATP synthesis is actually driven by ∆Ψ rather than ∆pH [288, 289]. 
Interestingly, the stability of the resonance-stabilized structure appears to depend on CL 
balanced chain symmetry to stabilize the two H-bonds between phosphate groups and 
the hydroxyl group in the glycerol. In fact, an imbalance in the length of the pair of 
chains on the two sides of the headgroup was proposed to disfavor the resonance 
structure [290]. 
CL is also required for optimal activity of a number of mitochondrial anion carriers 
such as ANT [291, 292], and carnitine–acylcarnitine, citrate, phosphate, pyruvate and 
tricarboxylate carriers [293-296], and to the assembly and function of TIM (protein 
translocase of the IMM) and TOM (protein translocase of the OMM) [126]. Given the 
large amount of CL-binding proteins in the IMM, it was even suggested that most (if 
not all) proteins of this membrane are associated with CL molecules [113]. 
An interesting final observation in yeast is that CL has also been shown to affect 
cellular processes which were not previously associated with mitochondrial function, 
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including cell wall and vacuolar biogenesis [297, 298], hence extending its area of 
influence to extra-mitochondrial levels. A general scheme is provided in Fig. 5 
emphasising some of the aforementioned lipid-protein associations in mitochondrial 
membranes, which have been proposed as playing an important functional role. 
 
Fig. 5: Mitochondrial membrane proteins for which a proper lipid environment is 
necessary. The phospholipids for which physiological interactions with mitochondrial 
membrane proteins have been reported, or those which have been pointed as being required for 
specific mitochondrial enzyme optimal activity are shown in the picture.  
 
1.7.2. Mitochondrial membrane lipids in cell death 
 
1.7.2.1 Cardiolipin and cytochrome c as partners in cell death dances 
 
The mitochondrial hemoprotein cyt c holds several cellular functions, but the best 
characterized regards its role in mitochondrial electron transport, as an effective shuttle 
of electrons between mitochondrial respiratory complexes III and IV, and in 
programmed cell death (Fig. 6), by interacting with several proteins and forming the 
apoptosome [299]. High relevance has also been given to the interaction of cyt c with 
two anionic phospholipids, namely mitochondrial CL, and the plasma membrane PS 
[299]. Cyt c/CL complexes normally represent only a small portion of both cyt c (about 
10-15%) and CL (2-3%) [173, 300]. Under conditions promoting oxidative stress, cyt c 
can act as an anionic phospholipid specific oxygenase [299], oxidizing CL [301]. In 
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fact, the binding of cyt c to anionic phospholipids causes a structural alteration in the 
protein converting it from an electron shuttle into a potent peroxidase [119].  Both 
peroxidation and hydrolysis of CL occur during apoptosis, therefore it is thought to play 
an important role during the process, particularly in the release of pro-apoptotic factors 
[173, 299, 302]. Additionally, a significant enrichment of the outer leaflet of the IMM 
as well as of the OMM with CL during apoptosis sets the stage for its binding to cyt c 
and production of the CL/cyt c complex with peroxidase activity. The changes in CL 
membrane distribution during apoptosis are likely associated with its interactions with 
tBid at the MCS’s, contributing to mitochondrial cristae reorganization and to the 
release of pro-apoptotic factors, such as cyt c [303, 304]. CL has also an important role 
in the anchoring of caspase-8 to mitochondria during death receptor-induced apoptosis 
[305].  
Therefore, in the context of apoptosis, the role of cyt c changes from an electron-carrier 
in the respiratory chain to a CL-specific peroxidase in mitochondria; consequently, 
oxidized CL binds poorly to cyt c resulting in cyt c release from mitochondria [306, 
307], making it available to apoptosome constitution.  
 
 
Fig. 6: CL and cyt c interactions. At physiological conditions (A), interactions of cyt c with 
the mitochondrial specific phospholipid CL result in CL/cyt c complex formation which work as 
a precise and powerful oxidant. Upon stress stimulus (B), the CL/cyt c complex acts as a CL-
specific peroxidase, oxidizing CL. Therefore, under oxidative stress, the binding of CL to cyt c 
converts it from an electron (e-) carrier to a CL-specific peroxidase, resulting in cyt c release to 
the IMS and oxidized CL product accumulation in the mitochondrial membranes. In addition, 
pro-apoptotic Bax may translocate from the cytosol to the OMM, assembling into large 
multimers, which allow the release of IMS proteins, such as cyt c. 
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1.7.2.2. Mitochondrial lipid rafts in the boundary between life and death 
 
Lipid rafts are heterogeneous microdomains of plasma membrane that contain high 
concentrations of chol and sphingolipids [308-310]. In response to intra or extracellular 
stimuli, lipid rafts can include or exclude proteins to variable extents [309]. During the 
induction of apoptosis, these “platforms” recruit and concentrate apoptotic signaling 
molecules at the plasma membrane, such as CD95/Fas and other death receptors (e.g. 
TNF related apoptosis inducing ligand, TRAIL), fas-associated protein with death 
domain (FADD), procaspases-8 and -10, Bid, Bad [309], JNK and apoptosome 
constituents [311]. This event, which involves the clustering of apoptotic molecules in 
lipid rafts as a general process involved in apoptosis, has recently been coined as 
CASMER (acronym for cluster of apoptotic signaling molecule-enriched rafts). 
CASMER represents a novel lipid-raft-based supramolecular entity, which acts as a 
death-promoting scaffold where death receptors and downstream signaling molecules 
are brought together, thus facilitating protein-protein interactions and the transmission 
of apoptotic signals. This makes, for instance, cancer cells more vulnerable by 
prompting a potent apoptotic response [311, 312]. Rafts are mostly abundant at the 
plasma membrane, but can also be found in the biosynthetic and endocytic pathways 
[309]. In fact, lipid rafts have been proposed to reside within multiple intracellular 
membranes, including the endosomal system, mitochondria, the Golgi, phagosomes and 
lysosomes [313]. 
In mitochondria, raft-like domains are enriched in GD3, but show a relatively low 
content in chol [105]. Under pro-apoptotic stimulation, raft-like microdomains detected 
in mitochondria have been proposed as contributing to apoptosis-associated 
modifications and late apoptogenic events [178]. For instance, GD3 was shown to be 
more abundant in mitochondrial lipid rafts upon CD95/Fas-mediated apoptotic signals, 
interfering with the MPT induction, and leading to cyt c release and subsequent cell 
death promotion [175]. GD3 molecules seem to form well-ordered structures connected 
to the internal mitochondrial cristae in mitochondria from CD95/Fas-treated cells [175]. 
A large number of mitochondrial proteins has been identified in lipid rafts, such as ATP 
synthase, VDAC-1, VDAC-2 [176] and mitochondrial fission protein (hFis) [177], 
which are involved in the modulation of mitochondrial functions and cell fate. For 
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instance, VDAC-1 can interact with GD3 in mitochondrial lipid microdomains, 
resulting in disturbance of the MPTP and subsequent cyt c release [175]. Moreover, 
hFis was found to be concentrated in linear sucrose gradient fractions corresponding to 
mitochondrial lipid microdomains associated with GD3 resulting in interference with 
mitochondrial membrane fission events in CD95/Fas-treated cells [175]. GD3 has been 
considered as an actual mitochondrial structural component involved in the opening of 
the MPTP, by contributing to the formation of a multimolecular complex that includes 
VDAC-1, Bcl-2 family and fission proteins, such as hFis [177]. On the other hand, upon 
CD95/Fas crosslinking, Bax, Bak, caspase-8 and tBid are recruited to GD3-enriched 
mitochondrial raft-like microdomains, where CL is also present [105, 175]. 
 
1.7.3. The obscure role of mitochondrial PS 
 
PS is a minor component of membranes, only making up 2-10% of total membrane 
phospholipids [314]. However, PS still represents one of the most abundant anionic 
phospholipid in mammalian membrane systems [315]. 
Under normal conditions, PS is almost exclusively sequestered in the inner layer of the 
plasma membrane. The externalization of PS on the cell membrane may result from 
decreased aminophospholipid translocase activity [316] or activation of a Ca2+-
dependent scramblase [317]. The externalization of PS in apoptotic cells is recognized 
by macrophages, leading to subsequent phagocytosis [318]. However, the induction of 
PS exposure on cell surface is not restricted to apoptotic cells [314]; for example, the 
exposure of PS on the surface of activated platelets initiates the blood-clotting cascade 
[319, 320]. PS also becomes exposed on the outside of sperm cells during their 
maturation [321, 322]. Other processes involving PS concern the regulation of key 
proteins in the intracellular signaling system including protein kinase C (PKC) [323-
325], c-Raf-1 kinase [326, 327], nitric oxide (NO) synthesizing enzymes [328], adenyl 
cyclase [329], neutral sphingomyelinase [330],  Na+/K+ ATPAse [326], dynamin-1 
[331], as well as synaptogamin and K-Ras [314, 332]. 
Besides the plasma membrane, PS can be also found in the ER, Golgi complex and 
mitochondria [333]. However, the molar ratio of PS in the plasma membrane has been 
estimated to be around 4- and 10-fold higher than that found in the ER and 
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mitochondria, respectively [89]. As opposed to what happens in the plasma membrane, 
the mechanisms that retain PS on the luminal leaflet of the ER remain functional during 
an apoptotic insult [333]. The PS distribution in other organelles where it is less 
abundant, such as mitochondria, has been less well defined because of difficulties 
inherent to purification procedures [333]. In fact, PS topology has currently only been 
determined with certainty in the plasma membrane due to its easy accessibility [333]. 
So far, it has not been possible to exactly determine the distribution pattern of PS in 
mitochondria either in normal (is it maintained in IMM?) or under stress conditions 
(does it become exposed to cytosol or, as in ER, is it kept away from the it?). Therefore, 
the functional relevance this phospholipid holds in these particular organelles was not 
yet clarified. 
 
1.8. Mitochondria as a particularly susceptible target to 
chemical toxicity 
 
Mitochondria can represent a primary or secondary drug target, having been therefore 
pointed out as the cause for the side effects induced by many drugs and toxins [334, 
335]. This is not surprising, given the crucial role mitochondria play in cellular energy 
production, their central position in cell metabolic network and their involvement in 
several signaling pathways [336]. However, the downstream impact of drug-
mitochondria interactions is hardly appreciated due to the complexity of mitochondrial 
physiology. Certain characteristics of mitochondria, mainly concerning the high 
membrane potential (about 200 mV), the basic pH in the matrix (about 8) and the great 
membrane extension, favor the selective accumulation of xenobiotics in the matrix 
and/or the IMM, creating an efficient trap effect [337, 338]. Therefore, mitochondria 
can predictably accumulate lipophilic compounds of cationic character and weak acids 
in their anionic forms. In the latter case, the undissociated acids may penetrate the IMM 
and, once their protons are released inside the alkaline matrix, the molecules become 
trapped inside the organelle [339]. A list of some drugs with clinical interest, which 
hold mitochondria-mediated toxicity, is presented in Table I, and a summary of 
mitochondrial membrane targets involved in mitochondriotoxicity is depicted in Fig. 7. 
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Table I: Therapeutic applications, effects on isolated mitochondria and sites of toxicity 
manifestations in vivo of some mitochondriotoxic drugs with clinical relevance. 
Drug Therapeutic 
Application 
Mitochondrial effects Site of toxic 
effects in vivo  
References 
Acetaminophen Analgesic Induction of MPT Liver  [340] 
Amiodarone Antiarrhythmic Oxidative stress; complex I 
inhibitor; uncoupler 
Lung and liver  [341] 
Bupivacaine Anaesthetic Uncoupler Heart and muscle  [342] 
Chloramphenicol Antibiotic Inhibition of mDNA-encoded 
protein synthesis 
Blood [343] 
Diclofenac Anti-
inflammatory 
Uncoupler; ANT and ATPase 
inhibitor 
Liver [344] 
Doxorubicin Anticancer 
agent 
Oxidative stress Heart [345] 
Fenofibrate Hyperlipidemia ∆Ψ depolarization; complex I 
inhibitor; inhibition of state 3 
with glutamate/malate but not 
succinate 
Liver and kidney [346, 347] 
 
Flutamide Antiandrogen / 
prostate cancer 
Inhibition of state 3 with 
glutamate/malate and 
succinate; increase in state 4 
with succinate 
Liver [348] 
Nimesulide Anti-
inflammatory 
Uncoupler; induction of MPT Liver [349] 
Quinidine Antiarrhythmic; 
antimalarial 
Inhibition of  mitochondrial 
potassium channel; inhibition 
of ATPase 
Liver and heart 
(ventricular 
tachycardia) 
[350, 351] 
Tamoxifen Breast cancer 
therapy 
Uncoupler Eyes, liver and 
blood 
[352] 
Tetracycline Antibiotic Inhibition of mDNA-encoded 
protein synthesis 
Liver [353] 
Troglitazone Antidiabetic 
drug 
Induction of MPT Liver [354] 
 
Bioenergetic failure is an obvious manifestation of mitochondrial toxicity. There are 
several ways by which chemicals can affect mitochondrial bioenergetics, including 
inhibition of the respiratory chain, induction of the MPT and inhibition of substrate 
carriers, among others [335]. Inhibition of the electron flow through the electron 
transport chain is a well-defined mechanism for xenobiotics to exert their 
mitochondriotoxicity.  
NADH:ubiquinone oxidoreductase (complex I) is the complex of the respiratory system 
showing the highest susceptibility to inhibition [335], probably due to its complex 
structure. More than 60 different types of compounds are known to inhibit complex I, 
and this number is still growing. The list of inhibitors of complex I includes pesticides, 
phenolic pollutants, neuroleptics and natural neurotoxins, antihistaminic, antianginal, 
and antiseptic drugs, fluorescent dyes, and myxobacterial and other antibiotics [335]. 
Rotenone (a rodenticide) is the trademark inhibitor of complex I, but there is a 
significant number of other molecules, which are also effective inhibitors of this 
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complex (papaverine, meperidine, cinnarizine, amytal, haloperidol, ketoconazole and its 
analogs, and the so-called fibrates and some of their derivatives) [355-359].  
 
 
Fig. 7: Schematic representation of some mitochondrial targets involved in xenobiotic-
induced toxicity. I, II, III, IV, V: complexes I, II, III, IV and V, respectively; mDNA: 
mitochondrial DNA. 
 
Succinate:ubiquinone oxidoreductase (complex II), apart from being the target of 
common inhibitors usually employed in experimental studies (malonate, carboxin, 3-
nitropropionic acid), is also the target of vitamin E analogs such as α-tocopheryl 
succinate, some cis-crotonalide fungicides, diazoxide, some fluoroquinolones, 
chloramphenicol succinate, and anthracycline drugs [334, 335, 360]. 
A number of inhibitors exists also for ubiquinol:cyt c oxidoreductase (complex III), 
including the classic inhibitor antimycin A (the active constituent of the piscicide 
Fintrol) and the natural product myxothiazole [359]. Other known inhibitors include 
quinol antagonists (other than myxothiazole) like strobilurines and oudemansins, 
undecylhydroxydioxobenzothiazole (UHDBT), undecylhydroxynaphtoquinone 
(UHNQ), and similar compounds, funiculosin, quinolones such as 
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heptylhydroxyquinoline-N oxide (HHQNO), substituted phenols, and metal cations 
(namely zinc ions) [335]. The sensitivity of different organisms to particular inhibitors 
of this complex varies greatly [361-365] allowing safe application of some of these 
compounds as fungicides and antimalarial, antiprotozoan, and anticancer drugs [366-
371]. 
Inhibitors of complex IV (cyt c oxidase) can be divided in four categories [372]: (a) 
non-competitive heme-binding inhibitors (e.g. azide, cyanide, sulfide, formate and 
hydroxylamine), (b) inhibitors that compete with oxygen, such as CO and NO, (c) 
inhibitors that compete with cyt c (high molecular-weight polylysine, histones, cationic 
lysosomal proteins, protamine, and some other high molecular-weight synthetic and 
natural polycations) and (d) non-competitive inhibitors not affecting the heme groups, 
such as local anesthetics (e.g dibucaine, lidocaine, and tetracaine), phosphate ions and 
alkaline pH. 
ATP synthase (complex V) is actively inhibited by mycotoxins, such as aurovertins A-
E, leucinostatins A and B, venturicidin and ossamycin, citreoviridin, efrapeptin, and the 
more traditional oligomycins A-D [335]. Other inhibitors of complex V include 
naturally occurring flavonoids [373], propranolol [374], local anesthetics [375], 
paraquat [376], several pyrethroid insecticides [377], diethylstilbestrol [378], several 
cationic dyes [379], organotin compounds [380] and apoptolidins [360]. 
Another type of interference with the mitochondrial respiratory system and with the 
generation of transmembrane potential, in particular, results from the action of 
alternative electron acceptors that extract electrons from intermediates in the respiratory 
chain, competing with their natural substrates [359]. Compounds that act in this manner, 
bypassing sites in the chain that are essential for energy generation, include quinones 
such as doxorubicin, menadione (MEN), and paraquat [359]. 
Uncoupling of the oxidative phosphorylation also constitutes a well defined mechanism 
underlying mitochondrial toxicity, which takes place at the membrane level. The term 
“uncoupling” means that protons pumped by the respiratory complexes are not used by 
ATP synthase to produce ATP.  Uncoupler action facilitates proton migration across the 
IMM, and the resulting dissipation of the proton gradient between the IMS and the 
matrix leads to the production of heat rather than to ATP synthesis [336]. Therefore, in 
this process, the electron transport along the respiratory system and the extrusion of 
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protons by the mitochondrial proton pumps become functionally disconnected 
(uncoupled) from the ADP phosphorylation catalyzed by the ATP synthase. Uncouplers 
of the oxidative phosphorylation may act as direct protonophores (such as 2,4- 
dinitrophenol), shuttling protons back to the matrix, as ionophores, exchanging hydrogen 
ions for other mono- or divalent cations, or just by generally increasing the permeability 
of the IMM in a non-specific manner [359]. Typical examples of uncouplers include 
carbonyl cyanide phenylhydrazones (carbonylcyanide p-
trifluoromethoxyphenylhydrazone, FCCP and carbonyl cyanide 3-
chlorophenylhydrazone, CCCP), substituted phenols, trifluoromethylbenzimidazoles, 
salicylanilides and the ionophores gramicidins and valinomycin [335]. However, 
nonsteroidal anti-inflammatory drugs (NSAIDs) [359], local anesthetics [381], some 
antitumor drugs, antipsychotic, hypolipidemic, and antimycotic compounds [359] and 
various herbicides and insecticides [382-384] may also promote uncoupling of oxidative 
phosphorylation. 
The channels embedded in the mitochondrial membrane may also represent targets for 
particular drugs.  Potassium channel openers such as nicorandil and diazoxide as well as 
antidiabetic and antitumor sulfonylureas modify the activity of different mitochondrial 
channels, hence impairing their role in maintaining the electrolyte homeostasis of 
mitochondria [359]. 
A particular channel in the mitochondrial membrane, which can also constitute a target 
for drug-induced mitochondrial toxicity, is the MPTP. The opening of this mega-
channel in the mitochondrial membrane leads to mitochondria swelling and collapse of 
the ∆Ψ. Promoters of MPT include calcium, ischaemia, ROS, agonists of the 
mitochondrial benzodiazepine receptor, among others [385]. Toxicity of compounds 
such as t-butyl-hydroperoxide and valproic acid, as well as the chronic hepatotoxicity of 
diclofenac and other NSAIDs, has been proposed to be mediated by this mechanism 
[386, 387]. 
Another toxicity mechanism targeting mitochondria involves mitochondrial DNA 
(mDNA) damage by oxidation or inhibition of mDNA synthesis [388]. Unlike nuclear 
DNA, mDNA is not protected by histones and its repair is considered less efficient 
[359]. Therefore, mDNA is more likely to undergo mutations than nuclear DNA [389]. 
Furthermore, mitochondrial DNA strands are located in close proximity to sites where 
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ROS are generated. Nucleoside analogues such as fialuridine are well-known 
mitochondrial toxins, acting as substrates for mitochondrial DNA polymerase γ [388]. 
DNA polymerase γ dysfunction induces a progressive depletion of mDNA, ultimately 
interfering with the synthesis of essential proteins of the mitochondrial respiratory 
system [390, 391]. Nucleotide reverse transcriptase inhibitors (NRTIs) have also been 
proven to selectively inhibit mDNA synthesis by interfering with mitochondrial 
polymerase γ [392]. 
 
1.8.1. Mitochondrial membrane lipids as toxicological and therapeutic 
targets 
 
Mitochondrial membrane lipids, due to the role played in mitochondria-mediated 
processes, which dictate cell survival or death, constitute a susceptible target for the 
therapeutic/toxic action of drugs and pollutants. In this context, the modulation of 
mitochondrial membrane lipid composition and structure emerges as a potential strategy 
for pharmacological purposes. 
A wide range of mitochondrial membrane-associated processes, such as electron 
transport, ∆Ψ generation and oxidative phosphorylation, ROS production, MPT and 
release of pro-apoptotic proteins are, as previously described, dependent on 
mitochondrial membrane lipids. In this section, we will discuss how some of these 
processes can be impaired/modulated by membrane-active compounds, which affect the 
physical properties of mitochondrial membrane lipids. 
As previously mentioned, a common effect through which a great number of compounds 
promote mitochondrial dysfunction concerns the uncoupling of oxidative 
phosphorylation, by a variety of mechanisms. The herbicide paraquat, which constitutes 
a typical example for a redox cycling xenobiotic, seems to uncouple oxidative 
phosphorylation of rat liver mitochondria by the conjunction of several effects, such as 
lipid peroxidation, redox chain inhibition and impairment of ATP synthase activity 
[376]. Compounds whose physico-chemical characteristics confer them a protonophoric 
activity can also induce the uncoupling of oxidative phosphorylation. The majority of 
these compounds are lipophilic weak acids [335], possessing 1) bulky lipophilic 
portions, 2) the presence of an acid-dissociable group and 3) a strong electron 
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withdrawing-moiety [393, 394]. The activity of these uncouplers depends on their 
solubility in lipid membranes, and on the stability of the ionized form in the membrane. 
Such compounds can easily penetrate into the mitochondrial membranes and migrate 
through the thickness of the IMM bilayer, shuttling protons from the IMS to the 
mitochondrial matrix and, hence, promoting the dissipation of the proton gradient across 
the IMM and the collapse of ∆Ψ, eliminating the driving force for the ATP synthesis.  
It is predictable that membrane lipid composition and structure should modulate the 
protonophoric activity and efficiency of these compounds. In fact, a strict correlation 
between the uncoupling activity of substituted phenols and their physico-chemical 
properties such as hydrophobicity, acidity, and stability of the ionized intermediate in the 
membrane lipid phase has been reported, emphasizing the role that the lipid component 
of the membrane has in oxidative phosphorylation uncoupling [394]. An example of an 
uncoupler whose activity has been suggested to depend on the physical properties of 
membrane lipids is FCCP. An effective influence of lipid composition and dielectric 
constant of the bilayer on the transport of protons across membranes by FCCP has been 
proposed [395].  
Another example of membrane-mediated uncoupling activity comes from NSAIDs, a 
wide group of compounds used in the treatment of fever, pain and inflammation [396]. 
Their main action is exerted by inhibition of cycloxygenases, but besides this direct 
inhibitory effect, their propensity to induce biophysical changes in membranes has been 
considered to contribute to their anti-inflammatory action [397, 398]. In the particular 
case of nimesulide (NIM), there is a relevant amount of evidences supporting its 
protonophoric activity [344, 349, 399, 400], correlated with its lipophilicity and weak 
acid character. Additionally, this NSAID has been related with the induction of MPT 
and interference with Ca2+ homeostasis [349, 400]. Besides uncouplers, local anesthetics 
such as dibucaine, lidocaine and tetracaine, which inhibit complex IV, showed a positive 
correlation between the toxicity and the degree of lipophilicity of the molecule [336, 
401]. This fact led to the assumption that the effects of these compounds on 
mitochondrial functioning reflect a non-specific interaction of anesthetics with the IMM 
lipid bilayer in which respiratory complexes such as cyt c oxidase and other vital 
proteins are embedded [402]. 
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Table II: Mitochondria-active drugs that exert effects on the membrane lipid bilayer 
component, with repercussions for mitochondrial physiology.  
Drug Membrane effects Mitochondrial effects References 
DDE Induces concentration-dependent 
fluidizing effects into the hydrophobic 
core in the gel phase and induces a 
limited ordering effect on the outer 
regions in the fluid phase; disorders 
membranes with high cholesterol 
Inhibits complex II; decreases 
respiration and ∆Ψ 
[413, 414] 
DDT Exerts moderate disordering effects on 
cholesterol-enriched membranes; 
increases the permeability of liposome 
membranes; acts as a fluidizer of DPPC 
and egg PC bilayers. 
Decreases the RCI and ADP/O 
ratios; promotes potential 
depolarization 
[411, 423-425] 
Doxorubicin Sequesters available CL Promotes oxidative stress; 
stimulates state 4, inhibits state 3 
and decreases the RCI; induces 
MPT  
[345, 406, 409, 
426] 
Endosulfan Promotes a slight increase in the proton 
permeability either in the fluid or the gel 
phase of DPPC and mitochondrial fluid 
lipid dispersions 
Stimulates state 4 at lower 
concentrations and inhibits it at 
higher ones, whereas state 3 is 
always inhibited; decreases the 
RCI and ADP/O ratios 
[419, 420] 
Ethylazinphos Increases the passive proton 
permeability of reconstituted lipid 
bilayers, inducing phase separation; 
increases the permeability of liposome 
membranes 
Decreases ∆Ψ; stimulates state 4 
and inhibits state 3 
[418, 423]  
Lindane Destabilizes the gel phase of liposomes; 
these effects being more pronounced in 
bilayers of short-chain lipids; in DMPC 
+ DSPC mixtures interacts with the 
more fluid lipid species inducing lateral 
phase separation; increases the 
permeability of liposome membranes 
Promotes oxidative stress; 
decreases the RCI and ADP/O 
ratios 
[415, 423, 427, 
428] 
Anaesthetics Nonspecific interaction with the lipid 
phase in which complex IV is 
embedded*; affect membrane fluidity; 
alter the lateral pressure profile of the 
lipid bilayer, interfere with the hydrogen 
bond network in the water-lipid interface  
and/or promote hydrophobic mismatch 
Inhibit complex IV*; inhibit 
NADH oxidation at 
concentrations that did not affect 
respiration with succinate as the 
substrate**; affect ATP synthesis 
and the ∆Ψ***; depolarize neural 
mitochondria by inhibition of the 
electron transport chain**** 
[226-230, 402, 
429-433] 
Metoprene Broadens and shifts the main phase 
transition of DMPC liposomes to lower 
temperatures  
Decreases ∆Ψ; stimulates state 4 
and inhibits state 3 and uncoupled 
respiration; inhibits MPT 
[421, 422] 
Nimesulide Increases membrane fluidity Uncoupler; induces MPT [349, 434] 
Parathion Disturbs the gel phase of liposomes; 
orders the fluid phase either in the 
hydrophobic core or in the outer regions 
of the membrane; increases the 
permeability of liposome membranes 
Decreases the RCI and ADP/O 
ratios; decreases ∆Ψ; affects 
complexes II and V and the 
phosphate transporter  
[416, 417, 423]  
 
* dibucaine, lidocaine, and tetracaine 
** halothane, methoxyflurane, trichloroethylene, and chloroform 
*** phenols and nitrosophenols 
**** isoflurane and sevoflurane 
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Another case of drug activity in mitochondria, as exerted in the lipid moiety, is 
exemplified by the antineoplastic agent doxorubicin. Doxorubicin is a classic example of 
a redox cycling xenobiotic acting at the level of the mitochondrial electron transport 
chain. The high affinity of doxorubicin for CL accounts for its mitochondria-selective 
toxicity [403]. Thus, incubation of cardiac mitochondria with this drug stimulates state 4 
respiration, inhibits state 3 respiration and decreases the respiratory control index (RCI) 
[403]. Doxorubicin stimulation of state 4 respiration in vitro has been attributed to 
several factors, including the diversion of electrons from the respiratory chain generating 
a doxorubicin semiquinone radical intermediate, increased oxidative stress and 
mitochondrial membrane damage with consequent decrease of ∆Ψ [403, 404]. The redox 
cycling involving doxorubicin also results in oxidation of mitochondrial glutathione 
[405], induction of the MPT [406], and cardioselective oxidation of mitochondrial DNA 
in vivo [407]. On the other hand, the high affinity of doxorubicin towards CL implies 
that a number of processes depending on this essential phospholipid are compromised by 
doxorubicin-CL complexation. This is the case for the activity of the pyruvate- [296] and 
phosphate-carriers [408] and cyt c oxidase [409]. Due to the role CL plays in the 
unfolding of mitochondrial-directed precursor proteins, the presence of doxorubicin also 
inhibits the transport and incorporation of numerous nuclear-encoded proteins from the 
cytosol into the mitochondrial matrix [410]. 
Finally, there are a number of pesticides for which mitochondrial toxicity seems to have 
a strong membrane perturbation-associated component (Table II). That is the case of 
DDT (2,2-bis(p-chlorophenyl)-1,1-trichloroethane) [411, 412] and its metabolite DDE 
(2,2-bis(p-chlorophenyl)-1,1-dichloroethylene) [413, 414], lindane [412, 415], parathion 
[416, 417], ethylazinphos [418], endosulfan [419, 420] and metoprene [421, 422].  
 
1.9. Modulation of mitochondrial lipid composition as a 
therapeutic strategy 
 
Taking into account previous considerations, there are several reasons that make 
mitochondria promising targets for the action of therapeutic drugs. On one hand, they 
are entangled in cell physiology, composing a site where many decisive physiological 
processes take place and to which many others converge. This implies the presence of a 
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great variety of critical proteins, whose activity is susceptible to be regulated. On the 
other hand, mitochondrial lipid composition, although obeying a characteristic pattern, 
displays a highly dynamic behaviour, depending on the physiological or pathological 
conditions. This plasticity in lipid composition, sensitive to external modulation, may 
substantiate the emergence of interesting therapeutic applications. In fact, by 
modulating the lipid composition of mitochondrial membranes and, hence, interfering 
with mitochondrial function, it is predictably possible to regulate the balance between 
cell life and death by exerting an external influence. In this context, work aiming at 
screening the mitochondrial repercussions of diets with different fat composition may 
be instrumental to influence cell fate. Studies tentatively establishing a correlation 
between particular diets and their effects on mitochondria membrane lipid composition 
and physiology will open new trends to identify the etiology of diseases and to develop 
novel therapeutic strategies. One possibility would be to establish dietary interventions 
which counteract membrane lipid properties associated to the occurrence of several 
diseases. In fact, dietary benefits have been revealed for some pathologies, namely heart 
disease. Increasing evidences have been accumulated of a strict correlation between the 
prevalence of cardiovascular diseases in mammals and the type of lipids included in the 
diet [435-437]. Benefits provided by tuna fish and sunflower seed oils were found in 
cases of reduced ventricular fibrillation in occlusion, ventricular tachycardia and risk of 
sudden cardiac death [438] and by fish oil, in cases of reduced atherogenesis, mortality 
from coronary heart disease intimal hyperplasia and atherosclerosis [439-443]. 
Preventive effects and cardioprotective properties have also been reported for rapeseed 
oil (optimised oils) [444], including reduction of mortality rate and infarct size [445]. 
Thus, this oil has been suggested to be used as a functional supplement, aiding in stroke 
prevention and protection. Dietary benefits towards some kinds of cancer have also 
been reported, with an inverse correlation between fish oil consumption and the 
occurrence of male and female colorectal cancer [446] and breast carcinoma [446, 447] 
having been proposed. Advantages from a dietary control have also been proposed for 
type 2 diabetes [448]. Some mitochondrial fatty acid oxidation disorders may also be 
targeted by dietary intervention [449]. 
An example of how diet may represent a valid therapeutic approach is given by the 
manageable modulation of the acyl chain unsaturation in CL. In fact, CL was suggested 
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to be more susceptible to undergo acyl chain changes upon dietary manipulation, as 
compared to other phospholipid classes such as PC and PE [165]. Moreover, some 
studies revealed that tetraoleoyl-CL (TOCL) did not undergo oxidation when cyt 
c/TOCL complexes were incubated in the presence of H2O2 [166]. On the other hand, 
the enrichment of mitochondrial membranes with non-oxidizable molecular species of 
CL was proposed as a potential mechanism for protecting cells against apoptosis [166]. 
Conversely, an increase in PUFAs, propitiating the increased generation of highly 
oxidizable CL species, would make the targeted cells more susceptible to oxidative 
modification and, ultimately, to apoptotic cell death. This approach may represent an 
interesting perspective when attempting to develop antitumor strategies to overcome the 
increased resistance of tumor cells to pro-apoptotic drugs [166]. 
Taking all previous data into account, it seems fair to emphasize the relevance that 
dietary approaches may hold in a therapeutic context. The synergistic effects of diet and 
pharmacological drugs, namely mitochondrially-active compounds, could also represent 
a valid path to explore. 
Some evidences have been accumulated underlining the influence of dietary lipids on 
the action of certain membrane-active drugs (e.g. anaesthetics and alcohols) [450]. A 
correlation between diet-induced changes in membrane lipid composition and 
pharmacological effect of volatile anaesthetics such as halothane, isoflurane, 
methoxyflurane and cyclopropane has been established [451]. The authors demonstrated 
that the increased anaesthetic action in rats fed a fat-free diet was specifically reversed 
by linoleic acid supplementation. The action of the local anaesthetic tetracaine was also 
proposed to be dependent on lipid membrane composition [452]. Curcumin, a natural 
spice used for generations in traditional medicines, was proposed to indirectly regulate 
the action of membrane proteins by changing the physical properties of the membrane 
rather than acting by direct binding to proteins [453]. 
Focusing specifically on mitochondria, it was reported that the ATPase of heart 
mitochondria from animals fed diets with an high content in long chain fatty acids 
exhibited increased oligomycin sensitivity and decreased 2,4-dinitrophenol-induced 
stimulation [454]. The authors suggested that in vivo changes in the thickness of the 
lipid bilayer might alter mitochondrial ATPase activity. 
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Most drugs used with pharmacological purposes have been designed to target specific 
membrane proteins, at relatively low concentrations. However, some of these drugs 
hold side pharmacological effects at higher concentrations [455]. These less specific 
effects towards membrane-associated proteins may arise from the interaction of 
lipophilic drugs with the lipid bilayer, causing changes in their structural and elastic 
properties, and resulting in alterations of the distribution of the proteins in the plane of 
the membrane and/or in their functional conformation [225, 455-457]. The intricate 
interplay between lipids and membrane protein structure and function makes it 
reasonable to argue that lipid bilayers may influence drug action towards membrane 
protein targets also at low concentrations. The disruption of membrane lipid rafts and 
alterations of protein distribution between raft and non-raft domains have been proposed 
as ways by which drugs may modulate membrane protein activity with relative 
specificity [458]. 
Considering all data mentioned above, the use of specific diets to modulate membrane-
active drugs should seriously be taken into account in situations of either managing 
membrane-localized toxicity or potentiating treatment in a disease context. Diet 
manipulation may then represent a way to reduce the toxic outcomes brought by the use 
of some drugs. Further work is necessary in order to fully appraise the potential of 
dietary interventions to improve the chemotherapeutic activity of pharmacological 
agents. In this context, membrane lipid-mediated therapeutic strategies have been 
proposed [235], in which the molecular targets are the lipids and the structures they 
form (membrane-lipid therapy). The ultimate goal of this approach is to develop drugs 
that, by regulating membrane-lipid composition and/or structure, control the activity of 
membrane-associated proteins. It is predictable that membrane-lipid therapies could also 
be successfully used in the context of mitochondrial disease and dysfunction, due to the 
strict association of lipids such as CL with mitochondria membrane proteins and their 
involvement in mitochondrial function. Recent evidences suggest membrane-lipid 
therapies as potentially useful either by themselves or in combination with other 
therapies, to treat common pathologies, such as cancer, cardiovascular diseases, 
neurodegenerative processes, obesity, metabolic disorders, inflammation, and infectious 
and autoimmune diseases. However future studies should be addressed to determine the 
full potential of this novel therapeutic approach [459]. 
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1.10. Hypotheses of the present work 
 
The unifying hypothesis for the work present in this thesis is that the modulation of 
mitochondrial lipid composition should alter the physiology of these organelles and 
their susceptibility to drug-mediated injury. This single hypothesis was divided into four 
tandem specific sub-hypotheses: 
 
A) The toxic action of lipophilic drugs (namely FCCP, MEN and NIM) upon 
mitochondria functioning reflects, at least in part, the perturbation exerted 
by these compounds in mitochondrial membrane physical properties. 
Moreover, the nature and extent of the effects exerted by lipophilic 
compounds at the membrane level depend on physico-chemical peculiarities 
of each compound. 
 
B) An accurately established feeding protocol for rats can originate significant 
and reproducible alterations on the membrane lipid composition of rat liver 
mitochondria, with functional outcomes at the level of decisive steps in 
mitochondria-mediated physiological processes. 
 
C)  Diet-induced changes in mitochondrial membrane lipid composition can 
modulate the effects exerted in vivo by the abovementioned drugs (FCCP, 
MEN and NIM) on mitochondrial membrane physical properties and, hence, 
on mitochondrial functioning. 
 
D) Diet-induced changes in mitochondrial membrane lipid composition, 
mimicked in membrane model systems, can modulate the membrane 
binding and conformational dynamics of proteins such as cyt c. 
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1.11. Outline of the present thesis 
 
Taking into account the work hypotheses previously formulated, the experimental work 
was developed on the basis of a stepwise program, comprising the following specific 
steps: 
 
1) The effects exerted by three well known mitochondriotoxic drugs (FCCP, 
MEN and NIM) on membrane physical properties were studied using 
different biophysical approaches and a variety of membrane lipid models as 
well as isolated mitochondrial membranes (section 2.1). 
 
2) A feeding protocol was tentatively established in order to promote 
reproducible changes in the membrane lipid composition of rat hepatic 
mitochondria as well as a consistent influence on specific parameters of 
mitochondria physiological functions. After having selected a diet 
containing 20% rapeseed oil and a feeding program over 33 days, 
mitochondria membrane lipid and protein composition and relevant 
parameters of mitochondrial functioning (namely regarding to states 3 and 4 
of respiration, uncoupled respiration, RCR and ADP ratio, fluctuations of 
transmembrane potential and induction of MPT) were systematically studied 
for rats fed the modified and the control diet, at three time points of diet 
administration (11, 22 and 33 days) (section 2.2.3).  
 
3) The parameters of mitochondrial functioning studied in the precedent 
section were evaluated under the influence of the aforementioned 
mitochondria-active drugs (FCCP, MEN and NIM), on mitochondria 
isolated from rats fed the modified and the control diet (section 2.2.4). 
 
4) The influence of membrane lipid composition on the binding and 
conformational dynamics of cyt c was assessed by using membrane models 
mimicking the lipid composition of liver mitochondria membranes from rats 
fed the modified and the control diet (section 2.3).  
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2.1. Effects of mitochondrially-active drugs on membrane 
physical properties 
 
2.1.1. Introduction 
 
It has been extensively demonstrated that lipophilic compounds such as clinically-used 
drugs [434, 460, 461] and environmental pollutants, including insecticides [422, 462, 
463] and organotins [464], promote alterations of membrane lipid physical properties, 
thus affecting membrane-associated functions. Transport and catalytic activities of 
membrane proteins have in fact shown a consistent dependence on the structure and 
dynamics of the membrane lipid bilayer [219, 225, 236]. 
Membrane fluidity has been one of the most studied properties of lipid structure [465] 
and one of the most evoked membrane physical feature susceptible of being altered by 
the incorporation of membrane-active compounds, with impact on membrane 
physiology. In fact, membrane fluidity, although poorly defined in physical terms, has 
revealed a high biological relevance [466]. However, as important as maintaining 
membrane fluidity within adequate limits is to preserve a critical balance between 
conditions promoting bilayer stability and those providing it with a curvature stress, 
which was shown to be beneficial for the activity of a number of membrane proteins. 
Therefore, another membrane property evoked as being responsible for drug-induced 
membrane perturbations regards the propensity to form non-lamellar phases. Non-
bilayer lipids have been proposed to play a role in the fusion and fission processes that 
take place in cells [234] and in the recruitment of proteins involved in signal 
amplification [217, 235]. Concerning mitochondrial functioning, fluidity as well as 
membrane curvature stress seem to play a crucial role. If, on one hand, fluidity might 
propitiate protein-protein and multimolecular encounters, conditions favouring HII 
arrangements and intermediate structures have been proposed as playing an important 
role in MCS’s, where the MPTP is formed [237]. Other related membrane properties, 
namely concerning the lateral pressure profile and the presence of different lipid-driven 
microdomains, have shown to be important for mitochondrial function and to be 
affected by membrane-active compounds [219, 225, 236]. 
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By using different biophysical approaches, the present section focuses on investigating 
alterations in the membrane physical properties induced by the incorporation of 
recognized mitochondriotoxic compounds (FCCP, MEN and NIM). Assays of 
membrane binding, calcein release, DSC, quenching and fluorescence anisotropy 
allowed to assess xenobiotic-induced physical disturbances in different membrane 
systems as well as predicting drug preferential localization across the lipid bilayer 
thickness. As a starting step, model membranes prepared from a single lipid species, 
dipalmitoylphosphatidylcholine (DPPC), were used. This lipid was chosen as 
representing a phospholipid class, which constitutes a major component of eukaryotic 
membranes, mitochondrial membranes included (see chapter 1, Fig. 2). Aiming at 
establishing more accurate models of biomembranes, binary and ternary membrane lipid 
models, including a mitochondrial membrane mimetic lipid system consisting of 
dioleoylphosphatidylcholine (DOPC), dioleoylphosphatidylethanolamine (DOPE) and 
tetraoleoylcardiolipin (TOCL), at 1:1:1 molar ratio, were used to evaluate drug-lipid 
interactions in conditions increasingly closer to physiologic. The capacity of compounds 
to induce non-lamellar phases was assessed by 31P NMR, using the ternary lipid system 
in the presence of Ca2+ (at 1: 1 molar ratio to CL). 
 
2.1.2. Materials and Methods 
 
2.1.2.1. Materials 
 
The lipids DPPC, palmitoyloleoylphosphatidylcholine (POPC), DOPC, 
dipalmitoylphosphatidylethanolamine (DPPE), DOPE and TOCL (at least 98% pure) 
were obtained from Avanti Polar Lipids, Inc. (Murcia, Spain). FCCP, MEN and NIM 
were purchased from Sigma Chemical Co. (St. Louis, MO, USA). The probes (NBD-
PE), calcein, DPH, DPH-PA and TMA-DPH (trimethylammonium-diphenylhexatriene) 
were purchased from Molecular Probes, Inc. (Eugene, OR, USA). All the other 
chemicals were of the highest commercially available purity. 
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2.1.2.2. Preparation of multilamellar vesicles (MLVs) for DSC, NMR and 
fluorescence polarization studies 
 
Adequate portions of DPPC or mixtures of DPPE:TOCL (7:3 molar ratio) and 
DOPC:DOPE:TOCL (1:1:1 molar ratio) were dissolved in chloroform, and 
subsequently evaporated to dryness in a rotary evaporator. The dry residues were 
hydrated under N2 atmosphere by gentle shaking with an adequate volume of buffer (10 
mM Tris-maleate plus 50 mM KCl, pH 7.0, for DPPC and DPPE-TOCL liposomes and 
50 mM HEPES plus 0.2 mM NaCl, pH 7.5, for DOPC-DOPE-TOCL liposomes) at a 
temperature above the transition phase of the respective lipid preparations (room 
temperature for the ternary unsaturated lipid mixture, 55°C for DPPC and 65°C for 
DPPE-TOCL mixture). DPPC and DPPE-TOCL preparations (150 mM in lipid) used in 
DSC assays and DPPC and DOPC-DOPE-TOCL preparations (345 µM) used in 
spectrofluorimetric assays were vortexed three times for 1 min to disperse aggregates. 
For spectrofluorimetric purposes, lipid preparations were also briefly sonicated (3 x 30 
sec) in a low energy water sonicator to decrease scattered light. Drugs were then added 
to the liposome suspensions from concentrated solutions (FCCP and MEN in ethanol; 
NIM in dimethylformamide, DMF), and the preparations were allowed to equilibrate 
overnight at the temperatures at which liposomes were prepared (i.e. at temperatures 
above Tm,). Control samples were prepared with equivalent volumes of solvent. 
 
2.1.2.3. Preparation of unilamellar vesicles for membrane binding and 
calcein release studies 
 
Adequate portions of POPC or a mixture of DOPC:DOPE:TOCL (1:1:1 molar ratio) 
were dissolved in chloroform, and MLVs were prepared as previously described. For 
binding experiments, a lipid concentration of 5 mM was used. For calcein release 
measurements, lipid vesicles (40 mM in lipid) were prepared as described before, but 
using a buffer contained 30 mM calcein for the hydration of lipids. Lipid suspensions 
were then submitted to several freeze/thaw cycles and extruded 10 times through 100 
nm nucleopore polycarbonate filters (Whatman Millipore, USA).  
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2.1.2.4. Preparation of mitochondrial membranes for fluorescence 
polarization studies 
 
Mitochondrial membranes obtained from isolated mitochondria [467] and resealed after 
5 freeze/thaw cycles in liquid nitrogen were  kept at 4°C, in a buffer 10 mM Tris-
maleate, 50 mM KCl (pH 8.5) to which the protease inhibitor phenylmethylsulfonyl 
fluoride (PMSF; 10 µM) was added. The protein content was determined by the biuret 
method [468]. Samples containing 2.48 mg of protein/mL (corresponding to a lipid 
concentration of approximately 200 µM) were used. 
 
2.1.2.5. Incorporation of probes 
 
A small volume of the fluorescent probe (NBD-PE, DPH or TMA-DPH) solution in 
ethanol (for NBD-PE) or DMF (for DPH, DPH-PA and TMA-DPH) was injected into 
liposome suspensions (5 mM in phospholipid for binding studies and 345 µM for 
fluorescence polarization) to get adequate probe/lipid ratios (0,5% g/g for NBD-PE; 
1:200 for DPH, DPH-PA and TMA-DPH). Then, liposome suspensions were incubated 
overnight in the dark, before the incorporation of drugs. Control samples were prepared 
with equivalent volumes of ethanol or DMF. 
In the case of the mitochondrial membrane suspension, fluorescent probes (DPH and 
TMA-DPH) were added to attain a concentration of 1 µM (probe to lipid molar ratio of 
1:200) and the preparations were incubated at least for 1h. Control samples were 
prepared with equivalent volumes of DMF. 
 
2.1.2.6. Spectrofluorimetric measurements 
 
2.1.2.6.1. Binding studies 
 
The extent of the interaction of xenobiotic with membrane models was evaluated by 
monitoring the fluorescence of the incorporated lipid probe NBD-PE in the wavelength 
range of 490 to 650 nm, following excitation at 465 nm. The values obtained at the 
emission peak (528 nm) for each drug concentration were subtracted from the intensities 
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of fluorescence in a control sample without drug (but containing an equivalent amount 
of solvent) and then plotted as a function of drug to lipid molar ratio. 
 
2.1.2.6.2.  Calcein release studies 
 
Liposomes containing entrapped calcein were incubated with drugs (MEN or NIM) for 
10 min at room temperature. The extent of calcein release was determined by 
monitoring the fluorescence in the wavelength range from 495 to 580 nm, following 
excitation at 490 nm. The values obtained at the emission peak (510 nm) were 
normalized to the total amount of calcein released after vesicle disruption with 0.1% 
Triton X-100 and plotted as function of drug to lipid molar ratio. 
The permeability of liposome membranes was calculated using the following equation: 
 
 
 
where % PX is the percentage of calcein release induced by X concentration of the 
compound, IX is the fluorescence intensity with X concentration of the compound, IC is 
the control fluorescence intensity and IT is the maximal fluorescence intensity after lysis 
by Triton X-100. Ethanol or DMF added at the same amount of MEN/NIM solution 
showed to hold no significant effect on calcein release. 
 
2.1.2.6.3.  Fluorescence quenching and anisotropy assays 
 
Fluorescence quenching and anisotropy measurements in liposomes containing DPH or 
DPH-PA (TMA-DPH) and drugs, or the corresponding solvent (controls), were 
performed in a Perkin-Elmer LS 55 Luminescence Spectrometer at a controlled 
temperature (50°C for DPPC liposomes; 25 and 70°C for the mixture 
DOPC:DOPE:TOCL and 25, 37 and 50°C for the isolated mitochondrial membranes). 
Excitation and emission wavelengths were set to 361 and 432 nm for emission and 
excitation spectra acquisition and also for the fluorescence anisotropy measurements. 
Fluorescence values were corrected for light scattering contributions by subtracting the 
intensities from unlabelled samples at the same conditions (such contributions were 
x 100    [1] % PX =                                                                  
IX – IC 
IT 
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always negligible, less than 0.5%). All fluorescence intensity data were corrected from 
reabsorbtion and inner filter effects [469]. 
Fluorescence lifetime measurements were made with a Fluorolog Tau-3 Lifetime 
system. Modulation frequencies were acquired between 5 and 110 MHz. Integration 
time was 8 sec. Manual slits used were 1.0 mm, slits for excitation monochromator were 
7.000 (side entrance) and 0.5 mm (side exit) and for emission monochromator 7.000 
(side entrance) and 7.000 (side exit). All measurements were made using Ludox as a 
reference standard (τ = 0.00 ns). The probes were excited with vertically polarized light 
and resulting fluorescence intensities were recorded with the analyzing polarizer 
oriented parallel (III) and perpendicular (I┴) to the excitation polarizer allowing the 
determination of steady-state fluorescence anisotropy (rss) for each labelled sample by 
the following equation [469]: 
 
⊥
⊥
×+
×−
=
I2GI
IGI
r
II
II
ss   [2] 
 
where G is the grating correction factor given by the ratio of vertically to horizontally 
polarized emission components, when the excitation light was polarized in the 
horizontal direction. 
 
2.1.2.7. Differential scanning calorimetry 
 
MLVs (150 mM in phospholipid) prepared as described above, containing different 
amounts of drug in order to obtain different drug:lipid molar ratios, or solvent (control), 
were sealed into aluminum pans and heating scans were performed over an appropriate 
temperature range, on a Perkin-Elmer Pyris 1 differential scanning calorimeter at a scan 
rate of 5°C/min. To check data reproducibility, three heating scans were recorded for 
each sample. To compensate the effect of high heat capacity of the aqueous medium on 
the baseline, an estimated amount of buffer in the sample was used in the reference pan. 
Data acquisition and analysis were performed using the software provided by Perkin 
Elmer. Distinct temperatures were automatically defined for each endotherm: the onset 
temperature (T0) and the temperature at the endotherm peak (Tm). To define the range of 
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the phase transition or lateral phase separation (Tf-To), a third temperature was 
determined (Tf) by extrapolating to the baseline a tangent to the descendent slope of the 
endothermic peak. These critical transition temperatures were estimated as the mean 
value of three heating scans in at least three different samples from the same 
preparation. To determine the total amount of phospholipid contained in each pan, the 
pans were carefully opened at the end of the experiment and the content was dissolved 
in chloroform plus methanol (3:1). The phospholipid content was determined by 
measuring the amount of inorganic phosphate [470], after hydrolysis of the extracts in 
70% HClO4, at 180°C, for 60 min [471]. Finally, peak profiles and enthalpy (∆H) 
values were normalized to the exact phospholipid content in each pan. 
 
2.1.2.8. 
31
P NMR 
 
For 31P NMR studies, suspensions containing 5 mg of a mixture of DOPE:DOPC:TOCL 
(1:1:1) were obtained as described above. Drugs were added to the liposome 
suspensions from concentrated solutions and the preparations were allowed to stabilize 
overnight. The samples were loaded into a 5-mm diameter NMR tube and a small 
volume of a CaCl2 solution was added to reach 1:1 Ca2+:CL molar ratio. Controls were 
prepared with a few µl of solvent, corresponding to the volume of the drug solution 
assayed. Spectra were obtained using a Varian Unity 500 NMR spectrometer operating 
at 202.33 MHz with a 5-mm broadband probe over a 30-kHz sweep width in 60 x 1024 
data points. A 90° pulse width of 14.09 µs was used. Composite pulse decoupling 
allowed removing any proton coupling. Generally, 800 free induction decays were 
processed using an exponential line broadening of 100 Hz prior to Fourier 
transformation. Probe temperature was maintained to ±0.2°C by the variable 
temperature unit of the NMR spectrometer. 
 
2.1.2.9. Statistical analysis of data 
 
DSC and fluorescence anisotropy data, namely transition temperature midpoints (Tm), 
transition temperature ranges (Tf-To) and enthalpy changes (∆H), quenching percentages 
and anisotropy values were expressed as means ± standard deviation of 3-4 independent 
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experiments. Multiple comparisons were performed using one-way ANOVA with the 
Student-Newman-Keuls as a post-test. A value of p<0.05 was considered statistically 
significant. 
 
2.1.3. FCCP 
 
2.1.3.1. Introduction 
 
As a consequence of the central role of mitochondria in cellular bioenergetics, 
interference with any of the pivotal steps in the mechanisms of energy production 
network results ultimately in cell damage [472]. A well-known mitochondrial target for 
xenobiotics is the IMM. Increased permeability of the IMM to protons results in 
uncoupling of oxidative phosphorylation. The protonophoric activity of several agents 
leads to the dissipation of the proton gradient across the IMM and, hence, to the 
collapse of the ∆Ψ, impairing the driving force for ATP synthesis. Electron transport 
and the pumping of protons to the IMS become functionally disconnected (uncoupled) 
from ATP synthesis [472]. Although the uncoupling phenomenon has been normally 
associated to mitochondrial dysfunction and cell damage [473], recent evidences show 
that a partial and transient uncoupling is beneficial in specific cases such as during 
excitotoxicity [474] or for post-ischaemic functional recovery [475]. The prevention of 
excessive mitochondrial calcium accumulation or a lowered rate of ROS production by 
the respiratory chain have been proposed as potential mechanisms for neuroprotection 
[474] derived from a “mild” uncoupling effect [476]. The same effect has been related 
to FCCP-induced ROS-dependent cardioprotection [475]. 
FCCP (Fig. 8) is a classical uncoupler of oxidative phosphorylation. The mechanism of 
action of FCCP at the IMM level has been previously described [477]. FCCP is a weak 
acid with notorious lipophilic characteristics that allow it to migrate through the 
thickness of the bilayer in an electrically neutral form (protonated), as well as in the 
anionic form due to the charge delocalization provided by its conjugated ring structure 
[478]. Classically, it has been described that the lipid composition and dielectric 
constant of the bilayer might play a role in FCCP-induced proton translocation across 
the IMM [395]. However, how FCCP-lipid interactions can modulate uncoupling and 
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the extent to which the physical properties of the membrane lipid bilayer influence 
FCCP activity are aspects that remain to be clarified. 
 
Fig. 8: Chemical structure of FCCP (carbonylcyanide p-trifluoromethoxyphenylhydrazone). 
 
2.1.3.2. Results 
 
2.1.3.2.1. FCCP interferes with the thermotropic behaviour of model lipid membranes 
 
DSC studies were performed to investigate the effects of FCCP on the biophysical 
properties of two membrane models: DPPC liposomes, as a classical model system for 
biophysical studies, and a mixed lipid system containing DPPE plus TOCL 
(representing two important lipid classes of the IMM) at a 7:3 molar ratio. As expected, 
DSC thermograms of DPPC bilayers showed two endotherms, corresponding to a pre-
transition at 34.6ºC, with a low enthalpy change, and a main transition, with a sharp 
peak centered at 41.9ºC and involving an enthalpy change of 39.5 J/g (Table III). The 
addition of FCCP to DPPC liposomes abolished the pre-transition peak, even at the 
lowest concentration used (FCCP:DPPC molar ratio of 1:48). Increasing concentrations 
of FCCP, from 1:48 to 1:6 FCCP:phospholipid molar ratio, promoted a shift of the 
temperature range at which lipid dispersions undergo gel to liquid-crystalline phase 
transition towards progressively lower temperatures. The highest uncoupler 
concentration assayed promoted a decrease of Tm of about 3.7ºC (Table III). 
Additionally, the temperature range at which the transition takes place displayed a 
progressive broadening in the presence of increasing concentrations of the uncoupler, 
reflecting a decrease of the cooperativity of the DPPC phase transition. At the highest 
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FCCP concentration assayed, Tf-To increased 2.6ºC relatively to the control. However, 
FCCP did not significantly affect the enthalpy change of the DPPC main transition 
(Table III). 
 
Table III: Characterization of the phase transitions detected by DSC (temperature of the 
endothermic peak, Tm, transition temperature range, Tf-T0, and enthalpy change, ∆H) in DPPC 
liposomes. Liposomes were incubated with FCCP to obtain FCCP:DPPC molar ratios from 1:48 
to 1:6, or with a volume of ethanol corresponding to the maximal volume of the FCCP solution 
assayed for the control (FCCP:DPPC molar ratio of zero in the Table). 
FCCP:DPPC Tm  (ºC) Tf – T0 (ºC) ∆H (J/g) 
0 (control)  41.92±0.30 3.36±0.36 39.48±0.32 
1:48 41.15±0.52* 4.04±0.60* 39.93±0.51 
1:24 40.35±0.35** 4.62±0.40** 40.02±0.59 
1:12 39.40±0.22** 4.96±0.39** 40.05±0.53 
1:6 38.20±0.39** 5.96±0.33** 39.58±0.46 
a) Values presented are means ± standard deviation of four DSC experiments. Comparisons were 
performed using one-way ANOVA, with the Student-Newman-Keuls as a post-test for the following 
paired observations: liposomes with FCCP:DPPC molar  ratios of 1:48, 1:24, 1:12 or 1:6 versus control 
liposomes (without FCCP). **, P <0.01; *, P <0.05. 
 
Liposomes containing DPPE and TOCL prepared at a molar ratio of 7:3 showed a 
single, although broad (Tf-To≈11ºC), endotherm centered at about 48.7 °C (Fig. 9 and 
Table IV). This reflects the formation of an ideal mixture, as previously reported [479], 
despite the fact that the lipid components of the mixture display, when isolated, a large 
gap between their transition temperatures (64ºC for DPPE and below 0ºC for TOCL). 
The addition of FCCP (1:12 and 1:6 FCCP:phospholipid molar ratio) induced an 
alteration of the phase behaviour of the lipid mixture, promoting the appearance of a 
new endothermic component with a higher transition temperature than the control single 
peak, but an enthalpy change significantly lower than that regarding the main 
endotherm (about one tenth for the highest FCCP concentration, Table IV). The 
appearance of this new endothermic component in the presence of FCCP, at 
temperatures closer, but still below, the phase transition of pure DPPE systems, suggests 
the formation of DPPE-enriched lipid domains. Regarding the enthalpy (∆H) of the 
transitions, it was noticed that the value found in control conditions (20.2 J/g of 
phospholipids) is approximately equivalent to the sum of the transition enthalpies of the 
two endotherms obtained in FCCP-containing lipid preparations (Table IV). This 
supports the hypothesis of occurrence of lateral phase separation, excluding that any 
other endothermic process was taking place. 
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Table IV: Characterization of the phase transitions detected by DSC (temperature of the 
endothermic peaks, Tm, transition temperature range, Tf-T0, and enthalpy change, ∆H) in 
DPPE:TOCL (7:3) liposomes. Liposomes were incubated with FCCP to obtain FCCP:lipid 
molar ratios from 1:12 and 1:6, or with a volume of ethanol corresponding to the maximal 
volume of the FCCP solution assayed for the control (FCCP:lipid molar ratio of zero in the 
Table). 
FCCP:lipid Peak 1 Peak 2 
 Tm  (ºC) Tf – T0 (ºC) ∆H (J/g) Tm  2 (ºC) ∆H 2 (J/g) 
0 (control) 48.66±1.52 11.12±2.12 20.20±0.61 ---------- ---------- 
1:12 45.60±2.58* 11.45±1.33 19.64±0.54 57.32±2.66 0.34±0.07 
1:6 41.95±0.55*** 11.74±1.61 18.38±0.57** 53.33±2.25 1.54±0.62* 
a) Values presented are means ± standard deviation of three DSC experiments. Comparisons were 
performed using one-way ANOVA, with the Student-Newman-Keuls as a post-test for the following 
paired observations: liposomes with a FCCP:lipid molar ratio of 1:12 or 1:6 versus control liposomes 
(without FCCP), or liposomes with a FCCP:lipid molar ratio of 1:6 versus liposomes with a FCCP:lipid 
molar ratio of 1:12 in the case of peak 2.  ***, P <0.001; **, P <0.01; *, P <0.05. 
 
 
 
Fig. 9: DSC thermograms of liposomes prepared with a mixture of DPPE and TOCL (7:3, 
molar ratio) in the absence (cont.) or the presence of FCCP at the FCCP:lipid molar ratios 
indicated on the scans. The DSC profiles were originated from heating scans. The thermograms 
presented are typical of at least three independent experiments. 
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2.1.3.2.2. FCCP favors hexagonal II phase formation in mixed non-bilayer and 
bilayer lipid systems 
 
 
Fig. 10: 
31
P NMR spectra of aqueous dispersions of DOPC:DOPE:TOCL (1:1:1) with 
CaCl2 (1:1 to CL) at different temperatures (indicated in the figure), in the absence 
(Control) or the presence of FCCP at a 1:6 FCCP to phospholipid molar ratio (FCCP). For 
each sample, the spectrum was first averaged at 25°C over a period of about 20 min, and then 
the process was repeated over a range of temperatures with 15°C increments. Each sample (600 
µl) contained 5 mg of total lipid. 
 
The influence of FCCP on the propensity of a heterogeneous lipid system containing 
bilayer (DOPC) and non-bilayer forming phospholipids (DOPE and TOCL plus 
calcium) for HII phase formation was assessed by 31P NMR. In the absence of FCCP, 
the mixture of DOPC:DOPE:CL:Ca2+ (1:1:1:1, molar ratio) at 25ºC was shown to be 
organized in extended bilayers, evidenced by the characteristic asymmetrical 31P NMR 
lineshape with a low-field shoulder and a high-field peak [480] separated by 
approximately 10 ppm (Fig. 10). However, a small peak downfield of phosphoric acid 
(which was set at 0 ppm) is also noticed in this spectrum, evidencing the coexistence of 
lipids organized in HII phases. As the temperature increased, the hexagonal (HII) 
component in the spectrum became more evident and, at 70ºC, it predominated 
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relatively to the bilayer component. Simultaneously, a progressive reduction of 
spectrum width was observed, which is compatible with a bilayer to HII transition, 
affecting a significant part of the lipid vesicle population. 
The incorporation of FCCP at the molar ratio of 1: 6 (FCCP to lipid) had a remarkable 
effect on lipid phase behaviour. Thus, for the FCCP-containing lipid system, the 
lineshapes at and above 25ºC are significantly different from those of the control 
preparation (Fig. 10). At 40ºC, the HII component prevailed over the bilayer one and, at 
70ºC, a lineshape typical of lipids in the HII phase, with a reversed asymmetry compared 
to the bilayer spectra and reduced width, was observed. 
 
2.1.3.2.3. FCCP distributes along the hydrocarbon moiety of lipids in the lamellar 
phase, but closer to the methyl terminal groups of hydrocarbon chains in the HII lattice 
 
Fig. 11: Excitation and emission spectra of the fluorescent probe DPH incorporated in 
DPPC (A) or in  DOPC:DOPE:TOCL (1:1:1) with CaCl2 (1:1 to CL) liposomes (B) as 
affected by different ratios of FCCP:lipid (0, solid line; 1:96, dashes; 1:48, dots; 1:36, dash-
dot; 1:24, dash-dot-dot). Spectra were obtained after overnight incubation with FCCP or ethanol 
(control; solid line). Results are representative of at least 3 independent determinations. 
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In order to investigate the preferential location of FCCP upon incorporation into 
lamellar/HII lipid structures, steady-state fluorescence intensities and lifetimes were 
measured in liposomes labelled with two probes: DPH, buried in the hydrocarbon core 
[481], and DPH-PA, which is anchored at the lipid/water interface due to its charged 
group, monitoring the region of the bilayer corresponding to the upper portions of 
phospholipid acyl chains [482]. As a first approach, the effects of FCCP on the 
spectroscopic properties of both probes were studied in vesicles prepared with a single 
lipid species (DPPC). FCCP revealed to act as a potent quencher of both DPH and 
DPH-PA incorporated in DPPC liposomes, as illustrated for DPH in Fig. 11A. The 
same kind of profile was obtained for the excitation and emission spectra of DPH-PA-
labelled liposomes (data not shown). Thus, for both probes, FCCP decreased the amount 
of absorbed light and induced a reduction of emitted light showing a strict dependence 
on FCCP concentration (Fig. 12). At the lower FCCP:phospholipid molar ratio assayed 
(1:96), FCCP decreased the fluorescence signal to approximately 50% and at the molar 
ratio of 1:24, a merely residual fluorescence was emitted by both probes. 
 
Fig. 12: Fluorescence (% of control) of FCCP on the emission of DPH (black bars) and 
DPH-PA (white bars) incorporated in DPPC liposomes, as a function of uncoupler 
concentration. The graph represents the data from at least three independent experiments for 
each condition. Comparisons were performed using one-way ANOVA, with the Student-
Newman-Keuls as a post-test for the following paired observations: 1) liposomes with a 
FCCP:lipid ratio of 1:24, 1:36, 1:48 or 1:96 versus control liposomes (without FCCP); ***, P 
<0.001; **, P <0.01; 2) liposomes labelled with DPH-PA versus liposomes labelled with DPH, 
for the same FCCP concentration; º, P <0.05; ns, not significant. 
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Fig. 13: Quenching effect of FCCP on the emission of DPH (black bars) and DPH-PA 
(white bars), as a function of uncoupler concentration, in liposomes consisting of a mixture 
of DOPC:DOPE:TOCL (1:1:1) plus Ca
2+
 (at 1:1 Ca
2+
:CL molar ratio) at 25ºC (A) or 70ºC 
(B). In the graph are represented the results of at least three independent experiments for each 
condition. Comparisons were performed using one-way ANOVA, with the Student-Newman-
Keuls as a post-test for the following paired observations: 1) liposomes with a FCCP/lipid ratio 
of 1:24, 1:36, 1:48 or 1:96 versus control liposomes (without FCCP); ***, P <0.001; **, P 
<0.01; *, P <0.05; ns, not significant; 2) liposomes labelled with DPH-PA versus liposomes 
labelled with DPH, for the same FCCP concentration (ns, not significant). 
 
In order to also appraise FCCP distribution in the HII lipid arrangements, quenching 
effects were evaluated when fluorescent probes were incorporated in liposomes 
composed of a mixture of DOPC:DOPE:TOCL (1:1:1) with Ca2+ 1:1 to CL. Quenching 
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assays were performed at two different temperatures: 25ºC, at which the lamellar 
arrangement prevailed, and 70ºC, at which the HII phase was the most relevant 
arrangement, according to 31P NMR spectra (Fig. 10). Once more, typical excitation and 
emission spectra of fluorescence quenching were observed in the mixed lipid model 
system labelled with DPH, at different quencher (FCCP) concentrations (Fig. 11B). The 
same kind of profile was obtained when the mixed lipid model system was labelled with 
DPH-PA, regardless the temperature of the assay. Thus, at both temperatures assayed, 
FCCP was able to quench DPH and DPH-PA incorporated in this model system, in a 
concentration dependent manner (Fig. 13), although the quenching effects were less 
drastic than in DPPC liposomes (Fig. 12). 
The quenching efficiency of FCCP in each model system can be better compared after 
determining the Stern-Volmer constant (KSV) from the equations [483]: 
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where (I, τ) and ( I0, τ0 ) are the fluorescence steady state intensities and lifetimes in the 
presence or absence of quencher (Q) respectively and KSV and KD are the Stern-Volmer 
constants, which indicate the extension of quenching. While KSV reflects the occurrence 
of both dynamic (collisional) and static (resulting from the formation of a complex 
between the probe and the quencher) quenching processes, KD reflects exclusively a 
dynamic quenching process. According to these equations, the Stern-Volmer plots of 
I0/I and τ0/ τ against the concentration of FCCP were drawn. Fig. 14A illustrates the 
results obtained for quenching of DPH fluorescence by FCCP in DPPC liposomes, 
clearly showing that although a linear lifetime Stern-Volmer plot (τ0/τ against the 
concentration of FCCP) has been obtained, a non-linear plot for the steady-state 
fluorescence intensity (I0/I against FCCP concentration) with a positive deviation was 
observed. Furthermore, since the amount of collision quenching represented by the 
lifetime Stern-Volmer plot is smaller than the quenching observed by steady-state 
fluorescence measurements, an additional quenching process should be taking place, not 
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influencing the observed excited state lifetime. Indeed, similar Stern-Volmer plots with 
an upward curvature, concave towards the y-axis, have been reported in the literature as 
being related with a non-purely collisional quenching process, associated with a static 
quenching component. This type of positive deviation is usually interpreted in terms of 
a "sphere of action" static quenching model [483]. According to this model, 
instantaneous or static quenching occurs if the quencher molecule (in this case FCCP) is 
very near to, or in contact with the probe, at the exact moment it happens to be excited. 
 
Fig. 14: (A) Stern-Volmer plots of the probe DPH incorporated in DPPC liposomes as a 
function of uncoupler concentration. Stern-Volmer plots were obtained from steady state 
fluorescence measurements (squares) and from fluorescence lifetime measurements (circles). 
(B) Fluorescence quenching of the probe DPH incorporated in DPPC liposomes as a function of 
uncoupler concentration now fitting the sphere of action model. 
 
The probe molecules that are instantaneously quenched are therefore unobservable. The 
only observable probe molecules are those for which no adjacent molecules of FCCP 
exist. Hence, only a certain fraction of the excited probe is quenched by the Stern-
Volmer collisional mechanism [483]. Moreover, this model presumes that the quencher 
(FCCP) is located inside a spherical volume (V) adjacent to the probe and assumes that 
the probability for the quencher to be inside this volume at the time of excitation 
depends on the volume itself and on the quencher concentration [483, 484], according to 
the following equation: 
 
V[Q]
Iτ
τI
ln
0
0 =
 
[5] 
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Based on this equation, it was possible to calculate the spherical volume where both 
FCCP and probe are located, which was given by the slope of the linear plot represented 
on Fig. 14B. Finally, we used the volume of the sphere of action (V) to assess the 
collision component of the observed quenching [483] by the introduction of an 
additional factor ( [ ]QVe ) in the fluorescence intensity ratio, which accounts for the 
fluorophore-quencher proximity effect and corrects the steady-state intensities [483], as 
shown by the following equation: 
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The slopes of these corrected steady-state fluorescence linear plots correspond to Stern-
Volmer constants (KSV) resultant from the collisional quenching between FCCP and the 
fluorophore DPH or DPH-PA in either DPPC liposomes or liposomes composed of the 
phospholipid mixture. The KSV values calculated by the corrected steady-state Stern-
Volmer plots (Table V, column a) are equal (within the error) to the values of KD (Table 
V, column b) calculated from the slope of linear regressions of the experimental lifetime 
Stern-Volmer plots (Fig. 14A). For this reason and also because no specific interactions 
between probes and FCCP have been identified either in absorption or in fluorescence 
spectra, we assume that the applied sphere of action model is suitable to explain the 
observed quenching. 
Although the KSV values are adequate to evaluate the extension of the quenching for 
each probe individually, the comparison of quenching effects using two different probes 
(DPH and DPH-PA) requires the calculation of the bimolecular quenching rate constant 
(Kq=KD/τ0). This parameter reflects the efficiency of quenching or the accessibility of 
the fluorophores to the quencher [483], eliminating the specificity of the probe, which is 
related with the fluorescence lifetime of the probe (τ0), experimentally measured in the 
absence of the quencher. Therefore, the analysis of the Kq values (Table V, column c) 
indicates that: a) in DPPC liposomes, FCCP efficiently quenched the fluorescence of 
both probes (DPH and DPH-PA); b) in the ternary lipid system an higher Kq value was 
obtained with DPH-PA than with DPH at the lowest temperature (25ºC), but the 
opposite was observed at the highest temperature (70ºC). Thus, in conditions at which 
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the mixture of lipids is preferentially organized in a lamellar structure (25ºC), the Kq 
value obtained with DPH was about 55% of that with DPH-PA, reflecting a preferential 
location of FCCP molecules closer to the outer regions of the lipid bilayer. In contrast, 
at 70ºC, temperature at which 31P NMR spectra showed that HII phase predominates 
(Fig. 10), FCCP seems to locate closer to DPH and, hence, farther from the aqueous 
lipid interface, as represented in Fig. 15. In fact Kq in these conditions was about six 
times higher for DPH than for DPH-PA (Table V). These findings suggest a localization 
of FCCP molecules at the periphery of HII tubes and at the interstices between HII tubes, 
which is the most hydrophobic region of the HII structure predictably occupied by DPH 
(Fig. 15). 
 
 
Table V: Values of the Stern–Volmer constants and the bimolecular quenching constant (Kq) 
obtained from measurements of fluorescence quenching of DPH and DPH-PA. Lipid 
suspensions consisted of DPPC or a lipid mixture of DOPC:DOPE:TOCL (1:1:1) with Ca2+ 1:1 
to CL at 25ºC or 70ºC. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(a), (b) and (c) Values are means ± standard deviation of three fluorescence quenching experiments. 
Comparisons were performed using one-way ANOVA, with the Student-Newman-Keuls as a post-test for 
the following paired observation: liposomes labelled with DPH-PA versus liposomes labelled with DPH. 
***, P <0.001; **, P <0.01; *, P <0.05. 
 (a) KD values calculated from the slope of the lifetime linear plots (τ0/τ versus [FCCP]) obtained from 
data fitting to equation [4]. 
(b) KSV values calculated from the slope of the steady-state fluorescence linear plots (I0/Ie
V[FCCP] versus 
[FCCP]) obtained from data fitting to equation [6]. 
(c) Kq values calculated using the KD values of column (a) and experimental τ0 of the probe. 
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DPPC 
DPH 3.29+0.42 3.20+0.27 4.22+0.14 
DPH-PA 1.60+0.10* 1.28+0.36** 3.59+0.69*** 
Lipid 
Mixture  
25°C  
(Lα Phase) 
DPH 0.30+0.42 0.29+0.40 0.31+0.05 
DPH-PA 0.32+0.02 0.32+0.01 0.56+0.01* 
Lipid 
Mixture  
70°C  
(HII Phase) 
DPH 0.28+0.02 0.25+0.0 3.60+0.15 
DPH-PA 0.24+0.57 0.24+0.12 0.58+0.14* 
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Fig. 15: Representative diagram showing the proposed distribution of FCCP and 
fluorescent probe (DPH and DPH-PA) molecules in lamellar and non-lamellar lipid 
phases. 
 
2.1.3.2.4. FCCP affects the lipid order in lamellar and hexagonal II lipid structures 
 
The effects of FCCP on lipid dynamics and phospholipid acyl chain packing were 
studied by fluorescence anisotropy, using the rotational correlation time (θ) of the probe 
to which FCCP localises closest in each preparation, meaning DPH in DPPC liposomes, 
DPH-PA at 25ºC and DPH at 70ºC in preparations containing a mixture of 
DOPC:DOPE:TOCL (1:1:1) with Ca2+ 1:1 to CL. The rotational correlation time was 
calculated from measured steady-state fluorescence anisotropy (rss) values and τ 
variation, considering that the rotational motion of the probe was not hindered (r∞=0), a 
condition assured when the measurements are made above Tm [5], as shown by the 
following equation.  
 






−
−
= ∞
ss0
ss
rr
rr
τθ  [7] 
 
The decay of rss from its initial value (r0) to the final value r∞ can be characterized by the 
rotational correlation time, θ, which gives information about the dynamics of the probe 
motion and therefore also about the fluidity of the lipid environment surrounding the 
probe. 
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Results (Fig. 16) show that FCCP promoted a significant increase of fluidity of the lipid 
mixture at 25ºC (lamellar phase), which was evident even for the lowest FCCP:lipid 
molar ratio (1:96). However, when FCCP molecules predominantly reside in the most 
disordered regions of the lamellar or inverted hexagonal lattices (the central region of 
DPPC bilayers and the interstices between HII cylinders formed by the mixed lipid 
system at 70ºC, respectively), its effects on hydrocarbon chain packing, monitored by 
DPH, were negligible as expected (Fig. 16). Consistently, DSC also showed that the 
transition enthalpy (reporting the extension of hydrocarbon chain interactions) was 
negligibly affected by FCCP in DPPC liposomes. 
 
 
Fig. 16: Rotational correlation time (θ) of DPH in DPPC liposomes (squares) and DPH or 
DPH-PA in DOPC:DOPE:TOCL:Ca
2+
 (at 1:1:1:1 molar ratio) preparations at 25ºC 
(triangles) and 70ºC (circles), respectively, as a function of the uncoupler concentration. 
Results are means ± standard deviation of at least three independent determinations. 
 
2.1.3.3. Discussion 
 
FCCP is a weak acid mostly known for its uncoupler properties on mitochondria. Since 
the OMM is very permeable, FCCP can easily reach the IMS of mitochondria. In this 
acidic compartment, due to the extrusion of protons by the mitochondrial proton pumps, 
FCCP is protonated and, in its uncharged form, moves across the IMM, losing its 
acquired proton in the matrix, because of the inside-out difference of approximately 0.6 
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pH units [472]. In its negative form, FCCP is driven back out across the membrane by 
the inside-out negative ∆Ψ. The net result of this process is the shuttling of protons to 
the mitochondrial matrix, short-circuiting both the transmembrane proton concentration 
gradient and the ∆Ψ, compromising mitochondrial ATP synthesis [477]. 
Since the mechanism of action of FCCP involves the diffusion of both the uncharged 
and anionic forms of the molecule across membranes, it is predictable that the 
composition and physical characteristics of the lipid environment are susceptible to 
interfere with the uncoupling process. In fact, it was demonstrated that the presence of 
negatively charged lipids in the membrane decreases the concentration of the anionic 
form of FCCP at the membrane-solution interface and the FCCP ability to act as a 
protonophore [393]. 
Due to its lipophilic character, assured in the anionic form by charge delocalization 
provided by the conjugated ring structures [478], FCCP is assumed to easily incorporate 
into membranes. Therefore, as demonstrated for many other lipophilic compounds [422, 
434, 460-464, 485], FCCP should be able to disturb membrane physico-chemical 
properties, the nature and the severity of the disturbance being predictably dependent on 
the composition of the lipid bilayer. In the present study, FCCP-lipid interactions were 
investigated using different membrane systems and different biophysical approaches. 
For the present studies, FCCP concentrations expressed in terms of FCCP:lipid molar 
ratios from 1:96 to 1:6 were used. Considering that the most commonly used 
concentration of FCCP to promote proton shuttling across the IMM is 1 µM, 
corresponding to 1 nmol FCCP per mg of liver mitochondrial protein [486] and in view 
of the value of Fleischer et al. [487] of 0.18 mg of phospholipid/mg liver mitochondrial 
protein and the phospholipid average molecular weight of 775 [488], we can calculate 
that a FCCP:lipid molar ratio of 1:96 corresponds to roughly 1 nmol FCCP per 0.4 mg 
of mitochondrial protein, which is a concentration of the same order of magnitude of the 
one used to promote uncoupling of isolated mitochondria. Taking into account that 
several studies with cell cultures use FCCP concentrations from 2 to 10 µM [489-492], 
we predict that our data could be reliably extrapolated for the mitochondrial membrane. 
Moreover, we should also consider the occurrence of FCCP localized effects on the 
membrane, namely in lipid microdomains whose composition may assure a higher 
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affinity for the compound and, hence, where it could attain higher concentrations (for 
instance in CL-enriched domains, as suggested for DSC studies). 
The steady-state fluorescence anisotropy has been revealed to be a very sensitive 
technique to monitor alterations of fluidity into artificial as well as native membranes 
[422, 434, 460-464, 485, 493]. This technique is particularly reliable when fluorescence 
decay experiments are conducted in parallel, since then it is possible to confirm whether 
anisotropy changes are due to alterations of the lipid order rather than to changes in the 
fluorescence lifetime of the fluidity probe [494]. Data presented in this work show that a 
FCCP concentration as low as 1:96 FCCP to lipid molar ratio promoted a significant 
increase of fluidity at 25ºC in a membrane prepared from the main classes of IMM 
phospholipids, i.e. PC, PE and CL (Fig. 16). At this temperature, lipids are organized in 
a Lα lamellar phase, as reflected by 31P NMR spectra (Fig. 10), and FCCP molecules are 
preferentially localized in the outer regions of the bilayer monitored by DPH-PA, as 
suggested by the Kq values (Table V). As denoted by the high value of θ in the control 
preparation (without addition of FCCP), this system shows a high level of lipid packing 
in the upper regions of the hydrocarbon chains, probably due to the interaction of the 
phospholipid headgroups, particularly those of the anionic phospholipid (CL), with 
calcium ions. The ability of Ca2+ to increase lipid order has been previously 
demonstrated in bacterial PE and CL-containing liposomes [488]. On the other hand, 
the fluidizing drug tamoxifen, which shares with FCCP the ability to decrease the Tm of 
saturated PC species [495], also promotes an increase of fluidity in the outer regions of 
CL plus Ca2+-containing lipid systems [496]. Therefore, FCCP should promote the 
disruption of the tight packing of the upper portions of phospholipid acyl chains, which 
in turn impairs Ca2+ coordination by the respective phospholipid headgroups. 
Considering the significant local concentrations calcium may predictably attain at the 
interface of the anionic IMM [497], FCCP may promote relevant alterations of the 
dynamic equilibrium between different membrane lipid microdomains, particularly 
when involving CL-enriched domains, hence influencing lipid-protein and protein-
protein interactions. 
The DSC studies performed in the present study also showed that FCCP is able to 
induce lateral phase separation (Fig. 9, Table IV), efficiently segregating CL from the 
zwitterionic lipid PE, in a mixture of DPPE:TOCL used as a model of an heterogeneous 
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membrane. FCCP is likely excluded from the saturated lipid-enriched domains, 
preferentially partitioning into the most disordered CL-enriched domains. This 
behaviour is consistent with that observed in DPPC liposomes, where the thermotropic 
profile skewed towards lower temperatures suggesting a non-homogeneous FCCP 
distribution in the plane of the membrane, with a preference for the liquid-disordered 
regions. FCCP-induced formation of PE-rich domains and lateral phase segregation 
should have significant implications for the functionality of mitochondrial membranes. 
Firstly, due to the tendency of PE to form structures with negative curvature, an 
eventual destabilization of the bilayer with impact on membrane permeability is 
predictable. Secondly, the destabilization of the dynamic heterogeneous membrane 
structure and the appearance of leaky interfacial regions between coexisting 
differentiated lipid domains should have disastrous consequences for the normal 
mitochondrial membrane functioning. 
FCCP also disturbed the phase behaviour of the IMM model containing 
DOPC:DOPE:CL at 1:1:1 molar ratio, including calcium at a ratio with CL of 1:1. By 
using 31P NMR, it was shown for the first time that FCCP promotes the formation of a 
highly curved non-lamellar phase, increasing the negative curvature strain in membrane 
systems composed of bilayer and non-bilayer preferring lipids (Fig. 10). As indicated by 
the quenching studies (Table V), FCCP shows a distribution similar to that reported for 
other hydrophobic molecules such as alkanes [498, 499], accumulating in the core of the 
bilayer phase and preferentially residing in the interstices of the HII phase, partitioning 
in the more disordered regions in both phase lattices. This behaviour explains FCCP 
ability to favor the lamellar/inverted hexagonal (Lα/HII) phase transition, by filling out 
the volumes between HII cylinders and, hence, relaxing hydrocarbon-packing 
constraints [498]. 
The conjunction of a high propensity to induce lateral phase separation and to initiate 
the formation of non-lamellar phases may provide FCCP with a high potential to disturb 
mitochondrial membranes, namely at the MCS’s, which are enriched in CL [97], lipid 
with which FCCP has a preferential interaction, as previously discussed. CL, besides 
providing a high organization of the respiratory chain components [500], has been 
proposed as mediating the targeting of pro-apoptotic proteins to mitochondria, actively 
participating in the release of proteins relevant for apoptosis execution [237]. 
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Peroxidation, hydrolysis and re-distribution of CL seem to occur early in apoptosis 
[304]. Therefore, destabilization of CL-enriched bilayer domains caused by FCCP, 
eventually facilitated by the increased calcium concentration in the mitochondria [497], 
should have implications in mitochondrial apoptotic signaling. 
Additionally, quenching results suggest that FCCP incorporated in DPPC or 
DOPC:DOPE:TOCL:Ca2+ (1:1:1:1, molar ratio) lamellar structures displays a broad 
distribution, from the hydrophobic core to the outer regions of the lipid bilayers. This 
distribution across the bilayer thickness is consistent with the ability of FCCP to migrate 
through the IMM when performing its uncoupler activity [395, 477, 478]. Parallel 
studies performed with other weak acid-drug harboring protonophoric activity, the 
NSAID NIM, which will be discussed in a following section, showed also a wide 
distribution of the uncoupler molecules across the bilayer, although distinct effects on 
membrane physical properties were observed. From this information we can infer that: 
a) as expected, different molecular mechanisms may lead to perturbations at the 
membrane level promoting protonophoresis, eventually with different efficiency; b) the 
secondary effects resulting from membrane physical disturbance induced by different 
drugs used for a same pharmacological purpose (e.g. mild uncoupling) may be 
modulated by structural design. 
We are aware that model lipid systems and their ionic environment are not as complex 
as those present in biological systems. Nevertheless, there are several lines of evidence 
that show that structural and material properties of lipid bilayers, which are relevant for 
the functionality of native membranes, may be adequately modeled in artificial lipid 
systems, showing a tight correlation with lipid composition [219, 225]. 
In summary, the present study provides evidence that FCCP promotes distinct 
biophysical effects in different lipid systems and in differentiated regions of lipid 
mixtures prepared to resemble the heterogeneous composition of native membranes. 
Moreover, some of the effects here described for FCCP may actually interfere with its 
uncoupling activity. Although FCCP protonation/deprotonation cycles, which occur 
under physiological conditions, are extremely complex to mimic in model lipid systems, 
data reported in the present work may provide useful insights into the role of 
mitochondrial lipid membrane composition in the interaction of modulators of the 
mitochondrial function, at concentrations physiologically relevant. 
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Therefore, our studies point to two distinct aspects of toxicological significance: a 
toxicokinetic one, indicating that alterations of mitochondrial lipid composition, as 
those occurring in malignant cells [501] or as a consequence of the diet [134, 135], may 
interfere with FCCP partition and localization into the membrane, modifying its impact 
on mitochondrial activity; and a toxicodynamic aspect, suggesting that the uncoupler 
may modulate the physical properties of the membrane, with predictable repercussions 
in its uncoupling activity and secondary pharmacological effects. These aspects may 
contribute for a better understanding of uncoupler-membrane interactions in a 
toxicological context, aiding in the future design of more efficient uncouplers for 
pharmacological purposes. 
 
2.1.4. Menadione 
 
2.1.4.1. Introduction 
 
Menadione (2-methyl-1,4-naphthoquinone or vitamin K3; MEN) is a polycyclic 
aromatic ketone (Fig. 17) that can function as a precursor in the synthesis of vitamin K. 
MEN reduction at the level of complex I [502, 503], which accounts for 50% of its 
metabolism [503], readily diverts the electron flow from the normal flux through the 
mitochondrial respiratory chain. At this level, MEN undergoes one-electron reduction 
producing a semiquinone radical, which in turn reduces molecular oxygen into 
superoxide anion radical, while being oxidized back to the initial quinone form. This 
generation of intracellular ROS through futile redox cycling may elicit rapid oxidation 
of biological molecules in both the mitochondrial matrix and cytosol and justifies the 
common use of MEN as a model compound to investigate the mechanisms of oxidative 
stress and apoptosis through redox cycling mechanisms [504].  
MEN pharmacological importance as a chemotherapeutic agent [505] in a cancer 
context, in particular in leukemia [506, 507], gastrointestinal [508] and lung [509] 
cancers, has been reported. Positive outcomes of the administration of MEN for 
pancreatic [510] and prostate cancer, in this latter case associated with vitamin C [511], 
have also been recognized. However, exposure to MEN has been associated with 
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several adverse effects, including hemolytic anemia [512, 513], cardiotoxicity [514], 
hepatotoxicity [515] and neuronal damage [516]. 
 
  
Fig. 17: Chemical structure of menadione (2-methyl-1,4-naphthoquinone). 
 
Given their lipophilic character, MEN molecules should hold a predictably high 
proneness to incorporate into membrane environments. Consistently with the 
incorporation of MEN into membranes, enhanced membrane fluidity was previously 
demonstrated and proposed as a mechanism mediating MEN toxicity in rat hepatocytes 
[517]. As previously referred, fluidity is a critical property of the lipid bilayer which 
interferes with the activity of membrane proteins [465] and modulates membrane-
associated functions such as active transport and selective permeability to protons and 
other cations [466]. However, the full picture of MEN-membrane interactions and 
functional repercussions involves further characterization of membrane physical 
properties, such as curvature stress associated to the lipid propensity to form non-
lamellar phases. As mentioned before, HII structures have been proposed to be present at 
MCS’s, where the MPTP pore is thought to be formed [237]. MPT was suggested as 
being essential for MEN-elicited apoptosis, promoting efflux of cyt c into the cytoplasm 
and subsequent activation of caspases 9 and 3 [518]. Although MEN was reported to 
induce MPT [519] in a process involving direct oxidation of mitochondrial pyridine 
nucleotides and modification of critical thiols of MPT pore components [520], other 
mechanisms may undergo MEN effects on this process. 
Also involving an action with bioenergetic repercussions, MEN was found to affect 
mitochondrial respiration, as reflected by changes in respiratory parameters: increase in 
respiratory state 4 and decreases in the RCI and ADP/O ratios [521]. MEN-induced 
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increase in state 4 respiration has been assigned to increased basal permeability of the 
IMM to protons, which may result from membrane physical perturbations. 
Attempting to approach membrane physical effects exerted by MEN, which could be 
associated with the impairment of mitochondrial functioning and apoptosis, biophysical 
studies were carried out in the present work, employing s range of different techniques 
and a variety of membrane preparations. These included membrane models mimicking 
the cardiolipin-enriched IMM (where most mitochondrial proteins lie), namely at the 
MCS’s (where MPTP is formed) and native mitochondrial membranes.  
These studies provided evidence that MEN affected membrane physical properties that 
may be critical for membrane protein activity and susceptible of compromising 
important mitochondria-driven cellular processes, including cell death, hence unveiling 
novel targets for MEN to exert its actions, either therapeutic or detrimental. 
 
2.1.4.2. Results 
 
2.1.4.2.1. Menadione binding to model membranes depends on lipid composition 
 
The interaction of increasing concentrations of MEN with NBD-PE-containing 
unilamellar vesicles composed of POPC (electrically neutral) or DOPC:DOPE:TOCL at 
1:1:1 molar ratio (negatively charged) induced a progressive decrease of the 
fluorescence intensity of the lipid probe. This effect, which can be assigned to binding 
or incorporation of the drug to/into NBD-PE-containing lipid bilayers, results from the 
high sensitivity of the fluorescent probe to the dielectric constant of its environment 
[522]. As expected, data obtained with both membrane systems pointed to a saturation 
type dynamics, indicating that MEN incorporation attained a limit at certain 
concentrations, which were much higher in POPC than in DOPC:DOPE:TOCL vesicles. 
In fact, the maximal difference between the fluorescence intensities at the peak of 
emission in the presence and in the absence of MEN was twofold higher in the former 
vesicles as compared to the latter (Fig. 18). This means that MEN bound/incorporated 
more strongly to/into the neutral bilayers than to/into those displaying a negative 
charge.  
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Fig. 18: Interaction of MEN with unilamellar vesicles composed of POPC (A), or a 
DOPC:DOPE:TOCL (1:1:1) mixture (B), as monitored by the  probes NBD-PE (circles, 
full line) and calcein (squares, dashed line). The extent of MEN binding to the membrane 
models was evaluated as the difference between the fluorescence intensities (∆F) of NBD-PE 
incorporated in lipid preparations without MEN (with ethanol in a volume corresponding to the 
maximum amount of MEN solution used) and in samples containing different MEN:lipid ratios, 
at 528 nm (corresponding to the peak of NBD-PE emission spectrum). Calcein release data 
represent the differences between the fluorescence intensity of calcein in MEN-containing and 
control preparations, normalized as percentages of the maximal fluorescence intensity 
corresponding to the total (100%) release of calcein, induced by Triton X-100. 
 
2.1.4.2.2. Menadione increases membrane permeability to calcein 
 
The effects of MEN on membrane permeability were addressed by using the fluorescent 
probe calcein, encapsulated in unilamellar vesicles with the same composition of those 
assayed for binding. The concentration at which calcein was encapsulated in vesicles 
promoted self-quenching of the probe. Therefore, membrane destabilization 
accompanied by calcein release was followed as an increase of the fluorescence 
intensity, as self-quenching decreased. As shown in Fig. 18, MEN increased the 
permeability of both membrane systems assayed; however, the membrane disturbance 
induced was stronger for POPC vesicles than for the lipid mixture (Fig. 18). This is 
consistent with the higher binding or incorporation of the drug observed in the former 
vesicles, indicating, as expected, that increased drug binding/incorporation led to 
stronger effects on membrane permeability. 
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2.1.4.2.3. Menadione affects the thermotropic behaviour of model lipid membranes 
 
In order to investigate the effects of MEN on membrane biophysical properties, DSC 
assays were performed using the same membrane models employed in the FCCP 
studies, referred in the previous section: DPPC liposomes and a mixed lipid system 
containing DPPE plus TOCL. DSC thermograms of DPPC bilayers showed, as 
expected, two typical endotherms (Fig. 19A), corresponding to the pre-transition at 
35.6°C, with a low enthalpy change, and the main transition, from a gel to a liquid-
crystalline phase, detected as a sharp peak centered at 41.5°C with an enthalpy change 
of 39.7 J/g (Table VI). MEN abolished the pre-transition peak (Fig. 19A), even at the 
lowest concentration assayed (MEN:DPPC molar ratio of 1:48), and increasing 
concentrations of MEN induced a shift of the main transition temperature range towards 
progressively lower temperatures, the highest MEN concentration assayed promoting a 
decrease of Tm of about 3.1°C (Table VI). MEN also promoted a progressive 
broadening of DPPC main transition, reflecting a decrease of the cooperativity of the 
transition, accompanied by an increase of the enthalpy (Table VI). 
 
Table VI: Characterization of the phase transitions detected by DSC (temperature of the 
endothermic peak, Tm, transition temperature range, Tf-T0, and enthalpy change, ∆H) in 
liposomes of DPPC or DPPE:TOCL (7:3). Liposomes were incubated with MEN to obtain the 
different drug:lipid molar ratios (indicated in the Table) or with a few µl of ethanol 
(corresponding to the maximal volume of the MEN solution assayed) for the respective control 
(MEN:lipid molar ratio of zero in the Table). 
MEN:Lipid 
molar ratio 
Tm  
(ºC) 
Tf – T0  
(ºC) 
∆H  
(J/g) 
Tm  2  
(°C) 
∆H 2  
(J/g) 
MEN:DPPC Peak 1 Peak 2 
0 (control) 42.43±0.4096 2.25±0.1849 38.54±0.5618 ---------- ---------- 
1:48 41.53±0.2145 2.75±0.05462* 39.68±0.3734 ---------- ---------- 
1:24 40.74±0.2228* 3.14±0.07364* 41.48±0.7017* ---------- ---------- 
1:12 40.32±0.2191** 3.56±0.07209** 42.08±0.6974* ---------- ---------- 
1:6 39.36±0.1759** 4.48±0.3725** 43.16±1.240* ---------- ---------- 
MEN:Lipid 
Mixture 
 
0 (control) 48.16±1.995 9.45±1.981 20.18±0.7718 ---------- ---------- 
1:12 46.79±1.721 10.53±1.711* 19.80±0.7893* 57.82±0.603 0.41±0.2195 
1:6 45.19±0.342* 11.07±2.048** 18.11±0.5554** 54.62±1.919* 2.79±0.7930** 
a)  Values presented are means ± standard deviation of three to four DSC experiments. Comparisons were 
performed using one-way ANOVA, with the Student-Newman-Keuls as a post-test for the following 
paired observations: liposomes with each MEN:lipid molar ratio versus control liposomes (without 
MEN). ***, P <0.001; **, P <0.01; *, P <0.05. 
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Fig. 19: DSC thermograms of liposomes prepared from DPPC (A) or a mixture of DPPE 
and TOCL 7:3 molar ratio (B), in the absence (Cont.) or presence of MEN at the 
MEN:lipid molar ratios indicated on the scans. The DSC profiles were originated from 
heating scans. The thermograms are typical representations of at least three independent 
experiments. 
 
As previously shown, liposomes prepared from DPPE and TOCL form an ideal mixture 
at a molar ratio of 7:3, showing a single, but broad (Tf-To≈10°C) endotherm centered at 
about 48.2ºC (Fig. 19B and Table VI), which makes this mixture prone to undergo 
lateral phase separation. The addition of MEN to these liposomes promoted the 
emergence of a new endothermic peak with a higher transition temperature than the 
single peak of the control lipid preparation (without drug), suggesting the formation of 
DPPE-enriched lipid domains. Regarding the enthalpies of the transitions (∆H), the sum 
of the enthalpies corresponding to the two endotherms exhibited by MEN-containing 
lipid preparations was approximately equivalent to the enthalpy of the control 
preparation, confirming the occurrence of lipid domain formation (Table VI). On the 
other hand, the enthalpy of the second peak significantly increased as the concentration 
of MEN increased (from 1:12 to 1:6 MEN:lipid molar ratio), reflecting an enlargement 
of the segregated DPPE-enriched domains (Table VI). Interestingly, this peak was also 
shifted to lower temperatures as MEN concentration increased. 
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2.1.4.2.4. Menadione changes the membrane phase equilibrium in mixed non-
bilayer and bilayer lipid systems favoring the hexagonal II phase 
Fig. 20: 
31
P NMR spectra of aqueous dispersions of DOPC:DOPE:TOCL (1:1:1) with 
CaCl2 (1:1 to cardiolipin) at different temperatures (indicated in the figure), in the absence 
(Control) or the presence of MEN at a 1:6 drug to phospholipid molar ratio (Menadione). 
For each sample, the spectrum was first averaged at 25ºC over a period of about 20 min, and 
then the process was repeated over a range of temperatures with 15ºC increments. Each sample 
(600 µl) contained 5 mg of total lipid. 
 
The effect of MEN on lipid mesomorphism exhibited by a heterogeneous ternary lipid 
system containing bilayer (DOPC) and non-bilayer prone phospholipids (DOPE and 
TOCL plus calcium) was investigated by 31P NMR. This mixture somehow mimics the 
IMM, since it contains the three major components of that structure. As previously 
shown, the mixture of DOPC:DOPE:cardiolipin:Ca2+ (1:1:1:1 molar ratio) at 25ºC is 
mainly organized in extended bilayers (giving rise to the characteristic asymmetrical 31P 
NMR lineshape with a low-field shoulder and a high-field peak [480] separated by 
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approximately 10 ppm) but part of the component lipids is organized in an inverted 
hexagonal phase, as evidenced by the small peak downfield of phosphoric acid (set at 0 
ppm), which became more evident in the spectrum as the temperature increased (Fig. 
20). At 70ºC, the HII phase notoriously predominated relatively to the bilayer 
component, an effect likely prompted by the presence of Ca2+, which induces CL to 
form non-lamellar arrangements [238]. The incorporation of MEN (at a molar ratio of 1: 
6 to lipid) clearly affected lipid phase behaviour, the HII phase becoming the 
predominant component above 40ºC. Therefore, MEN seemed to promote the formation 
of non-lamelar structures (HII arrangements in particular) in the lipid model system 
assayed, an effect similar to that previously reported for FCCP. 
 
2.1.4.2.5. Menadione location within the membrane depends on lipid composition 
and structure 
 
The location of MEN along the depth of the bilayer was investigated by steady-state and 
time-resolved fluorescence using the probes DPH and TMA-DPH, which, similarly to 
DPH-PA locates closer to the lipid-water interface due to its charged group [523]. In 
DPPC liposomes, MEN induced a concentration-dependent reduction of DPH and 
TMA-DPH fluorescence (Fig. 21A and B). The extent of fluorescence quenching 
induced in both probes was evaluated by plotting steady-state fluorescence (F0/F) and 
lifetime measurements (τ0/τ) as a function of MEN concentration (Fig. 21C and D) 
according to the Stern-Volmer equations [3] and [4], now reporting to MEN. 
As shown in Fig. 21C and D, the dynamic quenching represented by the lifetime Stern-
Volmer plot (dotted line) was lower than the quenching gathered from steady-state 
fluorescence measurements (solid line) for both probes, indicating the occurrence of an 
additional static quenching process, which did not influence excited state lifetimes. 
Therefore, the quenching process was analyzed by a modified form of the Stern-Volmer 
equation, which accounts for the additional static quenching [469]: 
 
[ ]( )
[ ]QK1
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I
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This expression contemplates the dynamic quenching component characterized by the 
dynamic Stern-Volmer constant KD, as well as the static component, characterized by 
the static Stern-Volmer constant KS. The KD component was experimentally determined 
as the slope of the lifetime measurement plot. On the other hand, a plot of (I0/I) / (1+KD 
[MEN]) versus [MEN] yielded a straight line with an intercept of 1 and a slope of KS 
(data not shown).  
 
 
 
Fig. 21: Quenching effect of MEN on the emission of DPH (A) and TMA-DPH (B) 
incorporated in DPPC liposomes as a function of drug concentration, measured at 432 nm. 
The corresponding Stern-Volmer plots are represented for the probes DPH (C) and TMA-
DPH (D) as a function of MEN concentration. Stern-Volmer plots were obtained from steady 
state fluorescence measurements (black circles) and from fluorescence lifetime measurements 
(white circles). Lines are the best fit for equations [3] (solid line) and [4] (dotted line). Results 
are representative of at least three independent determinations for each condition. Comparisons 
were performed using one-way ANOVA, with the Student-Newman-Keuls as a post-test for the 
following paired observations: liposomes with a MEN/lipid ratio of 1:48, 1:24, 1:12, 1: 9 or 1:6 
versus control liposomes (without MEN); **, P <0.01; *, P <0.05; ns, not significant. 
Table VII: Values of the Stern-Volmer constant corresponding to the dynamic quenching (KD), 
the static quenching (KS), and the combination of the two types of quenching (KSV), as well as 
2. Experimental Work 
 
 89 
João P. Monteiro, 2012 
 
the bimolecular quenching constant (Kq) obtained from measurements of fluorescence 
quenching of DPH and TMA-DPH at different MEN:lipid ratios, for liposomes composed of 
DPPC or a lipid mixture of DOPC:DOPE:TOCL (1:1:1) with Ca2+ 1:1 to CL at 25ºC or 70ºC. 
Quenching studies with isolated mitochondrial membranes were also performed at the 
temperature range from 25 to 50ºC. 
Lipid Probe KD(M
-1
X10
-4
)  
(a) 
KS(M
-1
 X10
-4
) 
(b) 
KSV(M
-1
 X10
-4
) Kq(M
-1
 X10
-12
) 
(c) 
 
DPPC 
DPH 0.245±0.028 2.80±0.07 3.19±0.04 4.28±0.09 
TMA-DPH 0.178±0.008* 0.46±0.02** 0.642±0.121 ** 2.35±0.01** 
Lipid mixture  
25°C  
(Lα phase) 
DPH 0.182±0.005 0.146±0.008 0.362±0.004 0.416±0.004 
TMA-DPH 0.149±0.004* 0.123±0.004* 0.280±0.005* 0.726±0.016** 
Lipid mixture  
70°C  
(HII phase) 
DPH 0.920±0.058 0.966±0.110 2.50±0.08 4.33±0.29 
TMA-DPH 0.273±0.011** 0.267±0.020** 0.430±0.090** 3.93±0.06* 
Mitochondrial 
membranes  
25°C 
DPH 1.88±0.06 ______ 1.88±0.06 3.72±0.08 
TMA-DPH 0.265±0.014** 0.420±0.005 0.715±0.030** 1.53±0.01** 
Mitochondrial 
membranes   
37°C 
DPH 1.93±0.09 ______ 1.93±0.09 3.87±0.16 
TMA-DPH 0.304±0.03** 0.600±0.030 0.577±0.002** 2.76±0.08** 
Mitochondrial 
membrenes   
50°C 
DPH 1.87±0.05 ______ 1.87±0.05 4.00±0.06 
TMA-DPH 0.526±0.012** ______ 0.526±0.012** 2.98±0.10** 
Values presented are means ± standard deviation of three fluorescence quenching experiments. 
(a) KD values were calculated from the slope of the lifetime linear plots (τ0/τ versus [MEN]) based on 
equation [4]. 
(b) KS values were calculated from the slope of the linear plots (I0/I) / (1+KD [MEN]) versus [MEN] 
based on equation [8]. 
(c) Kq values were calculated using the KSV values and experimental τ0 of the probe. 
Values presented are means ± standard deviation of at least 3 experiments. Comparisons were performed 
using one-way ANOVA, with the Student-Newman-Keuls as a post-test for the following paired 
observations: lipid models labelled with TMA-DPH versus corresponding lipid models labelled with DPH 
at the same temperature, **, P <0.001; *, P <0.05. 
 
The quenching parameters obtained from the analysis of the Stern-Volmer plots (KD 
from collisional quenching, KS from static quenching and KSV, as the sum of both 
contributions) are shown in Table VII. 
In order to compare the quenching effects on DPH and TMA-DPH, the bimolecular 
quenching rate constant (Kq=KSV/τ0) [469] was calculated. This parameter, also shown 
in Table VII, reflects, as previously referred, the efficiency of quenching, which in the 
case of the present study depends on the accessibility of MEN molecules to the 
fluorescent probe, eliminating specificities related with the fluorescence lifetime of the 
probe (τ0). The analysis of Table VII data, showing that the Kq value obtained with DPH 
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incorporated in liposomes of DPPC was about 82% higher than that with TMA-DPH, 
suggests a clear preference of MEN to locate at the deeper hydrophobic regions of 
DPPC bilayers. 
Aiming at establishing a correlation between MEN membrane interactions and its 
effects on mitochondria, quenching analysis were extended to other more realistic 
membrane model composed of a lipid mixture of DOPC:DOPE:TOCL at 1:1:1 molar 
ratio, and also to suspensions of isolated mitochondrial membranes. 
Regarding the lipid mixture model at 25ºC, at which temperature 31P NMR data showed 
an existing balance between the hexagonal and the lamellar phases in the presence of 
MEN, this compound exhibited a preference to be localized closer to the upper 
segments of the lipid hydrocarbon chains, monitored by TMA-DPH. Indeed, in these 
conditions, the Kq value obtained with TMA-DPH was about 74.5% higher than that 
with DPH. In contrast, at 70ºC, when HII lipid arrangement clearly predominated, MEN 
showed a tendency to display an almost uniform distribution across the bilayer 
thickness, since the Kq value obtained with DPH was only about 10% higher than that 
obtained with TMA-DPH. 
It is worth mentioning that, when the lipid mixture in the presence of MEN adopted 
preferentially an inverted hexagonal structure (at 70ºC), Kq values for DPH and TMA-
DPH were respectively 10 and 5 times higher than those obtained at 25ºC (Table VII), 
temperature at which a significant component assigned to the lamellar structure was 
detected in the 31P NMR spectrum of the MEN-containing lipid mixture. This seems to 
indicate that MEN was more efficiently incorporated into this lipid system when 
arranged in HII phases, which may justify its tendency to favor this phase in detriment of 
the lamellar phase. 
In isolated mitochondrial membranes, MEN showed a high incorporation (similar to 
that into DPPC or the lipid mixture in the HII phase) with a preferential location in the 
inner bilayer regions close to DPH, which displayed higher quenching by MEN as 
compared to TMA-DPH. The nature of the quenching process also differed for the two 
probes. MEN quenched DPH fluorescence exclusively by a dynamic, collisional 
process. In contrast, MEN-induced quenching of TMA-DPH fluorescence involved, 
besides a dynamic process, a static one, which resulted from the formation of a non-
fluorescent ground-state complex between the probe and MEN. Taking into account 
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TMA-DPH localization in the bilayer, it seems reasonable to propose that MEN may be 
bound electrostatically to the headgroups of phospholipids. At the highest temperature 
assayed, the static quenching component disappeared due to complete dissociation of 
the weakly bound drug-probe complexes and TMA-DPH quenching became exclusively 
collisional in nature. 
 
2.1.4.2.6. Menadione affects lipid packing in isolated mitochondrial membranes 
 
The effects of MEN on lipid dynamics and phospholipid acyl chain packing were 
evaluated by determining probe rotational correlation time (θ) [523-525] in the single 
and ternary lipid models as well as in the mitochondrial membranes, using equation [7]. 
Since the location of MEN had been previously assessed, data regarding MEN effects 
on lipid fluidity, represented in Fig. 22, were gathered from the spectroscopic 
parameters provided by the probe to which MEN localized closest, in each lipid 
preparation. 
 
 
Fig. 22: (A) Rotational correlation time (θ) of DPH or TMA-DPH as a function of MEN 
concentration. (A) DPPC liposomes with DPH (black squares); mixture of 
DOPC:DOPE:TOCL (1:1:1) plus Ca2+ (at 1:1 Ca2+:cardiolipin molar ratio) at 25ºC with TMA-
DPH (white circle) and at 70ºC  with DPH (grey circles); (B) isolated mitochondrial membranes 
with DPH at 25ºC (black diamonds), 37ºC (grey diamonds) and 50ºC (white diamonds). Results 
are means ± standard deviation of at least three independent determinations. 
 
These results show that MEN promoted an increase of fluidity (decrease of θ) in the 
lipid mixture at 70ºC (hexagonal phase). However, in DPPC bilayers and in the lipid 
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mixture preparation at 25ºC (where a significant component in the lamellar phase exists) 
the influence of MEN on membrane fluidity was almost negligible, at least within the 
concentration range assayed (Fig. 22A). In contrast, mitochondrial membranes showed 
a significant increase in fluidity as a function of MEN concentration throughout the 
temperature range tested in (Fig. 22B). 
 
2.1.4.3. Discussion 
 
MEN generates intracellular ROS at multiple cellular sites through futile redox cycling 
[526]. MEN biological activity has been shown to promote either favorable or 
deleterious effects on cellular functioning. Low levels of MEN-induced oxidative stress 
have shown to mimic endogenous oxidant signals that trigger protection against 
ischaemic injury in the heart [527]. In contrast, higher concentrations of MEN were 
reported to induce toxic oxidative stress associated with tissue injury, mitochondrial 
DNA damage, and cell death [528-531]. In fact, MEN genotoxicity has been attributed 
to its ability to damage DNA via ROS generation [532]. On the other hand, therapeutic 
benefits of MEN have been described in the treatment of leukemia and gastrointestinal 
and lung cancers [506-509].  
MEN capacity to promote lipid peroxidation associated with its high propensity to 
incorporate into membranes due to its lipophilic character [533] has been related to 
MEN-induced human cancer cell degeneration [534]. MEN incorporation into 
membranes was demonstrated in the present work using liposomes of different 
composition and mitochondrial membranes. Concomitant disturbances of membrane 
physical properties were also detected by different techniques (DSC, 31P NMR, and 
spectrofluorimetry), likely related with MEN-induced increase of membrane 
permeability, as deduced by the calcein release assays (Fig. 18). Noteworthy, curves 
representing MEN-membrane binding/incorporation and MEN-induced calcein release 
as function of drug concentration almost overlapped (Fig. 18). The increase of calcein 
release from lipid vesicles in the presence of MEN might be associated to a decrease in 
lipid packing, which would favor the generation of small free volumes, hence 
facilitating calcein diffusion across the lipid bilayer. However, the appearance of 
discontinuities and defect lines in the interface regions between lipid domains at 
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different phases has been shown to promote an increase of membrane permeability even 
more efficient than the moderate increase induced by the occurrence of lateral 
membrane lipid separation [535]. Consistently, DSC studies carried out in the mixed 
lipid system (7 DPPE: 3 TOCL) showed that MEN, like FCCP, induced the segregation 
of DPPE-enriched domains (Fig. 19B), revealing its capacity to promote lateral phase 
separation. On the other hand, an increase of MEN concentration promoted a downshift 
of the transition temperature of the DPPE-segregated domains (Fig. 19B), as well as of 
the DPPC liposomes (Fig. 19A), reflecting the disordering effect associated with the 
incorporation of MEN in lipid bilayers. Uneven distribution of this xenobiotic into the 
membrane is suggested by MEN preferential interaction with zwitterionic 
phospholipids: DPPE in the mixture of DPPE:TOCL, as deduced from DSC studies, and 
POPC bilayers rather than the DOPC:DOPE:TOCL negatively charged membranes, as 
demonstrated by the binding studies (Fig. 18).  It should be expected that in protein-
enriched heterogeneous membranes, such as native mitochondrial membranes, MEN 
should exert perturbations in membrane lipid organization. Consistently, a decrease of 
DPH rotational correlation time in isolated mitochondrial membranes in the presence of 
MEN was observed (Fig. 22B). The higher quenching of DPH as compared with TMA-
DPH in these membranes, at different temperatures (Table VII) indicates a location of 
MEN within the lipid bilayer, although MEN displayed a more uniform distribution 
across the bilayer thickness at physiologic temperature (37ºC) (Kq with DPH only 1,4 
times higher than Kq with TMA-DPH). On the other hand, 31P NMR studies using 
membrane models composed of the three more representative lipid classes of 
mitochondrial membranes (PC, PE and CL) in the presence of Ca2+ (an important cation 
in the regulation of mitochondrial functioning) showed that MEN induced increased 
propensity for non-lamellar phase generation (Fig. 20), similar to what was already seen 
for FCCP. Altogether, these effects could promote an increase of the permeability of 
mitochondrial membranes, which could be on the basis of the reported MEN-induced 
increase of mitochondrial state 4 respiration (a state of passive respiration, relying on 
proton diffusion across the IMM [521]) and decrease of mitochondrial transmembrane 
potential (∆Ψ) [518]. Moreover, the perturbation of membrane physical properties could 
lead to the opening of pores in the membrane through which not only ions could diffuse, 
but also small molecules could be released. Consistently, MEN-induced activation of 
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apoptosis has been associated with a decrease of ∆Ψ and the release of cyt c from 
mitochondria to the cytosol [518]. MPT has also been proposed as being involved in 
this process, its induction being mediated by ROS generation through MEN redox-
cycling mechanism [536]. However, our results show that other mechanisms could be 
involved in the process by which MEN induced MPT. In fact, MEN high propensity to 
induce lateral phase separation in membrane models containing CL, along with its 
proneness to promote the formation of non-lamellar phases (Fig. 20) may modulate 
MEN action in CL-enriched mitochondrial membrane regions like the MCS’s [97], 
where structures of high curvature have been proposed to be present [237] and MPT 
pore is thought to be formed [254]. 
In conclusion, this study provides a significant amount of data showing that MEN holds 
considerable membrane activity, which matches its action as an apoptosis enhancer. 
Moreover, these data provide new elements for understanding previous results regarding 
MEN toxic effects on rat hepatocytes [517] or MEN-induced apoptosis mediated by 
MPT and involving mitochondrial cyt c release [518]. Finally, the biophysical approach 
to MEN cellular effects, namely regarding the induction of mitochondrial-mediated 
apoptosis, should provide new targets to be addressed by MEN or similar compounds in 
the treatment of diseases such as cancer, where the induction of apoptosis could 
constitute a therapeutic strategy. 
 
2.1.5. Nimesulide 
 
2.1.5.1. Introduction 
 
NSAIDs constitute a wide group of compounds used in the treatment of fever, pain and 
inflammation [537]. NSAIDs act mainly by inhibiting the activity of prostaglandin H2 
synthase (also known as cycloxygenase). Despite this direct inhibitory effect, NSAID-
induced biophysical changes in membranes have also been considered as contributing to 
their anti-inflammatory action [538]. NSAIDs have been assumed to affect many 
membrane processes and to inhibit several membrane-associated enzymes other than the 
aforementioned cycloxygenase, such as phospholipase A2 and phospholipase C [396, 
539, 540]. Transmembrane ion fluxes and cell-to-cell binding have also been decribed 
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as being affected by NSAIDs [540]. Nimesulide, 4-nitro-2-phenoxymethane-
sulfonanilide (NIM; Fig. 23) is a NSAID with a multifactorial mechanism of action 
[537, 541], which bases its anti-inflammatory action by preferentially inhibiting 
cycloxygenase-2 [539]. Although NIM causes a relatively low occurrence of 
gastrointestinal injury and exhibits good overall tolerance [542], rare but mild to serious 
NIM-associated hepatic adverse effects have been reported [543, 544]. The mechanisms 
underlying this idiosyncratic hepatotoxicity are unknown, but mitochondrial injury and 
oxidative stress have been implicated as contributing to liver damage in susceptible 
patients [544]. 
 
 
Fig. 23: Structural formula of nimesulide (4-nitro-2-phenoxymethane-sulfonanilide). 
 
There is a substantial body of evidence supporting the protonophoric activity of NIM 
[344, 349, 399, 400]. Mingatto et al. [349] showed that the nitro group is the main 
responsible for conferring to NIM a potent uncoupler activity and also NAD(P)H 
oxidant properties. The close parallelism between NIM-induced stimulation of state 4 
respiration and dissipation of ∆Ψ indicates that a protonophoric mechanism should be 
involved in NIM-promoted mitochondrial uncoupling [349]. In full agreement with data 
obtained in isolated mitochondria, NIM ability to stimulate respiration has also been 
demonstrated in intact cells [344, 400, 545] and in perfused whole heart preparations 
[344]. In addition to the uncoupling activity, induction of MPT [349, 400] and 
interference with Ca2+ homeostasis have also been attributed to NIM, within a 
concentration range easily attainable in vivo [349]. On the other hand, a NIM metabolite 
resulting from the reduction of its nitro group to an amine derivative, showed complete 
inability to promote mitochondrial responses and loss of hepatocyte viability [349, 545]. 
This fact has two important implications: firstly, mitochondrial-mediated hepatoxicity 
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should be assigned to the parent drug; secondly, NIM adverse mitochondrial effects and 
hepatocyte toxicity [545] should involve drug membrane interactions, since NIM, in 
contrast to its reduced metabolite, penetrates deeply into the hydrophobic region of 
membranes [545]. 
Although several studies have been conducted to elucidate the interaction of NIM with 
membranes discussing its implications for drug pharmacological activity [434, 484, 
546], it is not yet fully understood, however, how it exerts its deleterious actions on 
mitochondria by interaction with the mitochondrial membrane. Since the physical 
properties of mitochondrial membranes are extremely hard to fully characterize due to 
the complex membrane composition, lipid preparations that somehow mimic the CL-
enriched lipid bilayer of the IMM were used in the present work to perform biophysical 
studies. Besides unveiling the mechanisms of the interaction of NIM with mitochondrial 
membranes, this work can also contribute to identify novel targets for NSAID toxicity, 
hence allowing the future development of more selective drugs and diminishing the 
undesirable side-effects. 
 
2.1.5.2. Results 
 
2.1.5.2.1. Nimesulide binding to membrane model systems depends on lipid 
composition 
 
The interaction of NIM with unilamellar vesicles of POPC or DOPC:DOPE:TOCL 
(1:1:1) was studied using the fluorescent lipid probe NBD-PE, whose fluorescence 
intensity and maximum emission wavelength are strongly sensitive to the dielectric 
constant of the environment [522]. The interaction of NIM with both membrane models 
induced changes in NBD-PE fluorescence intensity, which showed dependence of NIM 
concentration (Fig. 24). It is clear that NIM binds (or incorporates) more strongly to 
zwitterionic (POPC) than to negatively charged (DOPC:DOPE:TOCL) vesicles (Fig. 
24), since, at the same drug concentration, NIM induced larger NBD-PE fluorescence 
intensity changes in the former lipid bilayers. At the physiologic pH used in this assay, 
NIM exhibits a negative charge [547]. As CL-containing bilayers are also negatively 
charged, the lower binding to these membranes should likely result from an electrostatic 
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repulsion between NIM molecules and the headgroups of the membrane anionic lipid 
components (CL). The spectral changes obtained with both membrane systems seem to 
point to a saturation type dynamics, which is compatible with a limited incorporation of 
the negatively charged drug into the membrane or a limited binding at the membrane 
surface. 
 
Fig. 24: Interaction of NIM with unilamellar vesicles composed of POPC (A), or a 
DOPC:DOPE:TOCL (1:1:1) mixture (B), as monitored by the probes NBD-PE (circles, 
full line) and calcein (squares, dashed line). The extent of NIM binding to the membrane 
models was evaluated as the difference between the fluorescence intensities (∆F) of NBD-PE 
incorporated in lipid preparations without NIM (with DMF in a volume corresponding to the 
maximum amount of NIM solution used) and in samples containing different NIM:lipid ratios, 
at 528 nm (corresponding to the peak of NBD-PE emission spectrum). Calcein release data 
represent the differences between the fluorescence intensity of calcein in NIM-containing and 
control preparations, normalized as percentages of the maximal fluorescence intensity 
corresponding to the total (100%) release of calcein, induced by Triton X-100. 
 
2.1.5.2.2. Nimesulide increases membrane permeability to calcein 
 
The effects of NIM on membrane permeability were assessed by the calcein release 
assay in unilamellar vesicles of the same composition of those assayed for binding. 
Vesicles were loaded with a calcein concentration at which self-quenching occurs, and 
membrane destabilization accompanied by calcein release was measured by an increase 
of the fluorescence intensity. NIM showed to increase the permeability of both 
membrane systems assayed (Fig. 24), although promoting higher calcein release from 
the zwitterionic vesicles, to which NIM is supposed to bind stronger. 
2.1.5.2.3. Nimesulide exerts moderate effects on the thermotropic properties of 
membrane models 
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The physical effects of NIM on membrane model systems (DPPC, and DPPE plus 
TOCL) were investigated by conducting DSC studies. The addition of NIM to DPPC 
bilayers abolished the pre-transition peak (data not shown), even at the lowest 
concentration used (NIM:DPPC molar ratio of 1:24). Increasing concentrations of NIM 
promoted a shift of the main transition towards lower temperatures (the highest NSAID 
concentration assayed promoted a decrease of Tm of about 1.9ºC) and a progressive 
broadening of the endotherm (Tf-To), but no significant effects on the enthalpy of the 
transition were noticed (Table VIII). 
The addition of NIM to DPPE:TOCL (7:3) liposomes did not promote relevant 
alterations of the thermotropic profile, although a broadening of the temperature range 
at which occurred the transition from a gel to a liquid-crystalline phase has been 
observed, suggesting a decrease of the cooperativity of this lipid system (Table VIII). 
 
Table VIII: Characterization of the phase transitions detected by DSC (temperature of the 
endothermic peak, Tm, transition temperature range, Tf-T0, and enthalpy change, ∆H) in 
liposomes of DPPC or DPPE:TOCL (7:3). Liposomes were incubated with NIM to obtain the 
different drug:lipid molar ratios (indicated in the Table) or with a few µl of DMF 
(corresponding to the maximal volume of the NIM solution assayed) for the respective control 
(NIM:lipid molar ratio of zero in the Table). 
NIM:Lipid molar 
ratio 
Tm  
(ºC) 
Tf – T0  
(ºC) 
∆H  
(J/g) 
NIM:DPPC  
0 (control) 42.46±0.27 2.87±0.08 38.40±0.94 
1:48 41.84±0.35* 3.29±0.24 38.50±1.25 
1:24 41.31±0.64 3.63±0.37 39.28±1.06 
1:12 41.11±0.66* 3.72±0.39 38.80±0.96 
1:6 40.59±0.65* 3.98±0.44 39.40±1.29 
NIM:Lipid 
Mixture 
 
0 (control) 49.40±0.31 9.45±0.99 20.08±0.14 
1:12 49.52±0.12 12.54±0.32* 19.94±0.16 
1:6 49.54±0.03 14.11±0.75*** 19.36±0.38 
Values presented are means ± standard deviation of three to four DSC experiments. Comparisons were 
performed using one-way ANOVA, with the Student-Newman-Keuls as a post-test for the following 
paired observations: liposomes with each NIM:lipid molar ratio versus control liposomes (without NIM). 
***, P <0.001; *, P <0.05. 
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2.1.5.2.4. Nimesulide stabilizes lamellar arrangements in models mimicking 
mitochondrial membranes 
Fig. 25: 
31
P NMR spectra of aqueous dispersions of DOPC:DOPE:TOCL (1:1:1) with 
CaCl2 (1:1 to CL) at different temperatures, in the absence (Control) or presence of NIM 
at a 1:6 NIM to phospholipid molar ratio (Nimesulide). For each sample, the spectrum was 
first averaged at 25ºC over a period of about 20 min, and then the process was repeated over a 
range of temperature with 15ºC increments. Each sample (600 µl) contained 5 mg of total lipid. 
 
The effect of NIM on lipid mesomorphism was studied similarly to the other drugs by 
31P NMR, using a mixture of DOPC:DOPE:CL (1:1:1), to which an aliquot of a CaCl2 
solution was added to obtain a calcium:CL ratio of 1:1. A molar ratio of 1:6 NIM to 
phospholipid was chosen for these studies, taking into account previous DSC results. In 
the absence of NIM, but adding an equivalent aliquot of DMF (vehicle control), the 
lipid mixture showed the coexistence of lipids organized in the lamellar and the HII 
phase, as previously referred. As the temperature increased, the HII component became 
progressively more pronounced. The addition of NIM promoted a stabilization of the 
lipid lamellar structures, since the peak characteristic of the lamellar phase is generally 
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more prominent in the presence of NIM than in the control lipid suspensions, at the 
same temperature (Fig. 25). 
 
2.1.5.2.5. Nimesulide preferentially concentrates on the outer regions of the lipid 
bilayer 
 
Fig. 26: NIM quenching data are represented as fluorescence intensity differences (∆ 
Fluorescence) between control liposomes (without drug added) and liposomes prepared in 
the presence of each drug concentration. Fluorescence of the probes DPH (black bars) and 
DPH-PA (white bars) was measured in DPPC liposomes at 50ºC (A) or in a mixture of 
DOPC:DOPE:TOCL (1:1:1) plus Ca2+ (at 1:1 Ca2+:CL molar ratio) at 25ºC (B) or 70ºC (C). 
Values are means ± standard deviation of at least three independent experiments for each 
condition. Comparisons were performed using one-way ANOVA, with the Student-Newman-
Keuls as a post-test for the following paired observations: liposomes with a NIM/lipid ratio of 
1:24, 1:12, 1:9 or 1:6 versus control liposomes (without NIM). **, P <0.01; *, P <0.05; ns, not 
significant. 
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The capacity of NIM to promote quenching of the fluorescent probes DPH and DPH-PA 
was used to assess the location of NIM upon incorporation into membrane models, by 
monitoring probe steady-state fluorescence intensities and lifetimes, as previously 
described in this section. NIM induced a concentration dependent reduction of the light 
emitted by DPH and DPH-PA incorporated in DPPC liposomes (Fig. 26A), which 
indicates a broad distribution of the drug across the bilayer thickness. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 27: (A) Stern-Volmer plots of the probe DPH-PA incorporated in DPPC liposomes as 
a function of NIM concentration, obtained from steady state fluorescence measurements 
(white circles) and from fluorescence lifetime measurements (black circles). (B) 
Fluorescence quenching of the probe DPH-PA incorporated in DPPC liposomes as a 
function of NIM concentration, now represented as fitting the static quenching model. 
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For better evaluating the efficacy of NIM as a quencher, Stern-Volmer plots of I0/I or τ0/ 
τ against NIM concentration were constructed according to the equations [3] and [4], 
following the procedure previously described for the other drugs in this section. 
Figure 27A illustrates the results obtained for NIM-induced quenching of DPH-PA 
fluorescence in DPPC liposomes (similar quenching profiles were obtained for DPH in 
the same liposomes). Since a non-linear Stern-Volmer plot was obtained for the steady-
state fluorescence intensity (I0/I against NIM concentration) with an upward curvature, 
concave towards the y-axis, the fluorophore should have been quenched both by a 
collisional process and by complex formation with NIM [469]. 
Similarly to MEN, NIM quenching process was analyzed by the modified form of the 
Stern-Volmer equation [8], which contemplates both the dynamic component 
characterized by the dynamic Stern-Volmer constant, KD, and the static component of 
the quenching process characterized by the static Stern-Volmer constant, KS [469]. 
As previously described for MEN, the dynamic quenching component, determined by 
lifetime measurements, that is, τ0/τ = 1 +KD [NIM], corresponds to the straight line in 
Fig. 27A. A plot of (I0/I) / (1+KD [NIM]) versus [NIM] yielded a straight line with an 
intercept of 1 and a slope of KS (Fig. 27B). 
NIM distribution was also appraised in the mitochondrial membrane mimicking lipid 
system used for the other drugs, composed of a mixture of DOPC:DOPE:TOCL (1:1:1) 
with a 1:1 Ca2+ to CL ratio. Quenching assays were performed at two different 
temperatures: 25ºC, where the lamellar arrangement prevailed, and 70ºC, temperature at 
which the HII phase was the most relevant lipid arrangement. NIM quenched both DPH 
and DPH-PA incorporated in this model system in a concentration dependent manner, at 
both temperatures assayed (Fig. 26B and C), although some differences were noticed 
regarding the nature of the quenching. DPH probe incorporated in the lipid mixture was 
quenched both by collisions and by complex formation with the quencher, as suggested 
by the linear lifetime Stern-Volmer plot, corresponding to the dynamic quenching, and 
the non-linear plot for the steady-state fluorescence intensity with a positive deviation 
(Fig. 28A). In the case of DPH-PA, quenching occurred mainly as a result of the 
formation of a non-fluorescent ground-state complex between the probe and NIM, 
since, in this case, only static quenching was observed (I0/I = 1 +KS [NIM]) and the 
dynamic quenching was negligible, being τ0/τ ≈1 (Fig. 28B). 
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Fig. 28: Stern-Volmer plots of the probe DPH (A) and DPH-PA (B) incorporated in 
liposomes consisting of a mixture of DOPC:DOPE:TOCL (1:1:1) plus Ca
2+
 (at 1:1 
Ca
2+
:CL molar ratio) at 70ºC as a function of NIM concentration. Stern-Volmer plots were 
obtained by steady state fluorescence measurements (white circles) and by fluorescence lifetime 
measurements (black circles). 
 
 
The quenching parameters obtained from the analysis of the Stern-Volmer plots (KD 
from collisional quenching, KS from static quenching and KSV, as the combination of 
both contributions) are shown in Table IX. 
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Table IX: Values of the Stern-Volmer constant corresponding to the dynamic quenching (KD), 
the static quenching (KS), and the combination of the two types of quenching (KSV), as well as 
the bimolecular quenching constant (Kq) obtained from measurements of fluorescence 
quenching of DPH and DPH-PA. Lipid systems consisted of liposomes of DPPC or a lipid 
mixture of DOPC:DOPE:TOCL (1:1:1) with Ca2+ 1:1 ratio to CL at 25 or 70ºC. 
Lipid Probe KD(M
-1
X10
-4
)  
(a) 
KS(M
-1
 X10
-4
) 
(b) 
KSV(M
-1
 X10
-4
) Kq(M
-1
 X10
-13
) 
(c) 
DPPC DPH 3.34±0.29 6.23±1.35 9.57±1.64 1.31±0.18 
DPH-PA 3.71±0.29  6.57±1.01  10.28±1.30  2.30±0.30* 
Lipid 
mixture  
25°C  
DPH 1.82±0.23 6.01±0.14 7.83±0.37 0.95±0.18 
DPH-PA  9.86±0.54* 9.86±0.54* 2.05±0.30* 
Lipid 
mixture  
70°C  
DPH 1.84±0.51 5.18±0.33 7.02±0.84 0.91±0.18 
DPH-PA  5.99±0.62  5.99±0.62  1.28±0.30* 
Values presented are means ± standard deviation of at least 3 experiments. Comparisons were performed 
using one-way ANOVA, with the Student-Newman-Keuls as a post-test for the following paired 
observations: liposomes labelled with DPH-PA versus liposomes labelled with DPH, *, P <0.05. 
(a) KD values were calculated from the slope of the lifetime linear plots (τ0/τ versus [NIM]; equation [4]) 
(b) KS values were calculated from the slope of the linear plots (I0/I) / (1+KD [NIM]) versus [NIM] based 
on equation [8] 
(c) Kq values were calculated using the KSV values and experimental τ0 of the probe. 
 
To compare NIM quenching effects on the two probes (DPH and DPH-PA), the 
bimolecular quenching rate constant (Kq=KSV/τ0) was calculated. The analysis of the Kq 
values (Table IX, column c) indicates that: a) in DPPC liposomes, NIM was slightly 
more efficient quenching the probe DPH-PA than DPH; and b) in the ternary lipid 
system a higher Kq value was obtained with DPH-PA than with DPH at both 
temperatures tested (25ºC and 70ºC), although the difference between NIM quenching 
efficiency towards DPH and DPH-PA has been attenuated at 70ºC. Thus, in conditions 
in which the mixture of lipids is preferentially organized in a lamellar structure (25ºC), 
the Kq value obtained with DPH was about 46% of that with DPH-PA, reflecting a 
preferential location of NIM molecules closer to the outer regions of the lipid bilayer. In 
contrast, at 70ºC, temperature at which the HII phase predominates, NIM seems to have 
a more uniform distribution, since the Kq value obtained with DPH was about 71% of 
that with DPH-PA. 
Static and dynamic quenching can be distinguished by their dependence on temperature. 
Higher temperatures result in faster diffusion, hence larger amounts of collisional 
quenching, and in the dissociation of weakly bound complexes, leading to smaller 
amounts of static quenching [469]. Data presented in Table IX shows that whereas the 
KD values (Table IX, column a) resulting from the quenching of DPH incorporated in 
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the ternary lipid mixture slightly increased with the increment of temperature (from 25 
to 70ºC), the KS values (Table IX, column b) of DPH and DPH-PA in the same lipid 
system decreased when the temperature was raised from 25ºC to 70ºC. Therefore, in the 
case of DPH-PA, quenching occurred mainly as a result of the formation of a non-
fluorescent ground-state complex between the probe and NIM, which suggests that NIM 
may be bound electrostatically to the headgroups of phospholipids (probably from 
DOPC and DOPE) and hence concentrated on the surface of the liposomes (Fig. 29). 
Similar behaviour has been observed with other ionic compounds that establish 
electrostatic interactions with the headgroups of vesicle phospholipids and, thus, are 
localized within an interaction radius of the system fluorophore-quencher, acting as 
static quenchers of fluorophores with similar locations [548]. 
 
 
Fig. 29: Representative diagram showing the proposed distribution of NIM and 
fluorescent probes (DPH and DPH-PA) molecules in lamellar and non-lamellar lipid 
phases. 
 
As for FCCP and MEN, the effects of NIM on lipid dynamics and phospholipid acyl 
chain packing were studied by fluorescence anisotropy, using the rotational correlation 
time (θ) of DPH-PA (the probe to which NIM was closest localized in both single and 
ternary lipid systems), calculated from the measured rss values and the variation of τ, 
considering that the rotational motion of the probe was not hindered [469, 494, 523], 
according to equation [7]. 
Since θ gives information about the probe motion, it indirectly reports the fluidity of the 
lipid environment surrounding the probe. Results (Fig. 30) show that NIM promoted an 
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increase of fluidity of the lipid mixture at 25ºC (where lamellar phase predominated). 
However, in the case of DPPC liposomes and the lipid mixture at 70º C (where HII 
phase prevailed), the influence of NIM on membrane fluidity was almost negligible, at 
least in the range of concentrations tested. 
 
Fig. 30: Rotational correlation time (θ) of DPH-PA as a function of NIM concentration in 
DPPC (black circles) and DOPC:DOPE:TOCL (1:1:1) plus Ca
2+
 (at 1:1 Ca
2+
:CL molar 
ratio) preparations at 25ºC (white circles) and at 70ºC (white triangles). Results are means 
± standard deviation of at least three independent determinations. 
 
2.1.5.3. Discussion 
 
NIM is a widely prescribed NSAID that acts by preferential inhibition of 
cycloxygenase-2 [539] and has been generally considered safe [541]. However, on the 
basis of some reported cases of severe liver injury, a significant risk of hepatotoxicity 
associated to NIM, especially when prescribed to susceptible patients has been unveiled 
[543]. Mitochondrial dysfunction has been pointed as a general mechanism underlying 
hepatotoxic action of NIM and many other NSAIDs [544]. Due to its lipophilicity and 
weak acid character (pKa 6.5;[547]), NIM can easily penetrate mitochondrial 
membranes, shuttling protons from the IMS to the mitochondrial matrix, hence leading 
to uncoupling of oxidative phosphorylation by a protonophoric mechanism [349]. 
Additionally, mechanisms such as induction of the MPT and Ca2+ efflux [349, 400] 
have been proposed to explain NIM-induced mitochondrial dysfunction and hepatocyte 
demise. 
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Although the concentrations at which NIM affects the activity of isolated mitochondria 
(5-25 µM) [349] are within the range of NIM therapeutic levels, which correspond to 
10-20 µM (2.86 to 6.50 mg/L as peak plasma concentration achieved after oral 
administration of a 100 mg dose, according to Bernareggi [542]), those are probably 
much higher than the concentration that reaches mitochondria, because of the high 
plasma protein binding [542]. However, several factors may interfere with NIM 
bioavailability which should be taken into account.  Firstly, since NIM is extensively 
metabolized, the liver representing the main metabolizing organ [542], its 
pharmacokinetics may be affected by hepatic insufficiency or by interaction with other 
chemical compounds, which are also known to be associated with hepatotoxicity (e.g. 
paracetamol, antibiotics, diclofenac, angiotensin-converting enzyme inhibitors). 
Secondly, due to its lipophilicity, NIM is prone to accumulate into the hydrophobic 
region of membranes, as demonstrated by Mingatto et al. [545], using isolated non-
energized mitochondria and according to the binding (Fig. 24B) and quenching data 
(Table IX) presented here for a mitochondrial membrane mimicking model. A third 
aspect to be considered is the potential of specific diets to modify membrane lipid 
composition, and therefore NIM incorporation in membrane systems and the resulting 
effects on membrane-dependent physiological processes, as will be explored in a 
following section of this work. 
In the same concentration range at which NIM showed to bind/incorporate in the IMM 
mimicking lipid system, it also induced calcein release (Fig. 24B). The same 
mechanisms proposed for MEN to increase calcein release from lipid vesicles can be 
applied for NIM: a) increase in the extent of trans-gauche isomerization and the rates of 
wobble and axial diffusion of the phospholipid acyl chains, creating small transient free 
volumes across the bilayer, hence facilitating passive diffusion of the fluorophore; b) 
induction of lipid lateral phase separation, leading to the appearance of leaky interfacial 
defects between adjacent domains, favoring concentration-driven calcein circulation 
through transitory pores. Probably, both mechanisms occur in the lipid systems assayed. 
Although DSC studies showed that NIM, unlike FCCP and MEN, did not promote clear 
lipid segregation in the dimeric system 7 TOCL: 1 DPPE (Table VIII), it did promote a 
significant broadening of gel-to-fluid transition, which reflects a decrease of the 
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Membrane perturbation induced by NIM was revealed not only by the decrease of 
cooperativity of the phase transition of the binary lipids system but also by the shift of 
the endotherm peak of DPPC liposomes to lower temperatures (Table VIII). On the 
other hand, in membrane models prepared with the main classes of lipids present in the 
IMM (DOPC:DOPE:TOCL, 1:1:1) in the presence of Ca2+ (a divalent cation which is 
accumulated in those organelles), NIM showed to be distributed across the bilayer 
thickness (Table IX) and to promote lipid disorder as evaluated by fluorescence 
anisotropy of DPH-PA (Fig. 30). The high value of θ in the control preparation (without 
addition of NIM), at 25ºC, denotes a high level of lipid packing in the upper regions of 
the hydrocarbon chains of this lipid system, probably due to the interaction of the 
phospholipid headgroups, especially those of the anionic phospholipid (CL), with 
calcium divalent ions. In previous studies using membrane models prepared from the 
polar lipid extracts of Bacillus stearothermophilus cell membrane, containing PE (80%) 
and CL (12%) as main phospholipid classes, it was shown that the addition of Ca2+ to 
those lipid preparations induced a shift of the transition phase to higher temperatures 
and a remarkable increase in the lipid order in the fluid phase, especially in the outer 
regions of the bilayer monitored by DPH-PA [488, 496]. On the other hand, it was 
demonstrated that the pharmaceutical drug tamoxifen, added to the bacterial lipid 
dispersions, promoted a disorder effect across the bilayer thickness that is more striking 
in Ca2+ supplemented liposomes and in the lipid bilayer depth surroundings occupied by 
DPH-PA [496]. Therefore, it is not surprising that NIM, sharing with tamoxifen the 
ability to induce a decrease of the transition temperature of saturated PC species [484, 
495, 549], also promoted an increase of fluidity in the outer regions of bilayers formed 
by CL plus Ca2+-containing lipid systems, probably due to the disruption of the tight 
packing of the upper portions of phospholipid acyl chains, which in turn impairs Ca2+ 
coordination by the respective phospholipid headgroups. However, negligible NIM 
effects on hydrocarbon chain packing, monitored by DPH-PA, were detected at 70ºC 
(Fig. 30). This must be related with the high level of disorder of the lipid preparations 
(denoted by the low value of θ in control conditions) compatible with a high amount of 
free volume which would be able to accommodate the drug molecules without 
aggravating the disordered motions of the lipid chains. In fact, the binding/incorporation 
of NIM predictably influences both the surface region of the vesicles, by interaction of 
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its charged group with the phospholipid headgroups, and inner regions of the bilayer, 
where the hydrophobic portion of NIM may intercalate between the phospholipid acyl 
chains, reducing the van der Waals interactions and decreasing the lipid acyl-chain 
order. These two types of interaction could be involved in the protonophoric action of 
NIM in mitochondria [349] and may explain the reported NIM-induced passive swelling 
of non-energized mitochondria suspended in isosmotic solutions of NH4Cl [399]. 
On the other hand, the preferential location of NIM in the outer regions of the bilayer, in 
the single lipid system (DPPC) as well as in mixed membranes at 25ºC, justifies NIM 
ability to stabilize the lamellar lipid arrangements (Fig. 29), as reflected by its effects 
shown on the 31P NMR spectra of the CL-containing lipid mixture (Fig. 25). NIM 
appears to counteract the increase in negative lipid curvature promoted by temperature 
[550], particularly in CL-containing membranes in the presence of Ca2+ [238]. The 
presence of the negatively charged group of NIM at the membrane surface creates a 
repulsive lateral pressure in the region of the phospholipid headgroups, increasing lipid 
motion at the outer regions of the hydrophobic bilayer and also affecting the 
spontaneous curvature by increasing the net headgroup area. The increased lipid motion 
induced by NIM at the outer regions of the hydrophobic bilayer (as monitored by DPH-
PA), might also counteract the monolayer bending around the small aqueous cylinder of 
the HII phase [550], hampering phase transition. 
By favoring and stabilizing lamellar structures over the hexagonal arrangements, unlike 
FCCP and MEN, NIM may interfere with membrane dynamics, for example at the CL-
enriched MCS’s, where non-bilayer lipids promote a high negative curvature [237]. 
Moreover, it has been reported that the activity and topological organization of 
membrane-associated proteins may be influenced by the non-lamellar propensity of the 
imbedding bilayer [220, 251, 550]. Finally, although the mechanisms of MPT 
occurrence are still controversial [551], some evidences have been accumulated 
showing the interference of the phase behaviour of lipids on MPT-associated processes 
[551-553]. 
Another interesting finding within this work is the broad distribution of NIM molecules 
across the bilayer thickness of the IMM mimicking lipid system, as assessed by NIM 
behaviour as a quencher of the fluorescent probes DPH and DPH-PA. This finding is 
consistent with the ability of this NSAID to cross the IMM, performing its uncoupling 
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activity [400, 545]. Moreover, the higher quenching of DPH-PA as compared with 
DPH, and the static nature of this quenching, suggests a probable electrostatic 
connection between NIM and the membrane surface. Considering that the conductance 
of MPTP is modulated by transmembrane and surface potentials [554], it is predictable 
that NIM may also interfere in this way with MPT, as has been reported in the literature 
[349, 400]. 
In summary, this study provides evidence that NIM interferes with the biophysical 
properties of different lipid systems, which are critical and susceptible of compromising 
important membrane processes, namely permeability, protein/lipid distribution at the 
membrane surface and the activity of membrane proteins. The present findings on NIM 
effects upon mitochondrial membrane-mimicking models suggest that research focused 
on membrane physical properties may provide new insights accounting for the side-
effects of this NSAID at the mitochondrial level, leading to interference with oxidative 
phosphorylation and MPT. This new knowledge about the profile of NIM interaction 
with membrane systems may prove important to the designing of more selective drugs, 
displaying less undesirable effects. 
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2.2. Dietary effects on mitochondrial membrane composition, 
function and toxicology 
 
2.2.1. Introduction 
 
Diet and its influence on overall cellular physiology have earned a huge interest in a 
time when healthy eating habits are increasingly rare. It has become apparent that diet is 
directly related with physiological alterations occurring at a sub-cellular level. In this 
context, a particular point of interest regards the effects diet exerts on mitochondrial 
bioenergetics. However, a large avenue remains still unpathed regarding the role of diet 
on mitochondrial physiology.  
Mitochondria are gaining increasing prominence as critical cell structures in the context 
of life and death. In addition to their energetic role as ATP producers, mitochondria are 
now perceived as having a much more intricate physiological role. In fact, besides 
influencing virtually all energy-dependent cell activity, mitochondria represent the point 
of convergence of relevant processes such as generation of ROS, Ca2+ homeostasis, 
apoptosis and intermediate metabolism [555]. As consequence of this pivotal role in cell 
physiology, mitochondria are predictably very susceptible to pharmacologic 
interactions. 
Ever since lipids were found to be strictly associated with respiratory enzymes [261], an 
increasing interest has been arising concerning the role of mitochondrial membrane 
lipid composition on bioenergetics. In fact, events such as protein biogenesis and 
membrane fusion and fission [84], production of energy via oxidative phosphorylation 
[84] and mitochondrial apoptotic signaling [170] have shown to be greatly influenced 
by the lipid content and spatial distribution in both mitochondrial membranes. Several 
lipids have been proposed as being part of the quaternary structure of mitochondrial 
membrane proteins, hence playing a crucial role in their enzymatic activity [237]. 
Studies have shown that dietary fat manipulations can alter the activities of 
mitochondrial electron transport chain complexes III [138], IV [129, 138], and V [138, 
140], as well as the amount of CoQ in mitochondrial membranes [268, 269]. Diet fat 
content, the ratio of dietary polyunsaturated/saturated fatty acids, and fatty acid chain 
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length have all been shown to alter H+-ATPase activity [140]. Alterations of cyt c 
oxidase and succinic, butyric, and glutamic dehydrogenase activities were also reported 
as a result of fat deficiency in rats [270, 271]. Specifically regarding fatty acids, it is 
interesting to note that diet content regarding fatty acid composition induces 
concomitant mitochondrial membrane lipid changes [128-130]. Subsequent adaptations 
of the mitochondrial electron-transport system related with the dietary fat type have 
been reported [556-559]. Mitochondrial production of ROS [142] and Ca2+-induced 
MPT [143] have also been reported to be influenced by diet. Hayashida and Portman 
[151] observed a 79% decrease in essential fatty acid content in mitochondria isolated 
from rats fed a fat-free diet. Johnson and Ito [152] determined the fatty acid 
composition of liver mitochondrial phospholipids from rats rendered deficient in 
essential unsaturated fatty acids and found marked reductions in the amounts of linoleic 
and arachidonic acids present in the β-position of ethanolamine-, inositol-, and choline-
glycerophosphatides. Both cyt c oxidase activity and the endogenous respiration of 
livers from fat-deficient rats were significantly higher when compared to normal fed rats 
[153]. Increased substrate oxidation [154, 155] and partial uncoupling of oxidative 
phosphorylation [156-158], measured in liver homogenates and liver mitochondria 
isolated from rats given lipid-free diets, were also described. 
Taking previous studies under consideration, the objective of the present work is to 
perform a thorough study regarding the effects of dietary lipid manipulation on liver 
mitochondrial physiology, focusing on several different aspects: a) alterations of 
membrane lipid composition and physical properties, b) alterations of relevant 
mitochondrial proteins and c) effects on mitochondrial bioenergetics, oxidative stress 
and calcium tolerance. The hypothesis is that direct manipulation of mitochondrial lipid 
composition will be reached by using a dietary approach and this will result in multi-
target alterations with consequences for mitochondrial homeostasis. Since the liver 
plays a crucial role in lipid metabolism [560], the present work focused on liver 
mitochondria, whose lipid composition is presumably susceptible to changes induced by 
a lipid enriched diet, as previously reported [561]. 
After establishing a protocol leading to consistent modifications in rat liver 
mitochondrial membranes, putative diet modulatory effects on the action of 
mitochondrially-active drugs were investigated. Therefore, this work attempts to unveil 
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the relevance that dietary approaches may hold in potentiating pharmacologic drug use 
or, in the opposite way, in counteracting drug inherent toxic side effects. 
 
2.2.2. Materials and Methods 
 
2.2.2.1. Materials 
 
FCCP, MEN and NIM were purchased from Sigma-Aldrich Chemical Co. (St. Louis, 
MO, USA). The probes DPH and DPH-PA were purchased from Molecular Probes, Inc. 
(Eugene, OR, USA). All the other chemicals were of the highest commercially available 
purity. 
 
2.2.2.2. Experimental design 
 
 
Fig. 31: General scheme of the dietary studies performed in the present study. 
 
Two months-old male Wistar rats were randomly divided into 2 groups and maintained 
on a reverse 12 h light–dark cycle with food and water ad libitum. An experimental diet 
was assigned to each group. The control group had access to a standard rodent diet, 
while the treated group was fed with a modified diet, which had the same composition 
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of the control diet but containing 20% rapeseed oil calorically adjusted for high fat (Fig. 
31; Table X). Both diets were purchased from Dyets Inc. (Bethlehem, PA) (Table XI). 
Animal weight and diet consumption were followed on a weekly basis. One rat from 
each group was sacrificed after 11, 22 or 33 days of diet consumption and organs (liver, 
heart and kidneys) were harvested and weighted, with a portion of the liver being stored 
at -80ºC for posterior processing.  Blood from rats sacrificed after 33 days of diet 
consumption was collected after decapitation to sterile tubes without additives. After 
blood clot formation, serum was separated by centrifugation at 1,600 g for 10 min at 
4ºC (Sigma 3-16K, 1333 rotor). The supernatant was then transferred to microcentrifuge 
vials and centrifuged at 16,000 g for 20 min at 4ºC (Eppendorf 5415 R, FL062 rotor). 
Serum samples were maintained for a short time at 4ºC for analysis by an external 
certified laboratory. 
 
 
Table X: Physical characteristics and composition of the oils included in the rodent diets used 
in this work. 
 Soybean oil  
(7% weight in the normal diet) 
Rapeseed oil 
(20% weight in the modified diet) 
Fat 100% 100% 
Cholesterol 0% 0% 
Energy Value 9.00 kcal/gram 9.00 kcal/gram 
Saponification 193 175 
Iodine No. 130.3 81.4 
Melting Point -16ºC -9ºC 
Density 0.922 g/mL 0.915 g/mL 
Alpha tocopherol --------- 19 ppm 
Other tocopherols --------- 48 ppm 
Fatty Acids (%)   
Palmitic (C16:0) 11.7 2.9 
Stearic (C18:0) 3.5 0.9 
Oleic (C18:1) 21.7 12.2 
Linoleic (C18:2) 55.7 12.3 
Linolenic (C18:3) 7.4 6.8 
Eicosenoic (C20:1) --------- 8,4 
Docosanoic (C22:0) --------- 1.2 
Erucic (C22:1) --------- 52.7 
Others --------- 2.6 
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Table XI: Composition of the diets used in this study. An effort was made so that the only 
significant difference was the presence of rapeseed oil (20%), and a calorie adjustment was 
made so that putative differences in rats were not related with obesity. 
 Control 
(AIN-93G Purified  
Rodent Diet) 
(g/kg) 
Modified 
(AIN-93G Purified Rodent 
Diet with 20% Rapeseed Oil) 
(g/kg) 
Casein 200 232.56 
Dyetrose 132 132 
Cornstarch 397.486 318.53 
Sucrose 100 0 
Cellulose 50 58.14 
Soybean Oil 70 0 
t-Butylhydroquinone 0.014 0.04 
Mineral Mix 35 40.7 
Vitamin Mix* 10 11.63 
L-Cystine 3 3.49 
Choline Bitartrate 2.5 2.91 
Rapeseed Oil 0 200 
Caloric density 
(kcal/kg) 
4040 4375 
*Vitamin mix contains among others, vitamin E acetate at a concentration of 15 g/kg. 
 
2.2.2.3. Liver mitochondria isolation and purification 
 
Mitochondria were isolated from the livers of the male Wistar rats according to a 
protocol established in our laboratory [562]. Homogenization medium contained 250 
mM sucrose, 10 mM HEPES (pH 7.4), 0.5 mM EGTA, and 0.1% fat-free bovine serum 
albumin. EGTA and bovine serum albumin were omitted from the final washing 
medium, adjusted at pH 7.4. The mitochondrial pellet was washed twice, suspended in 
the washing medium, and immediately used. Protein content was determined by the 
biuret method [468] calibrated with bovine serum albumin. For mitochondrial lipid 
content analysis, and with the concern of making sure that lipid analysed was 
exclusively of mitochondrial origin, mitochondrial suspensions were further purified by 
Percoll fractionation [563], as follows. A portion of the crude mitochondria suspension 
(not used for bioenergetic studies) was layered on top of a 30 mL solution consisting of 
30% Percoll, 0.25 M manitol, 1 mM EDTA and 25 mM HEPES (pH 7.4). Self-
generating Percoll gradient was developed by centrifugation at 45,000 g for 45 min at 
4°C. The mitochondrial band was separated from less-dense contaminants and broken 
mitochondria, collected with a Pasteur pipette, and washed twice in 15 mL of a buffer 
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containing 0.25 M sucrose and 10 mM HEPES, by centrifuging for 10 min at 20,000 g. 
The final pellet was suspended in about 2 mL of the same buffer. 
 
2.2.2.4. Mitochondrial lipid and protein composition 
 
Mitochondrial lipids were extracted by the method of Bligh and Dyer [564] and 
quantified by measuring the amount of inorganic phosphate [470], after hydrolysis of 
the extracts in 70% HClO4, at 180ºC, for 120 min [471]. 
Total lipid extracts were fractionated into the respective lipid classes by thin layer 
chromatography (TLC) using a mixture of chloroform-water-ethanol-triethylamine 
(30:7:35:35) as eluent and pre-washed Whatmann LK5 plates, activated with boric acid 
(2.5%, in ethanol) and subsequent exposition to high temperature (100ºC for 15 min). 
Plates were stained in iodine atmosphere and spots were identified by comparison with 
reference spots originated from synthetic forms of the phospholipids. Spots 
corresponding to each phospholipid class were scraped from the plate and extracted 
from the silica by a previously described method [488] for posterior use (mass 
spectrometry), or directly quantified after hydrolysis [470]. For the determination of 
phospholipid class relative proportions, the phosphorus content of each spot originated 
from a single application of lipid extract was quantified, as mentioned above, and 
expressed as a percentage, considering 100% the sum of the phosphorus content of all 
spots. Lipid extracts (total lipid extract and extracts of phospholipid classes) in 
chloroform were stored under nitrogen atmosphere, at -20ºC.  
Fatty acid composition was determined by gas-liquid chromatography after trans-
methylation, as previously described [565]. Before fatty acid derivatization, the 
exogenous heptadecanoic acid (C:17) was added to the lipid extract as an internal 
standard. Whole-cell fatty acid methylesthers (FAMEs) were analyzed with a Trace GC 
2000 (Thermo-Finnigan, Thermo Electron Corporation, Austin TX) with helium as 
carrier gas, using an Agilent J &W Scientific (Agilent Technologies, Inc., Santa Clara 
CA) capillary column (DB-225MS, 30 m × 0.25 mm ID × 0.25 µm thickness) and a 
temperature program as follows: 2 min at 140ºC, 4ºC min−1 to 220ºC, and 10 min at the 
upper temperature. Injector and flame ionization detector (FID) temperatures were kept 
at 250 and 270ºC, respectively. Samples of 4 µL were split-injected and solvent blanks 
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were periodically checked. FAMEs were identified by co-chromatography against 37-
component FAME mix standard and their relative concentrations were calculated by the 
percentage area method with proper normalization. Unsaturated indexes (UIs) and other 
parameters of interest regarding fatty acid composition (Table XIII) were calculated 
according to Pamplona et al. [566]. 
CL extracts were analyzed by electrospray ionization (ESI) mass spectrometry (MS), as 
previously described [567], using a  LXQ linear ion trap mass spectrometer (Thermo-
Finnigan, San Jose, CA) operating in negative mode. The samples for electrospray 
analysis were prepared by diluting 20 µL of the sample (obtained after extraction from 
the silica of TLC plates and ressuspended in 100 µL of chloroform) with 200 µL of 
methanol. Samples were introduced into the mass spectrometer using a flow rate of 8 
µL/min. ESI conditions were as follows: electrospray voltage, 4.7 kV; capillary 
temperature, 275ºC; sheath gas flow, 25 units. An isolation width of 0.5 Da was used 
with a 30 ms activation time for MS/MS experiments. Full scan MS spectra and MS/MS 
spectra were acquired with a 50 ms and 200 ms maximum ionization time, respectively. 
Normalized collision energy (CE) was varied between 15 and 20 (arbitrary units) for 
tandem mass spectrometry. Data acquisition was carried out on an Xcalibur data system 
(version 2.0). 
Changes in the mitochondrial content of selected proteins were assessed by western 
blotting. Small pieces of liver sample were homogenized in RIPA buffer (from Sigma 
Chemical Co., St. Louis, MO, USA), and protein content in the supernatants was 
quantified with the Pierce bicinchoninic acid (BCA) protein assay kit from Thermo 
Scientific (Rockford, IL). Homogenates were then diluted in Laemmli buffer (BioRad, 
Hercules, CA) to obtain equivalent amounts of protein, and denatured at 90ºC for 5 min. 
Each sample (25 µg of protein) was then separated on 12% SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) gels and electrophoretically transferred to polyvinylidene 
fluoride (PVDF) membranes (Millipore, Billerica, MA). Membranes were blocked for 
60 min at room temperature in Tris-buffered saline solution (137 mM NaCl, 20M Tris–
HCl; pH7.6) containing 0.1% Tween-20 (TBS-T) and 5% skimmed powder milk. The 
membranes were then incubated overnight at 4ºC with the following primary antibodies 
prepared in 1% skimmed powder milk in TBS-T: mouse monoclonal [7H10BD4F9] to 
ATP50 (ab58684; dilution 1:1000), mouse monoclonal [1D6] to MTCO1 (ab14705; 
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1:1000), mouse monoclonal [17D95] to NDUFS3 (ab14711: 1:1000) and rabbit 
polyclonal to VDAC/Porin (ab34726; 1:400) from Abcam (Cambridge, UK); goat 
polyclonal to ANT 2/3 (D-15) (sc-70205; 1:200), mouse monoclonal to SDH (2E3) (sc-
59687; 1:200) and goat polyclonal to tafazzin (D-20) (sc-49760; 1:200) from Santa 
Cruz Biotechnology, Inc. (San Diego, CA); mouse monoclonal to Cyclophilin D 
(MSA04; 1:1000) and Mitoprofile total OXPHOS rodent WB antibody cocktail 
(MS604; 1:1000) from MitoSciences (Eugene, OR); mouse anti-cytochrome C (556433; 
1:2500) from Pharmingen (San Diego, CA); monoclonal rabbit to pyruvate 
dehydrogenase (C5461; 1:1000) from Cell Signaling (Danvers, MA); rabbit anti-
mitochondrial uncoupling protein 2 (144-157) (662047; 1:2000) from Calbiochem, 
Merck4Biosciences, Merck KGaA, Darmstadt, Germany. As control for protein 
loading, membranes were also probed with monoclonal mouse anti-β-actin antibody 
(A5441; 1:2500) from Sigma-Aldrich Chemical Co. (St. Louis, MO, USA). Following 
antibody incubation and washing, membranes were incubated for 60 min at room 
temperature with an alkaline phosphatase-linked secondary antibody in a dilution of 
1:10,000 in TBS-T. The secondary antibodies used were goat anti-rabbit IgG-AP (sc-
2007), rabbit anti-goat IgG-AP (sc-2771), and goat anti-mouse IgG-AP (sc-2008), all 
from Santa Cruz Biotechnology, Inc (San Diego, CA). The membranes were processed 
for detection of proteins of interest using the ECF system (GE Healthcare, Piscataway, 
NJ) on the VersaDoc Imaging System (Bio-Rad, Hercules, CA) and the quantification 
was performed using Quantity One 1-D Analysis Software Version 4.6.9, PC (Bio-Rad, 
Hercules, CA). The strength of signal was expressed by calculating the difference 
between the average intensity of the bands and its corresponding local background. 
Molecular weight markers were obtained from Bio-Rad Laboratories, Inc. (Hercules, 
CA). 
 
2.2.2.5. Mitochondrial membrane fluidity 
 
Membrane fluidity of mitochondrial membranes (resealed in suitable buffer after 
submitting mitochondria to 5 freeze/thaw cycles in liquid nitrogen) was assessed by 
fluorescence anisotropy using DPH and DPH-PA as fluorescent probes. Mitochondrial 
membranes were kept at 4°C, in a buffer 10 mM Tris-maleate, 50 mM KCl (pH 8.5) to 
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which a protease inhibitor, PMSF (10 µM) was added. The protein concentration used 
was 2.48 mg/mL (corresponding to a lipid concentration of approximately 200 µM), and 
the probe concentration was 2 µM (probe:lipid molar ratio of 1:100). Probe 
incorporation time was at least 60 min. Fluorimetric measurements were performed in a 
Perkin-Elmer LS 55 Luminescence Spectrometer equipped with a thermostated cell 
holder and all data were recorded at controlled temperatures (25, 37 or 50°C). 
Excitation and emission wavelengths were set to 361 and 432 nm respectively, and slits 
of 5 nm were used for both excitation and emission wavelengths. The probes were 
excited with vertically polarized light and resulting fluorescence intensities were 
recorded with the analyzing polarizer oriented parallel (I║) and perpendicular (I┴) to the 
excitation polarizer allowing the determination of steady-state fluorescence anisotropy 
for each labelled sample, as shown by equation [2] [483]. 
Fluorescence values were corrected for light scattering contributions by subtracting the 
intensities from corresponding unlabelled samples (containing only DMF, the probe 
solvent) at the same conditions. These contributions were always negligible (less than 
0.5%). 
 
2.2.2.6. Oxygen consumption, transmembrane electric potential and calcium-
induced mitochondrial permeability transition determinations 
 
Oxygen consumption of isolated mitochondria was determined polarographically with a 
Clark-type oxygen electrode [568], connected to a suitable recorder, in a 1 mL 
thermostated water-jacketed chamber with magnetic stirring, at 30ºC. The standard 
respiratory medium consisted of 125 mM sucrose, 65 mM KCl, 2.5 mM MgCl2, 5 mM 
KH2PO4, 5 mM HEPES (pH 7.4). Mitochondria (1 mg/mL) and substrates 
(glutamate/malate, 10 mM and 5 mM respectively, or succinate 10 mM plus 3 µM 
rotenone) were added to the respiration medium and state 3 respiration was initiated by 
the addition of 50 nmol ADP (state 4 respiration was measured after deceleration 
resulting from ADP depletion). Addition of FCCP (1 µg/mL), subsequent to the 
establishment of state 4, allowed to determine the uncoupled respiration rate (FCCP 
state). RCI was calculated as state 3/state 4 and the ADP/O refers to the amount of ADP 
added in relation to the oxygen consumed inbetween the addition and depletion of ADP. 
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In the case of the assays with drugs (20 nmol MEN /mg of protein; 40 nmol NIM /mg of 
protein), these or the respective solvents (ethanol or DMF) were incubated in the 
mitochondrial suspensions for 3 min, before inducing state 3 respiration by addition of 
ADP. 
Mitochondrial transmembrane electric potential (∆Ψ) was estimated using an ion-
selective electrode to measure the distribution of tetraphenylphosphonium (TPP+) 
according to a previously established method [569] and by using an Ag/ AgCl2 electrode 
as reference. Mitochondria (1 mg/mL) were suspended with constant stirring, at 30ºC, in 
1 mL of the standard respiratory medium supplemented with 3 µM TPP+ and were 
energized by adding glutamate/malate, 10 mM and 5 mM respectively, or succinate 10 
mM plus 3 µM rotenone. The distribution of TPP+ was allowed to reach a new 
equilibrium (2 min) before making any further addition. ADP (125 nmol) was added to 
initiate phosphorylation. The electrode was calibrated with TPP+ assuming Nernstian 
distribution of the ion across the synthetic membrane, and ∆Ψ was expressed in mV. A 
matrix volume of 1.1 µl/mg protein was assumed. In the case of the assays using drugs, 
the mitochondrial suspensions were let to incubate with them (20 nmol MEN /mg of 
protein; 40 nmol NIM /mg of protein) or their solvents (ethanol or DMF respectively) 
for 3 min, after substrate and before ADP additions. FCCP was added through a 
sequence of 3 consecutive tritrations of 10 pmol FCCP/mg of protein, after 
establishment of the initial maximal membrane potential value, with 1 min elapsing 
between each addition. Equal volumes of ethanol, the solvent used for FCCP 
solubilization, had no significant effects on ∆Ψ. 
∆Ψ, as assessed with the TPP+ electrode, was also used to follow calcium-induced 
mitochondrial depolarization resulting from MPT induction. The assays were performed 
in 1 mL of the swelling medium (200 mM sucrose, 10 mM Tris-MOPS, pH 7.4, 10 µM 
EGTA, 1 mM KH2PO4, 1.5 µM rotenone, and 2.5 mM succinate plus 3 µM rotenone). 
CaCl2 (100 nmol/mg protein) was added to induce MPT, which was followed as the 
progressive decrease in the ∆Ψ observed after Ca2+ addition. 
Calcium-induced mitochondrial swelling was also determined to follow MPT induction. 
In this case, mitochondrial osmotic volume changes were followed as the decrease of 
absorbance at 540 nm using a Jasco V-560 UV/VIS Spectrophotometer (Jasco, Tokyo, 
Japan). Mitochondria suspensions (1.5 mg of protein) were added to swelling buffer 
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under constant stirring and temperature (30°C). Calcium (66.7 nmol/mg protein) was 
added to the preparation 1 min after starting the experiment. To confirm that the 
swelling observed in these experiments resulted from MPT induction, assays were 
performed where CsA (1 µM) was added to the mitochondrial preparation before the 
addition of calcium. When assaying drugs (200 nmol MEN /mg of protein; 100 nmol 
NIM /mg of protein), these or aliquots of the respective solvents were incubated in the 
mitochondrial suspensions for 3 min, before calcium addition. 
 
2.2.2.7. Adenine nucleotide content 
 
The mitochondrial content in adenine nucleotides was determined at the end of each 
phosphorylation cycle. An aliquot (250 µL) of each mitochondrial suspension was 
mixed with 250 µL of 0.3 M perchloric acid (HClO4) and immediately centrifuged at 
16,000 g for 5 min (Eppendorf Centrifuge 5415C). The supernatants were neutralized 
with 10 M KOH in 5 M Tris and centrifuged again at 16,000 g for 5 min. The 
supernatants were used for adenine nucleotide determination by separation in a reverse 
phase high-performance liquid chromatography (HPLC). The HPLC apparatus used was 
a Beckman-System Gold, consisting of a 126 binary pump model and 166 variable UV 
detector controlled by a computer. The detection wavelength was 254 nm and the 
column was a Lichrospher 100 RP-18 (5-lm) from Merck. An isocratic elution with 100 
mM phosphate buffer (KH2PO4; pH 6.5) and 1% methanol was performed with a flow 
rate of 1 mL/min. The required time for each analysis was 6 min. Adenine nucleotides 
were identified by their chromatographic retention time, absorption spectra, and 
correlation with standards. 
 
2.2.2.8. Citrate synthase activity 
 
Citrate synthase activity was assayed in order to assess the integrity of mitochondrial 
preparations. The activity was measured spectrophotometrically at 412 nm. 
Measurements were conducted at 30°C with constant magnetic stirring in a Jasco V-560 
spectrophotometer. To start the determination, portions of mitochondrial preparations 
(200 mg protein) were added to buffer (0.1 M Tris/HCl, pH 8.1) containing 0.1 mM 5,5-
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dithio-bis-(2-nitrobenzoic) acid (DTNB), 0.5 mM oxaloacetate and 0.31 mM acetyl 
CoA  [570]. Upon addition of Triton X-100 (final concentration about 0.25%), total 
activity of the enzyme was determined. 
 
2.2.2.9. Oxidative stress markers 
 
The rate of hydroperoxide production by isolated mitochondria was determined 
spectrofluorimetrically using a modification of the method described by Barja [571]. 
Briefly, mitochondria were incubated at 30°C with 5 mM glutamate/2.5 mM malate or 5 
mM succinate in 1.5 mL of phosphate buffer, pH 7.4, containing 0.1 mM EGTA, 5 mM 
KH2PO4, 3 mM MgCl2, 145 mM KCl, 30 mM HEPES, 0.1 mM homovanillic acid and 6 
U/mL horseradish peroxidase. The incubation was stopped after 15 min with 0.5 mL of 
cold (4ºC) 2 M glycine buffer containing 25 mM EDTA and NaOH (pH 12). The 
mitochondrial suspensions were then centrifuged at 850 g for 10 min. The fluorescence 
of the supernatants was measured and the rate of peroxide production was calculated 
using a standard curve of H2O2, since H2O2 oxidation of homovanillic produces a dimer 
which shows strong fluorescence at 420 nm upon excitation at 312 nm. 
Levels of lipid peroxidation in samples of liver tissue homogenates (prepared as for 
western blot analysis and diluted in phosphate buffer saline solution (PBS) to assure 1 
mg/mL protein concentration) were assessed by the fluorimetric determination of MDA 
adducts separated by HPLC using the ClinRep complete kit (RECIPE, Munich, 
Germany). Samples were derivatized and neutralized prior to injection, and the MDA 
fluorescent adducts were detected at 30oC, with excitation at 515 nm and emission at 
553 nm. The MDA content of samples was calculated using the external standard 
method via peak areas and was expressed as nmol/mg protein. For quality control of the 
analytical determinations ClinChek Controls were used (RECIPE, Munich, Germany). 
Extraction and separation of vitamin E (α-tocopherol) from liver tissue homogenate (1 
mg protein/mL) were performed by following a method previously described by 
Vatassery and Younoszai [572]. Briefly, 1.5 mL of sodium dodecylsulphate (SDS) 
(10mM) was added to 0.5 mg of liver tissue extract, followed by the addition of 2 mL of 
ethanol. Then 2 mL of hexane and 50 µl of 3 M KCl were added, and the mixture was 
vortexed for about 3 min. The extract was centrifuged at 1,666 g (Sorvall RT 6000, 
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refrigerated centrifuge) and 1 mL of the upper phase, containing n-hexane, was 
recovered and evaporated until dryness under a stream of N2 and kept at −80°C. The 
extract was dissolved in n-hexane, and vitamin E content was analyzed by reverse-phase 
HPLC. A Spherisorb S10w column (250 mm x 4.6 mm) was eluted with n-hexane with 
0.9% methanol, at a flow rate of 1.5 mL/min. Detection was performed by a UV 
detector at 287 nm (Gilson, Lewis Center, OH). The total content of vitamin E was 
calculated as nmol/mg protein. 
Protein reactive carbonyls were analyzed in samples according to the method described 
by Robinson [573] with slight modifications. A determined volume of liver tissue 
homogenate containing 20 µg of protein was derivatized with dinitrophenylhydrazine 
(DNPH). For this purpose, a volume (1V) of 12% SDS and two volumes (2V) of 20 
mM DNPH prepared in 10% trifluoroacetic acid (TFA) were added to each sample, 
followed by incubation in the dark for 5 min. After this period, the neutralization 
reaction was achieved by the addition of 1.5 volumes (1.5V) of 2 M Tris and 18% of β-
mercaptoethanol. A negative control was simultaneously prepared for each sample in 
the absence of DNPH. After the dilution of the samples in a Tris buffer solution (20 
mM) to obtain a final concentration of 5 µg/µl, 10 µg of protein were transferred to the 
gel for SDS-PAGE. From this point further, the procedure was equivalent to that 
already described for Western blotting analysis. A primary rabbit polyclonal anti-DNP 
antibody (1:2,000; Sigma Chemical Co., St. Louis, MO, USA) was incubated with the 
membrane for 2 h at room temperature. 
 
2.2.2.10. Statistical analysis 
 
Results were expressed as means ± standard deviation for a number of independent 
experiments, specified for each case. Multiple comparisons were performed using one-
way ANOVA with the Student-Newman-Keuls as a post-test and pairing was made for 
observations with normal versus modified diet rats sacrificed and processed in the same 
day (every particular parameter determined for a rat from the control group and for the 
rat fed the modified diet sacrificed in the same day was paired). A value of p<0.05 was 
considered significant. 
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2.2.3. Rapeseed oil-rich diet alters hepatic mitochondrial membrane 
lipid composition and disrupts bioenergetics 
 
The choice of rapeseed oil as a diet constituent in order to induce membrane lipid and 
function changes in hepatic mitochondria was made taking into account the previous 
knowledge available from a number of earlier studies. The interest on the use of 
rapeseed oil in this context arose from the observation that heart pathological lesions 
took place after longtime dietary exposure to that oil [574]. Bioenergetic studies 
revealed that the efficiency of rat heart mitochondria to oxidize substrates was 
substantially lowered when rapeseed oil was incorporated in the diet [147]. Decreased 
rates of ATP synthesis and ADP/O ratios were also associated with cardiac 
mitochondria isolated from animals fed diets containing rapeseed oils [144, 575]. On 
the other hand, it was described that rats fed a high erucic acid rapeseed oil-containing 
diet showed higher mitochondrial PC levels than rats fed a soybean oil-containing diet, 
and rats fed a diet with low erucic acid rapeseed oil had an increased content in cardiac 
mitochondrial CL [135]. Based on the reported effects on heart mitochondria, rapeseed 
oil was considered a suitable diet component aiming at promoting compositional and 
functional alterations in hepatic mitochondria, targeting the study of membrane 
structure-activity relationships at the mitochondrial level, which has deserved little 
attention so far. 
 
2.2.3.1. Results 
 
2.2.3.1.1. Dietary treatment did not interfere with animal health 
 
To evaluate potential diet-induced health alterations in the experimental animals, 
plasma analysis was performed by an independent specialized laboratory. Plasma was 
collected from 4 different rats from each diet group at the three experimental time points 
and then processed. The parameters measured were plasma urea, cholesterol, creatinine, 
triglycerides, uric acid, glucose and total protein and the activities of aspartate 
aminotransferase, alanine aminotransferase, creatine kinase, lactate dehydrogenase and 
ureic nitrogen/creatinine ratio. The only significant difference observed was a decrease 
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in the triglyceride content for the rats submitted to the 20% rapeseed oil diet (137±29.5 
for control rats and 56±7.1 for rats fed the modified diet, after 33 days of treatment; data 
not shown), what should be related to a decrease in carbohydrate intake, specially 
sucrose which is not added to the modified diet. 
 
Fig. 32: A) Growth (evaluated as body weight increase) and B) diet consumption by 2 
months Wistar rats fed a control diet (full circles) and a modified diet (open squares). 
Values depicted are means ± standard deviation for at least 12 rats per group or 8 diet 
quantifications. Comparisons were performed using one-way ANOVA, with the Student-
Newman-Keuls as a post-test for control diet rats versus rats fed the modified diet. **, P <0.01. 
 
Table XII: Alteration of organ weight to total animal weight ratio in rats fed a control or 
modified diet at the three experimental time marks. 
 Control diet Modified diet 
Weight/Animal 
weight x 1000
a)
 
11 days 22 days 33 days 11 days 22 days 33 days 
Liver 34.42±1.10 31.20±1.29 32.38±0.65 35.88±0.99 35.83±1.03* 34.06±0.96 
Heart 3.96±0.26 3.75±0.20 3.19±0.14 4.04±0.26 4.30±0.14* 3.71±0.15* 
Kidneys 6.73±0.09 7.04±0.13 6.61±0.15 7.18±0.18* 6.89±0.13 6.69±0.16 
a) Values presented are means ± standard deviation for at least 7 rats per group. Comparisons were 
performed using one-way ANOVA, with the Student-Newman-Keuls as a post-test for control diet rats 
versus rats fed the modified diet. *, P <0.05. 
 
Rats assigned to the modified diet showed a slight delay in growth (Fig. 32A), probably 
related to lower food intake (Fig. 32B). Besides the decrease in total weight, rats eating 
the modified diet showed an increase in heart weight (in relation to total weight) after 
22 days of treatment (Table XII). No apparent internal lesions were found in the organs 
of the animals of both groups. 
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2.2.3.1.2. Dietary treatment affected mitochondrial membrane lipid composition 
and fluidity 
 
Comparing the mitochondrial membrane lipid composition of rats fed the modified diet 
with that of control rats, the most striking difference in terms of major phospholipid 
classes regarded PC and PE content (Table XIII). PC content increased and PE 
decreased in liver mitochondria from rats fed the alternative diet, with the PC/PE ratio 
being 1.27 for control rats and 1.82 for rats fed the rapeseed oil enriched diet after 33 
days of treatment. For the same treatment time (33 days), a small but significant 
decrease in CL content was also found. Interestingly, differences in terms of 
phospholipid content were already noticed after only 11 days of modified diet treatment. 
 
 
 
Fig. 33: A) Alteration of the molar percentages of saturated (full circles and open squares) 
and unsaturated (full triangles and open diamonds) fatty acids in mitochondria of rats fed 
a control diet (full circles and full triangles) and a diet containing 20% rapeseed oil (open 
squares and open diamonds). B) Alteration of the saturated:unsaturated fatty acid ratio 
(Sat/Unsat ratio; black bars for the control diet rats and white bars for the modified diet rats) as 
a function of time. Values depicted are means ± standard deviation for 3 animals for 11 days 
experiments and 5 animals for 22 and 33 days. Comparisons were performed using one-way 
ANOVA, with the Student-Newman-Keuls as a post-test for control diet rats versus rats fed the 
modified diet. *, P <0.05. 
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Table XIII: Alteration of mitochondrial membrane lipid composition during the feeding 
protocol in terms of phospholipid major classes and fatty acids. 
 Normal diet Modified diet 
Phospholipid 
class (mol %)
a)
 
11 days 22 days 33 days 11 days 22 days 33 days 
PC 45.9±0.7 45.0±0.8 45.4±0.5 51.2±0.5** 52.8±0.8*** 53.1±0.5*** 
PE 34.7±0.7 35.8±0.7 35.8±0.4 30.1±0.7** 29.5±0.5*** 29.1±0.5*** 
CL 9.7±0.4 9.9±0.3 9.9±0.3 8.9±0.2 8.9±0.3 8.8±0.2* 
Others 9.7±0.3 9.4±0.3 9.0±0.4 9.6±0.7 8.9±0.3 9.2±0.4 
Fatty acid (%)
a)
  
C12:0 4.9±1.6 3.5±0.9 5.3±1.5 5.0±0.9 4.1±0.9 5.4±1.3 
C14:0 0.0±0.0 0.2±0.1 0.2±0.1 0.0±0.0 0.1±0.1 0.2±0.1 
C15:0 2.3±1.0 1.0±0.3 0.8±0.2 1.2±0.1 0.6±0.4 0.6±0.3 
C16:0 19.1±0.7 17.5±1.2 18.7±0.6 17.8±1.0 17.9±0.9 15.0±1.8 
C16:1 0.8±0.5 0.5±0.2 0.8±0.3 0.8±0.4 0.0±0.0 0.1±0.1 
C18:0 18.7±0.5 17.7±1.4 19.4±0.6 18.0±2.3 16.4±0.9 14.4±1.2* 
C18:1 5.5±2.3 6.0±2.0 4.2±0.9 8.7±2.5 10.8±0.8 11.2±0.7** 
C18:2 22.3±1.9 18.7±1.4 20.7±1.2 18.7±1.6 17.4±2.0 15.4±0.8* 
C20:0 0.0±0.0 0.0±0.0 0.0±0.0 1.6±0.9 0.8±0.6 2.3±0.8* 
C20:1 0.0±0.0 0.0±0.0 0.0±0.0 0.4±0.4 0.4±0.4 1.2±1.2 
C20:4 20.3±1.7 21.1±1.7 23.8±1.3 18.3±1.4 20.9±0.4 19.4±1.9 
C20:5 0.0±0.0 0.0±0.0 0.0±0.0 1.9±0.9 1.6±0.5* 3.3±1.2 
C22:0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.3±0.3 0.2±0.2 
C22:1 0.0±0.0 0.0±0.0 0.0±0.0 0.5±0.5 0.2±0.2 1.6±1.1 
C22:5 0.3±0.3 0.6±0.3 0.5±0.2 0.5±0.6 1.0±0.4 0.5±0.3 
C22:6 5.8±0.6 6.6±0.9 5.4±0.5 6.1±0.7 7.47±0.8 7.6±1.0 
C24:0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.4±0.4 
Length and 
saturation 
parameters
 b)
 
      
ACL 17.9±0.14 18.2±0.06 18.0±0.11 18.0±0.11 18.2±0.10 18.3±0.10 
DBI 168.4±7,5 184.5±3.8 176.5±7.5 168.9±3.5 188.0±5.3 187.3±8.7 
PI 152.0±6.7 172.1±3.8 162.3±7.9 154.8±6.3 177.1±8.4 177.1±10.8 
MUFA 6.3±1.8 6.9±1.7 4.9±1.0 10.3±3.0 11.4±1.3 14.1±1.9* 
PUFA 48.7±3.3 50.9±1.7 50.4±2.2 45.4±1.1 48.5±0.9 46.3±2.7 
PUFA n-3 6.2±0.4 7.7±0.4 5.9±0.4 8.5±1.5 10.1±1.7 11.4±0.7** 
PUFA n-6 41.5±3.6 43.3±2.0 44.5±2.1 36.9±2.5 38.3±2.3 34.9±2.5 
a) Values presented are means ± standard deviation for at least 7 rats for phospholipid classes 
determination and 3 rats (11 days) to 5 rats (22 and 33 days) for fatty acid determination.  
b) The average chain length was calculated as ACL = [Total12 x 12) + . . . + (Totaln x n)] / 100 (n = 
number of carbon atoms; Totaln = total percentage of fatty acids with n carbon atoms). The double bond 
index was calculated as DBI = Σ mol % of each unsaturated fatty acids x the respective number of double 
bonds. The peroxidizability index was calculated as PI = [(% monoenoic x 0.025) + (% dienoic x 1) + (% 
trienoic x 2) + (% tetraenoic x 4) + (% pentaenoic x 6) + (% hexaenoic x 8)]. Monounsaturated fatty acids 
were calculated as MUFA = Σ % (16:1 + 18:1 + 20:1 + 22:1). Polyunsaturated fatty acids were calculated 
as PUFA = Σ % (PUFA n–3 + PUFA n–6). Polyunsaturated fatty acids n–3 were calculated as PUFA n–3 
= Σ % (20:5 + 22:5 + 22:6). Polyunsaturated fatty acids n–6 were calculated as PUFA n–6 = Σ % (18:2 + 
20:4). 
Comparisons were performed using one-way ANOVA, with the Student-Newman-Keuls as a post-test for 
control diet rats versus rats fed the modified diet. ***, P <0.001; **, P <0.01; *, P <0.05. 
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In terms of fatty acid content, relevant differences occurred concerning particular fatty 
acids, which were absent in the control group (regular diet) but appeared in 
mitochondria from rats fed the modified diet, including n-eicosanoic (C20:0), 
eicosenoic (C20:1), eicosapentaenoic (C20:5), docosanoic (C22:0), erucic (or 
docosenoic; C22:1), and tetracosanoic (C24:0) acids. Also, significant alterations in 
fatty acid relative concentrations (expressed in molar percentages) occurred in liver 
mitochondria from rats fed the modified diet, namely with regard to estearic (C18:0) 
and linoleic acids (C18:2), which were decreased, and oleic acid (C18:1), which was 
increased (Table XIII). Overall, a progressive increase in hepatic mitochondrial content 
in unsaturated fatty acids was detected in rats fed the modified diet, at the expense of 
saturated fatty acids (Fig. 33A), resulting in a decrease in the saturated to unsaturated 
ratio (Fig. 33B). More specifically, the content in monounsaturated fatty acids (MUFA) 
and n-3 polyunsaturated fatty acids (PUFA) increased after 33 days of treatment with 
the modified diet (Table XIII). 
Alterations of the mitochondrial content in different CL molecular species as a 
consequence of diet manipulation were also evaluated (Fig. 34), given the increasing 
relevance of this particular phospholipid on mitochondrial physiology. Representative 
ESI-MS spectra obtained for CL from liver mitochondria from rats fed the control diet 
and from hepatic mitochondria from rats fed the rapeseed oil-containing diet are 
presented in Figs. 34B and C, respectively. ESI-MS data showed that the CL profile 
presented a distinct pattern, according to the available diet. While the ion [M-H]- at m/z  
1449.7, attributed to the CL (C18:1) (C18:2)3, corresponds to the most abundant species 
in mitochondria from control rats,  for rats fed the rapeseed oil diet, the most abundant 
CL ion was observed at m/z 1451.7, corresponding to CL (C18:1)2 (C18:2)2. Significant 
diet-induced alterations were observed in the relative abundances of other [M-H]- ions 
in the MS spectra of the CL, namely a significant decrease in the relative abundance of 
the ion at m/z  1447.7, corresponding to the symmetric (18:2)4 CL species and an 
increase in the relative abundance of ions corresponding to CL species containing 
longer fatty acyl chains. These alterations imply that the fatty acid composition of 
hepatic mitochondrial CL is rather susceptible to diet, and therefore, repercussions from 
alterations to such characteristic and physiologically important phospholipid may 
anticipate functional implications. 
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Fig. 34: Relative abundance of the [M-H]
-
 ions of  CL species observed in the ESI-MS 
spectra (A): black bars for CL extracts from rats fed a control diet and white bars for extracts 
from rats fed the diet containing 20% rapeseed oil. In insert, the CL species corresponding to 
each of the [M-H]- ions are presented. Values depicted are means ± standard deviation for 4 
animals, 33 days after the beginning of the treatment. Comparisons were performed using one-
way ANOVA, with the Student-Newman-Keuls as a post-test for control diet rats versus rats fed 
the modified diet. ***, P <0.001; **, P <0.01; *, P <0.05. B) and C) are representative ESI-MS 
spectra of CL extracts form liver mitochondria from rats fed the normal and the modified diet, 
respectively.  
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Putative repercussions of the formerly described lipid modifications on the fluidity of 
mitochondrial membranes were studied by fluorescence anisotropy. Two probes were 
used: DPH, which relocates in the lipid bilayer hydrocarbon core [481] and DPH-PA, 
which is anchored to the bilayer surface due to its charged group, with the DPH moiety 
intercalated between the upper portions of the fatty acyl chains, thus monitoring 
membrane fluidity at a region of the lipid bilayer somewhat less deep along the bilayer 
depth as compared to that probed by DPH [482]. Significant changes were only found 
for DPH-PA reported anisotropy and at temperatures lower than physiologic values 
(Fig. 35), with hepatic mitochondrial membranes from rats treated with the modified 
diet showing higher anisotropy values. Therefore, an increased molecular packing 
should be attained in these membranes in the regions monitored by DPH-PA. 
 
 
Fig. 35: Fluorescence anisotropy of DPH (full circles, open squares) or DPH-PA (full 
triangles, open diamonds) incorporated in hepatic mitochondrial membranes from rats 
fed a control diet (full circles, full triangles, full lines) or a diet containing 20% rapeseed 
oil (open squares, open diamonds, dashed lines). Values depicted are means ± standard 
deviation for 5 animals, 33 days after the beginning of the treatment. Comparisons were 
performed using one-way ANOVA, with the Student-Newman-Keuls as a post-test for control 
diet rats versus rats fed the modified diet. *, P <0.05. 
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Fig. 36: Diet-induced changes in the content of mitochondrial proteins: A) respiratory 
complex subunits (NDUFS8: NADH-ubiquinone oxidoreductase 23 kDa subunit), B) other 
respiratory complex subunits and uncoupling protein 2 (NDUFS3: NADH-ubiquinone 
oxidoreductase 30 kDa subunit; SDH: succinate dehydrogenase subunit A; MTCOI; 
mitochondria marker, cyt c oxidase subunit I; ATP50: F1-F0 alpha subunit of complex V; 
UCP2: uncoupling protein 2), C) other relevant mitochondrial proteins not related with the 
respiratory process (Cycl D: cyclophilin D; Pyr. Dehy.: Pyruvate dehydrogenase). 
Representative blots for the three different experimental time points are presented below the 
bars of the respective proteins. Each well was loaded with liver tissue samples from rats fed a 
standard rodent diet (N) or rats fed a modified diet containing 20% rapeseed oil (M; white bars) 
corresponding to 25 µg protein. Actin was used in every case as a protein loading control. 
Values are means ± standard deviation for at least 5 samples from different animals and 
represent alterations (∆) as percentage of the control. Comparisons were performed using one-
way ANOVA, with the Student-Newman-Keuls as a post-test for control diet rats versus rats fed 
the modified diet. **, P <0.01; *, P <0.05. 
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2.2.3.1.3. Dietary intervention held negligible effects on mitochondrial protein 
expression 
 
In terms of mitochondrial biology, several parameters were analyzed, including the 
content in specific nuclear and mitochondrial-encoded proteins involved in the oxidative 
phosphorylation. Apparently, the influence of diet on protein content was limited, at 
least for the time points studied, since no major changes were observed for the proteins 
tested. Concerning mitochondrial respiratory complexes, a decrease was only found in 
the levels of complex III subunit core 2, complex II SDHA and Complex IV MTCO1, 
and only for the 22 days timepoint (Fig. 36A and B). Besides the changes in proteins of 
the respiratory chain, we also explored possible differences regarding uncoupling 
protein 2, which has been reported to be involved in fatty acid translocation [576], and 
components of MPTP. Concerning the former, no differences were found when 
comparing the groups with different diets. When proteins of the MPTP were analyzed, 
differences were only found for ANT and only after 11 days of dietary treatment, with a 
decrease found for animals fed the alternative diet (Fig. 36C). No statistical differences 
were found for cyt c and for pyruvate dehydrogenase, as well as for tafazzin (Fig. 36C), 
an enzyme involved in CL maturation/remodeling [577]. Noticeably, no significant 
changes were found in protein expression for the 33 days time point. 
 
2.2.3.1.4. Modified-diet treatment led to significant changes on mitochondrial 
bioenergetics 
 
The effects of dietary changes on mitochondrial activity were studied. Alterations were 
evident after only 11 days of treatment with 20% rapeseed oil diet (Fig. 37). 
Mitochondria from rats fed this diet displayed decreased respiratory state 3 (Fig. 37A 
and C), increased respiratory state 4 (Fig. 37B and D) and decreased FCCP-uncoupled 
respiration (Fig. 37E and G), as compared to the control group. The RCI was lower in 
the diet-modified group (Fig. 37F and H), as well as the ADP/O ratio (Fig. 37I and J). 
Similar differences were observed when both complex I (glutamate-malate) and 
complex II (succinate) substrates were used. 
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Fig. 37: Oxygen consumption studies with liver mitochondria from rats fed a control diet 
(black bars) or a diet containing 20% rapeseed oil (white bars). Substrates used for the 
respiratory studies were a mixture of glutamate plus malate (Complex I) or succinate (Complex 
II). The parameters presented are respiratory states 3 (A and C) and 4 (B and D), uncoupled 
respiration (E and G), RCI (F and H) and the ADP/O ratio (I and J). Typical traces for a oxygen 
consumption determination as followed with a Clark type electrode are shown in K. Values 
depicted are means ± standard deviation for 7 animals (11 days), 8 animals (22days) and 15 
animals (33 days). Comparisons were performed using one-way ANOVA, with the Student-
Newman-Keuls as a post-test for control diet rats versus rats fed the modified diet. ***, P 
<0.001; **, P <0.01; *, P <0.05. 
 
Differences were also observed in mitochondrial transmembrane electric potential 
between the two groups (Fig. 38). Mitochondria from rats submitted to the modified diet 
developed lower electric potentials upon substrate addition, which became significantly 
different from the control after 22 days of treatment (Fig. 38A and C). The extent of 
ADP-induced depolarization also decreased in this group (Fig. 38B and D) and, in this 
case, significant differences were noticed at an earlier time point (11 days). Significant 
differences in the ∆Ψ attained after repolarization were detected after 22 or 33 days of 
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treatment, with mitochondria from rats fed the rapeseed oil enriched diet repolarizing 
for a lower ∆Ψ (Fig. 38E and G). Liver mitochondria from modified diet-fed animals 
took more time to phosphorylate ADP (what was reflected in an increase in the lag 
phase), which is in accordance with the decreased ADP/O ratio (Fig. 37I and J). In this 
case, the effect was already apparent after 11 days of treatment (Fig. 38F and H). The 
effects observed were clearly substrate-independent. 
 
 
Fig. 38: Mitochondrial transmembrane electric potential (∆Ψ) studies with liver 
mitochondria from rats fed a control diet (black bars) or a diet containing 20% rapeseed 
oil (white bars). Substrates used for the respiratory studies were a mixture of glutamate plus 
malate (Complex I) or succinate (Complex II). The parameters presented are initial potential 
developed upon substrate addition (A and C), depolarization induced by ADP (B and D), 
potential after repolarization (E and G) and the lag phase of the repolarization (F and H). 
Typical traces for transmembrane electric potential determinations as followed by a TPP+ 
electrode are shown in I. Values depicted are means ± standard deviation for 7 animals (11 
days), 8 animals (22 days) and 15 animals (33 days). Comparisons were performed using one-
way ANOVA, with the Student-Newman-Keuls as a post-test for control diet rats versus rats fed 
the modified diet. ***, P <0.001; **, P <0.01; *, P <0.05. 
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Table XIV: Quantification of adenine nucleotides and determination of ATP/ADP ratios, total 
energetic contents (ATP+ADP+AMP) and energy charges (ADP+2ATP)/ (ATP+ADP+AMP) in 
hepatic mitochondrial samples from rats fed a control or a modified diet containing 20% 
rapeseed oil. 
 Normal Modified 
 ATP
a)
 33.0±14.92 47.0±20.60 
ADP
 a)
  61.6±16.37 76,7±17,99 
AMP
 a)
  75.8±23.77 94.4±19.83 
ATP/ADP 0.46±0.11 0.55±0.14 
total energetic content
a)
  170.3±53.78 218.0±56.47 
energy charge 0.73±0.07 0.74±0.08 
 ATP
a)
  22.7±12.87 27.9±14.21 
ADP
a)
 55.8±10.03 66.9±11.90 
AMP
a)
  131.2±18.92 145.0±10.54 
ATP/ADP 0.36±0.15 0.36±0.12 
total adenine 
nucleotides
a)
  
209.6±17.11 239.7±17.61 
energy charge 0.47±0.14 0.49±0.12 
a) Values are presented in nmol/mg protein.Values shown are means ± standard deviation for 4 rats from 
each diet group (normal or modified diet). Comparisons were performed using one-way ANOVA, with 
the Student-Newman-Keuls as a post-test for liver mitochondria of control diet rats versus liver 
mitochondria of rats fed the modified diet. ***, P <0.001; **, P <0.01; *, P <0.05. 
 
Regarding the energy state of mitochondria, reflected by means of adenine nucleotide 
content, ATP/ADP ratio, total energetic content and energy charge, no significant diet-
induced changes were found between groups (Table XIV). 
Alterations induced by the modified diet on MPT parameters were found, although the 
high variability of the results prevented the detection of more robust statistical 
differences. When calcium-induced mitochondrial depolarization was evaluated by 
following potential fluctuations, liver mitochondria from modified diet-fed animals 
showed a higher rate of calcium-induced depolarization when compared to the control 
group (Fig. 39F and H). However, when the same phenomenon was assessed by 
following calcium-induced mitochondria swelling (Fig. 39J and K), differences were 
only visible after 33 days of treatment, with mitochondria from diet-modified animals 
consistently showing higher calcium susceptibility as compared to the control group. 
CsA, the classic MPTP inhibitor [578] prevented, as expected, calcium-induced 
mitochondrial swelling in both groups. 
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Fig. 39: Ca
2+
-induced MPT studies in liver mitochondria from rats fed a control diet 
(black bars) or a diet containing 20% rapeseed oil (white bars). Substrates used for the 
respiratory studies were a mixture of glutamate plus malate (Complex I) or succinate (Complex 
II). The parameters presented are initial potential developed upon substrate addition (A and C), 
maximum potential achieved after Ca2+ addition (B and D), membrane potential 2 min after 
Ca2+addition (E and G) and the rate of the depolarization induced by Ca2+ (F and H). Typical 
traces for Ca2+-induced MPT as followed with a TPP+ electrode (for 33 days, where the most 
significant differences occur) are shown in I. The rates of absorbance decrease as a result of 
mitochondrial swelling are shown in J, and K depicts typical absorbance traces for 
mitochondrial swelling experiments obtained after 33 days of dietary treatment (timepoint at 
which the most significant changes were found). Values depicted are means ± standard 
deviation for 7 animals per parameter/trace shown. Comparisons were performed using one-way 
ANOVA, with the Student-Newman-Keuls as a post-test for control diet rats versus rats fed the 
modified diet. ***, P <0.001; **, P <0.01; *, P <0.05. 
 
Since the results so far appeared to indicate that hepatic mitochondria on rats subjected 
to the modified diet were generally less functional and more susceptible to MPTP 
induction, this deterioration of mitochondrial function was further investigated. With 
this purpose, cytrate synthase activity was measured as a common quantitative marker 
enzyme for mitochondrial integrity [579], its basal activity reflecting the presence of the 
enzyme in solution due to leakage from damaged mitochondria. No statistical 
differences were found in the initial citrate synthase activity between the two animal 
groups (Fig. 40, left panel). When the total citrate synthase activity was evaluated, upon 
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detergent addition to promote the complete release of the enzyme, no differences 
between the two experimental groups were observed at the time point assessed (33 days 
of treatment; Fig. 40, right panel), which means that protein quantifications were 
accurate. 
 
Fig. 40: Parameters taken from the spectrophotometric determination of citrate synthase 
activity in liver mitochondria from rats fed a control diet (black bars) or a diet containing 
20% rapeseed oil (white bars). Percentage of damaged mitochondria (A) was calculated as the 
percentage of the initial protein activity in relation to the total citrate synthase activity (B), 
which was determined after detergent (Triton X-100) addition. Values depicted are means ± 
standard deviation for 5 animals sacrificed 33 days after the onset of the treatment. Comparisons 
were performed using one-way ANOVA, with the Student-Newman-Keuls as a post-test for 
control diet rats versus rats fed the modified diet. All comparisons were not significant. 
 
2.2.3.1.5. Dietary treatment had repercussions in oxidative stress 
 
Dietary effects on oxidative stress related endpoints were also investigated. Formation 
of hydroperoxide by the respiratory chain was determined in liver mitochondria from 
both dietary groups after 33 days of treatment. For rats fed the diet containing 20% 
rapeseed oil, H2O2 generated by mitochondria in the basal state (no substrate added) was 
significantly decreased (Fig. 41A and B). For glutamate/malate-respiring mitochondria 
(Fig. 41A), significant differences between groups were found when the respiration 
inhibitors rotenone (complex I) and antimicyn A (complex III) were added to promote 
hydroperoxide production, with the mitochondria from rats fed the alternative diet 
presenting lower H2O2 production. For succinate-respiring mitochondria (Fig. 41B), 
H2O2 production was decreased for the modified diet rats, but no significant differences 
between groups were found upon addition of the abovementioned respiratory inhibitors. 
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Fig. 41: Determination of oxidative stress markers in liver mitochondria (A and B) or 
tissue (C, D and E) from rats fed a control diet (black bars) or a diet containing 20% 
rapeseed oil (white bars). The parameters determined were hydroperoxide production in the 
absence (Basal) or presence of glutamate/malate mixture (A), or succinate (B) as respiratory 
substrate (Subst), and in the presence of substrate plus the respiratory inhibitors rotenone (Rot) 
or antimycin A (Ant A). Vitamin E (C), MDA (D) and protein carbonyl groups (E) contents 
were also assessed. A representative blot indicating protein-bound carbonyls present in the 
samples after 33 days of dietary treatment is shown in F. The presence of oxidized proteins in 
both groups is confirmed by the specificity of DNPH reactivity (N: normal; M: modified diet). 
Values depicted are means ± standard deviation for 7 animals sacrificed 33 days after the onset 
of the treatment (or 22 and 33 days, for E). Comparisons were performed using one-way 
ANOVA, with the Student-Newman-Keuls as a post-test for control diet rats versus rats fed the 
modified diet. **, P <0.01; *, P <0.05. 
 
Total tissue Vitamin E (Fig. 41C) was lower in the diet-manipulated group, although no 
differences were found for total tissue MDA, a marker of lipid peroxidation (Fig. 41D), 
and for protein carbonyl groups (Fig. 41E and F), regardless of treatment time. 
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2.2.3.2. Discussion 
 
Several studies have indicated a close relationship between mitochondrial function and 
lipid composition. In fact, PC, PE and CL were found to be required for the assembly of 
the mitochondrial respiratory system [262, 263]. Membrane lipid influence on 
mitochondrial membrane physiological processes goes beyond respiratory activity. In 
fact, an increasing number of other roles have been pointed out for mitochondrial lipids, 
including regulation of mitochondrial fusion and fission [580] and apoptosis [170]. 
Regarding the latter, mitochondrial lipid composition was found to change during the 
apoptotic process, one example being the membrane redistribution of CL [119]. CL 
provides a paradigmatic example for the role of phospholipids in mitochondrial 
membrane protein structure and function. CL has been implicated in a number of 
mitochondrial processes such as respiratory function, supercomplex formation, 
apoptosis induction [237], as well as in mitochondrial carrier protein assembly and 
function [581]. 
Evidences of the influence of lipids on mitochondrial function have been accumulated 
from a number of studies where mitochondrial lipid content has been manipulated by 
diet. Some of these studies showed lipid driven alterations of the physical properties of 
mitochondrial membranes [132-136], mitochondrial respiration [129, 137-141] as well 
as ROS production [142] and Ca2+-induced MPT [143]. 
The present study intends to be a step ahead in the current knowledge concerning the 
relationship between dietary lipid composition and mitochondrial function, and 
describes mitochondrial alterations in a bioenergetic context, which occur 
concomitantly with diet-induced changes in membrane composition and organization. 
The rapid promptness with which dietary fatty acids can influence membrane 
composition and function has been previously demonstrated by Innis and Clandinin 
[134, 135]. There is some controversy regarding the susceptibility of rat liver cellular 
and subcellular membranes to diet-induced changes. Some studies point out the liver as 
being more susceptible than the brain [129, 146] or the heart [131], while others report 
the liver to be more resistant to dietary changes and ageing than heart and skeletal 
muscle [168]. The nature of the diet and details of the feeding protocols should 
determine the susceptibility of cellular membranes of rat liver to undergo changes. In 
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the case of the feeding protocol used in this work significant alterations were indeed 
observed at the mitochondrial level. 
Our choice for a rapeseed oil-containing diet, between many other fat-enriched diets 
assayed so far, was based on the fact that this diet was demonstrated to promote changes 
in terms of phospholipid class relative concentrations in heart mitochondria [135]. 
Periods as short as 3 days were shown to be enough to achieve changes on 
mitochondrial lipid composition by dietary manipulation [150]. Many studies regarding 
the effects of rapeseed oil-enriched diets on membrane composition and function [134, 
135, 144, 162, 582] were triggered by the correlation which had been established 
between a long-time exposure to these diets and rat heart lesions, including necrotic 
foci, aggregations of mono-nuclear cells and an increase in the connective tissue 
elements. These adverse effects were attributed to erucic acid (C22:1), a major 
constituent in rapeseed oil [574]. Interestingly, recent studies point exactly in the 
opposite direction, foreseeing a preventive action for rapeseed oil in heart disease. 
Animals fed a rapeseed oil-enriched diet displayed reduced mortality rate and infarct 
size, and an increased probability of spontaneous reperfusion in the post-ischaemic 
period [445]. In this case, the content in α-linolenic acid (C18:3, n-3) would be 
responsible for most of the protective effects. Another study reported that regular intake 
of optimised rapeseed oils may help prevent oxidative stress [444]. These studies 
underline the potential cardioprotective action of rapeseed oils employed as a functional 
food supplement. Specific composition of rapeseed oil and general differences that may 
arise from the refining techniques used, percentage of the oil in the diet and general 
differences in the feeding protocols may account for such dissonant reported effects, at 
least to some extent. In the present work, feeding Wistar rats a 20% rapeseed oil diet for 
33 days did not result in relevant alterations of biochemical plasma parameters. 
Unaltered blood biochemistry was also previously reported for Wistar rats submitted to 
a 10% rapeseed oil diet [583]. On the other hand, no apparent internal lesions were 
found in the organs of the animals fed the rapeseed oil diet. Extra attention was given to 
the hearts of these animals, which showed increased weight in relation to total animal 
weight (Table XII), given the aforementioned reported effects of rapeseed oil-
containing diets on this organ. In fact, the observed increase in heart-to-total weight 
seems to be a consequence of the lower body weight exhibited by the animals, rather 
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than reflecting an increase of the organ weight itself. The differences in animal weight 
gain during the treatment are probably related to the decrease in the consumption of the 
modified diet. In fact, as a result of the calorie adjustment, the absence of sucrose in the 
modified diet probably makes the rats less avid for it. It was also previously reported 
that Wistar rats fed a high-content fat diet for up to 2 months were able to counteract 
obesity development by parallel increase in energy expenditure [584]. Therefore, it is 
unlikely that the high-fat modified diet used in the present study, which was calorically 
adjusted to the control one, would result in weight gain. 
Phospholipid composition found for the control group is coherent with previous reports 
for liver mitochondria from male Wistar rats [84, 585]. The most noticeable diet-
induced alteration in mitochondrial membrane lipid composition was a significant shift 
in the PC/PE ratio. PC content increased along the entire time frame of dietary 
treatment, with PE content following the opposite trend (Table XIII). This effect was 
already described for heart homogenates and heart mitochondria as a consequence of 
diets containing a significant amount of erucic acid, as rapeseed oil does [161], or 
including rapeseed oil itself [135]. An alteration of CL content in cardiac mitochondria 
was also reported [135], although in the opposite direction to that found in the present 
work, in hepatic mitochondria. Alterations in the content of PC and CL have also been 
found in studies involving other high-fat diets [169]. 
In terms of fatty acid composition, the main differences found in the present work after 
full dietary treatment (33 days) were a decrease in stearic and linoleic acid content and 
an increase in oleic acid content (Table XIII). On the other hand, new fatty acids (n-
eicosanoic, eicosenoic, eicosapentaenoic, docosanoic, erucic and tetracosanoic acids, 
Table XIII) appeared in minor concentrations in mitochondria from rats fed the 
modified diet, most of them being present in the constitution of the rapeseed oil (Table 
X). Although some of these fatty acids might be directly incorporated from the diet, 
they were not proportionally represented in membrane lipid composition. Thus, erucic 
acid, the major component in the rapeseed oil (Table X), only appeared at a very low 
concentration in liver mitochondrial phospholipids, consistently with what was 
previously described for rat liver membranes as compared to heart tissue [147]. 
Therefore, our results seem to be in agreement with studies [134, 135, 142] showing 
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diet-induced alterations of the mitochondrial membrane lipid composition in a manner 
that loosely reflects the composition of the dietary fat source. 
It was previously hypothesized [135] that alterations in membrane phospholipid classes 
could result from an adaptation mechanism to counteract changes in the pool of fatty 
acids available for phospholipid de novo synthesis, in order to preserve adequate 
membrane physical properties. Accordingly, the aforementioned enrichment in PC at 
the expense of PE observed in mitochondrial membranes from rats fed the modified diet 
(Table XIII) may represent a compensation for the increase in the unsaturated/saturated 
fatty acid ratio (Fig. 33). The increase of the unsaturation degree specially when 
associated to lipids with small headgroups, such as PE, could create a high propensity 
for the generation of HII structures [586, 587]. In contrast, PC molecules with a larger 
and more hydrated polar group would assure a balance between the lateral pressures 
exerted along the length of the lipid molecules, enabling the stabilization of the lamellar 
structure. 
Fluorescence anisotropy measurements showed that the alterations of membrane lipid 
composition in mitochondria from rats fed the rapeseed oil diet did not significantly 
disturb membrane physical properties, particularly at physiologic temperature (Fig. 35). 
However, in the outer regions of the mitochondrial membranes, a slight increase of lipid 
order was detected by the probe DPH-PA at 25ºC. This fact, which was not expected 
due to the diet-induced increase of lipid unsaturation degree (specifically reflecting an 
increase in MUFA and PUFA content), may however result from other membrane 
composition alterations, which were not studied in this work (e.g. the content in chol or 
the lipid/protein molar ratio). 
The specific fatty acid composition of CL molecules was investigated by means of mass 
spectrometry (Fig. 34). In fact, beyond the interest that this phospholipid holds given its 
participation in numerous mitochondrial processes, it was previously suggested that CL 
is more susceptible than other classes of phospholipids, such as PC and PE, to undergo 
acyl chain change upon dietary manipulation [165]. Changes in CL fatty acid 
composition in rats fed diets containing rapeseed oil have been previously reported 
[161, 162]. The fatty acid composition of CL differs among tissues and organs, 
containing higher levels of linoleic acid in rat heart than in brain or liver [129]. The CL 
species (18:2)3(18:1) ([M-H]- ion at m/z  1449.7), found as the major species in control 
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rats (Fig. 34) was previously reported as being the main species present in male Fisher 
rat liver [588]. The modified diet in our work had the effect of changing the major CL 
species to (18:1)2(18:2)2 CL ([M-H]- ion at m/z 1451.7), indicating in theory that one 
oleic acid replaced one linoleic acid as an hydrophobic chain (Fig. 34). This could 
reflect the increase in oleic acid and decrease in linoleic acid content of the lipid 
extracts from liver mitochondria of rats fed the rapeseed oil diet, meaning that the 
increased oleic acid was at least in part incorporated into CL. This alteration, as well as 
the increase of the CL species incorporating the docosahexaenoic acid, corresponding to 
the (18:1)2(18:2)(22:6) CL species with a molecular weight of 1500.7, identified by the 
[M-H]- ion at m/z 1499.7 (Fig. 34), were both previously reported in heart mitochondria 
of rats fed diets containing hydrogenated corn oil and essential fatty acid-deficient oil 
[165]. Biosynthesis of CL, either de novo synthesis in mitochondria or reacylation or 
remodeling during postsynthetic maturation, has been shown to be influenced by diet 
[119]. Specifically, the steps involving acyl-CoA:lysocardiolipin acyltransferase 1 
(ALCAT1), which performs coenzyme A-dependent reacylation of MLCL with a 
preference for linoleoyl-CoA and oleoyl-CoA as acyl donors, and tafazzin, involved in 
the remodeling of CL acyl chains by transferring linoleic acid from PC to MLCL, seem 
to be susceptible targets for diet manipulation. A preferential incorporation of oleic acid 
instead of linoleic acid may be reflected in a decrease in oxidizable CL in mitochondria. 
Apparently, tetraoleoyl-CL (TOCL) does not undergo oxidation within cyt c/TOCL 
complexes incubated in the presence of H2O2, and enrichment of cells with non-
oxidizable molecular species of CL was proposed as a potential mechanism for 
protecting cells against apoptosis [166]. Prevention of CL peroxidation may therefore 
prove important, because it could prevent the subsequent release of pro-apoptotic 
factors into the cytosol and activation of caspase cascades. Dietary approaches may then 
prove useful when attempting to externally regulate apoptosis, via changes in CL. 
Putative diet effects on the expression of mitochondrial proteins were then investigated 
(Fig. 36) since some studies have provided evidence of diet influence on protein 
expression [448, 589]. One of these studies [589] showed that male rats fed a high-fat 
diet displayed increased levels of COX subunit II, whereas the levels of UCP2 and COX 
subunit IV remained unchanged. Our work confirmed unaltered UCP2 expression, as 
well as complex IV content sensitivity to diet lipid manipulation, since subunit MTCOX 
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I was decreased, although only for the 22 days time point (Fig. 36B). No significant 
changes were found in protein expression by the end of the treatment (33 days). 
Therefore, diet-induced imbalance in protein expression seems to have been transitory, 
at least within the timeframe of our study. 
Dietary effects on mitochondrial bioenergetics (Fig. 37) were similar to those 
previously described for cardiac mitochondria isolated from chicks fed diets containing 
rapeseed oils, including a reduction in the respiratory efficiency and decreased ADP/O 
ratio [144, 575]. Studies pointing out that liver mitochondrial bioenergetics were not 
affected by dietary rapeseed oil [147] employed a diet whose composition was different 
from that used in our study. Similarly to our results (Table XIV), ATP/ADP ratios were 
previously reported to be preserved in rats fed diets with high lipid content [590]. 
A correlation between proton leak rate and mitochondrial membrane fatty acid 
composition has been proposed. In particular, a negative correlation between proton 
leak and linoleic acid content and a positive correlation between proton leak and long-
chain PUFAs, such as docosahexaenoic acid, have been previously demonstrated [139, 
591]. More specifically, it has been suggested that CL linoleic acid content is inversely 
correlated with mitochondrial proton leak [592]. Mitochondrial CL species, especially 
those with high linoleic acid content, were proposed to strongly bind many carrier and 
enzyme proteins that are involved in oxidative phosphorylation, some of which 
contribute to regulation of state 3 respiration [593]. Although not required for oxidative 
phosphorylation, CL increases the efficiency of this process under optimal conditions 
and decreases it via partial destabilization of respiratory supercomplexes [581]. 
Our results do not present significant changes in linoleic acid content in liver 
mitochondria (Table XIII), but a linoleic acid was replaced by an oleic acid in the major 
CL molecular species detected (Fig. 34). Therefore, the increase in state 4 respiration 
observed in mitochondria from rats fed the modified diet may be correlated with the 
decrease in CL linoleic acid content. Mass spectrometry data regarding the distribution 
of fatty acyl chains in CL species allowed to foresee changes in the balanced chain 
symmetry of CL species overall, which is proposed to be important for the stability of 
the resonance-stabilized structure of CL headgroups, when incorporated in 
biomembranes [290]. This structure involves the establishment of two H-bonds between 
the phosphate groups and the free hydroxyl group in the glycerol, after one phosphate 
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group picked up a proton from solution, a single electron remaining delocalized 
between the two phosphates. The resulting bicyclic headgroup conformation has been 
proposed to confer a high pK2 (>8.0) to CL, in consequence of which a higher pool of 
protons might become available to the membrane at physiologic conditions, eventually 
facilitating ATP synthesis. The high second CL pK also promotes the neutralization of 
proton charge on the C-side of the membrane, potentiating ∆Ψ energy generation for 
proton pumping. 
If diet-induced changes would favor an imbalance in chain symmetry of CL, as should 
be the result of incorporation of longer fatty acids such as docosahexaenoic acid (with 
the increase in the (18:1)2(18:2)(22:6) CL species), a disruption of the headgroup’s 
resonance structure might result in eventual repercussions on the efficiency of oxidative 
phosphorylation. This could explain the decreased respiratory parameters in 
mitochondria from rats fed the modified diet as compared to controls. Integrating all 
data concerning CL, and given its pivotal importance for mitochondrial physiology, it is 
reasonable to predict that the diet-induced small decrease in CL content accompanied by 
reconfiguration of CL molecules (Table XIII) may indeed cause disturbances that would 
be reflected in bioenergetic alterations. 
PC and PE have also been proposed as playing an important role in mitochondrial 
electron transfer, since they have been detected in complexes isolated from 
mitochondria [594]. Therefore, the significant changes in PC/PE ratio found in rats fed 
rapeseed oil-diet (Table XIII) could also have influenced protein-lipid interactions, with 
repercussions in mitochondrial bioenergetics. 
Regarding diet effects on mitochondrial ∆Ψ, studies are scarcer. However, a decrease in 
the ∆µH+ was described for liver mitochondria of rats fed a PUFA-deficient diet [595]. 
In agreement with our data (Fig. 38), a decrease of ∆Ψ was detected in liver 
mitochondria from mice fed a high fat diet [596]. 
Taken together, data from bioenergetics and membrane lipid composition studies 
suggest a complex dynamic mechanism coupling dietary fat with mitochondrial 
structure and functioning and bioenergetics efficiency, in agreement with previous 
reports [129, 138, 158]. The fact that the same type of respiratory/membrane potential 
effects were found regardless the respiratory substrates used (glutamate + malate or 
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succinate) strongly suggests that the causing alteration is lipidic in nature, although an 
effect downstream from complex II could be an alternative explanation. 
Liver mitochondria from rats fed the 20% rapeseed oil containing diet also displayed 
higher sensitivity to calcium-induced MPT (Fig. 39). Changes in the characteristics of 
the spontaneous mitochondrial swelling in vitro were reported as being a result of 
essential fatty acid deficiency [151, 597, 598]. It was also described that diet-induced 
manipulation of membrane phospholipids and PUFAs may alter the flux of Ca2+ across 
the mitochondrial membrane [206] and that variation of unsaturated/saturated fatty acid 
ratio in rat liver mitochondria composition may alter swelling properties [132, 599]. 
This is in agreement with our results where a decrease in the saturated/unsaturated ratio 
(Fig. 33) and an increased susceptibility to calcium-induced swelling (Fig. 39) were 
described. From the MPTP proteins analyzed, only the ANT showed to have been 
altered for the early time point (Fig. 36), although no significant alterations in MPT 
induction were found at that time point. Thus, it is unlikely that alterations in ANT, or 
CypD, were responsible for alterations in MPT induction. 
Increased susceptibility to swelling along with impaired respiratory parameters (lower 
ADP/O ratios) was previously described in the context of fat deficiency [597], with 
mitochondria being proposed as appearing “more fragile”. However, the increase in 
susceptibility to calcium-induced swelling and the decrease in functionality (respiratory 
parameters) found in our study are not related with putative changes in integrity, as was 
shown by citrate synthase activity assessment (Fig. 40). 
Diet-induced alterations of mitochondrial oxidative stress markers (Fig. 41) surprisingly 
indicate a decreased production of peroxides by the respiratory chain, regardless the 
absence or presence of respiratory inhibitors in mitochondria from rats fed the modified 
diet (Fig. 41A and B). When a mixture of glutamate plus malate was used as respiratory 
substrate, mitochondria from rats fed the alternative diet produced less hydroperoxide at 
all conditions tested (Fig. 41A). When succinate was used as substrate, hydroperoxide 
production was also lower at basal conditions and upon addition of the substrate, for 
mitochondria from rats fed the rapeseed oil diet. However, in this case, when respiratory 
inhibitors were added, the differences between both types of mitochondria were 
mitigated (Fig. 41B). These results suggest that the dietary protection that led to a 
decreased hydroperoxide production in mitochondria from rats fed the rapeseed oil diet 
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was mostly exerted on complex I. With the glutamate plus malate mixture as substrate, 
electron flow was always being diverted at the complex I (and complex III, except when 
antimycin A was added). When succinate and rotenone were added, no hydroperoxide 
could be generated in complex I through electron reverse flow, and differences between 
the two experimental groups were attenuated. When antimycin A was present, inhibiting 
the electron flow at complex III, no electron backflow occurs either, since there is an 
electrochemical impairment for complex I reverse functioning. The mechanism for the 
decreased hydroperoxide production by the respiratory chain is presently unknown but 
our data showed that it is independent of vitamin E content. The small, but significant 
decrease in tissue vitamin E content (Fig. 41C) may be related to diminished diet 
consumption in the modified diet group. Concerning MDA content, which presented no 
changes between the modified diet-fed and control groups, it concurs with reports 
claiming that it does not change upon rapeseed oil-enriched diet treatment, namely as 
reported in rat myocardium [445], and agrees with insignificant changes in fatty acid 
peroxidizability index (PI), shown in Table XIII. 
Previous reports propose a reduction in lipid peroxidation levels in the ischaemic brain 
of rapeseed oil-fed animals [445], which our work did not corroborate in liver tissue 
samples (Fig. 41D). Others indicate high-fat diets as having a similar effect to that 
reported in our study, decreasing mitochondrial H2O2 production in liver mitochondria 
from mice [600]. Fish oils were reported to also decrease hydroperoxide production in 
rat liver mitochondria in opposition to corn oil [142]. The effects of the rapeseed oil diet 
in decreasing ROS production are similar to those implemented by calorie restriction 
[601]. However, since our results also point to an increase in fatty acid unsaturation, 
positive effects of rapeseed oil in animal life span resulting from decreased ROS are 
probably counterbalanced by the increased susceptibility to lipid peroxidation [602]. 
One limitation in the present study would be the slightly different caloric content in 
both diets. The control diet had a kcal/kg ratio of about 4040, while the modified diet 
presented 4375 kcal/kg (Table XI), according to the vendor. Taking into account that rat 
daily diet intake is much less than 1 Kg, we believe that differences in daily calorie 
intake are diluted. A quick empirical exercise shows us that at the last week of treatment 
(when more experiments were conducted and more data acquired) diet consumption in 
the modified diet group was 93.3% of the control group (Fig. 32B). Taking into account 
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that the modified diet has 108.3% the calorie density of the control diet, we can consider 
that the lower diet consumption in the modified diet-fed group is actually counteracted 
by the slightly increased calorie density of this diet. Therefore, we strongly argue that 
calorie intake/diet composition is not a primary factor for the differences found in this 
study. 
In conclusion, the present study shows that dietary-induced changes in mitochondria 
membrane composition take place quite rapidly and alter bioenergetics at this organelle. 
Since time points longer than 33 days were not studied, it remains to be determined 
whether longer-term treatments would contribute to a progressive alteration in the 
mitochondrial protein content counteracting lipid-induced alterations in mitochondrial 
activity. Nevertheless, this study opens wide perspectives in terms of dietary modulation 
of mitochondrial membrane function and the subsequent possible therapeutic 
applications that may arise. In fact, dietary benefits have been revealed to some 
pathological conditions, namely heart disease, with a clear relationship between the 
prevalence of cardiovascular disease and the type of lipids present in the diet [436, 437]. 
Benefits in this context have been pointed to diets containing some fish and vegetal oils 
[440, 442, 443]. Interestingly, in the particular case of rapeseed oil, it has been 
suggested to constitute a functional supplement aiding in stroke prevention and 
protection, given its cardioprotective properties [444], including reduced mortality rate 
and infarct size [445]. Dietary benefits have also been reported in other contexts such as 
cancer [446, 447] and type 2 diabetes [448]. Taking all this into account, it seems fair to 
say that dietary approaches to treat and prevent several pathological conditions should 
not be overlooked. Possible synergistic effects between diet and pharmacological drugs 
could also represent a valid path to explore, as will be discussed after in more detail. 
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2.2.4. Drug-induced toxicity in rat liver mitochondria as affected by 
diet 
 
2.2.4.1. Introduction 
 
Table XV: Structures and known mitochondrial actions of the drugs used in this study. 
 
 
In the previous section it was shown that a diet containing 20% rapeseed oil induced 
rapid alterations (at the end of 11 days of treatment) in terms of mitochondrial 
membrane composition and bioenergetics, with a significant decrease of mitochondrial 
function after 33 days of modified diet treatment and increased susceptibility to the 
induction of the MPT. These findings prompted us to investigate how liver 
mitochondria from rats fed that diet behave in the presence of several hepatotoxic drugs. 
Since these compounds showed to interact distinctly with IMM mimetic models, we 
predicted that their action on mitochondrial function should be differently affected by 
diet-induced lipid changes. To test this prediction, controlled experiments were 
performed in order to compare the effects exerted by those compounds on mitochondria 
isolated from the liver of rats fed a control or a modified diet. 
In the introduction of this thesis we have listed several hepatotoxic membrane-active 
drugs, which promote membrane physical perturbations, with repercussions to 
mitochondrial function. We resorted to the drugs used in the biophysical studies 
presented before in this chapter (section 2.1), MEN, NIM and FCCP, the later being a 
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classical uncoupler of mitochondrial oxidative phosphorylation [475, 603] (Table XV), 
to test the aforementioned prediction, relying on the information gathered regarding the 
membrane interaction profile of these compounds. We hypothesize that 33-day 
treatment of Wistar rats with a 20% rapeseed oil-containing diet would modulate the 
toxicity exerted by FCCP, MEN, and NIM on rat liver mitochondria. 
 
2.2.4.2. Results 
 
2.2.4.2.1. Modified diet modulated menadione and nimesulide effects on 
mitochondrial respiration 
 
MEN and NIM were used for the investigation of putative repercussions of diet-induced 
changes on membrane composition on mitochondrial bioenergetic impairment by 
mitochondrially-active drugs (including effects on respiration and transmembrane 
electric potential endpoints). MEN and NIM concentrations of 20 nmol/mg of protein 
and 40 nmol/mg of protein, respectively, were chosen since they fall within the range 
suggested in literature for compromising respiratory parameters [521, 604]. 
As reported in the previous section, the modified diet promoted an increase in state 4 
respiration and a decrease in state 3, uncoupled respiration, RCI and ADP/O ratio (Fig. 
42A and B). MEN effects on hepatic mitochondria from control animals, namely an 
increase in state 4 respiration and a decrease in RCI and ADP/O ratio (Fig. 42A), were 
consistent with data reported in literature [521]. In a rather consistent manner, the 
effects of MEN on respiratory parameters were less pronounced in mitochondria from 
rats fed the rapeseed oil diet than from rats fed the standard diet (Fig. 42C and D). 
Differences between the respiratory parameters determined in the presence of the drug 
(added to mitochondrial suspensions) and in the presence of an equivalent amount of 
solvent (for controls) were significantly lower in mitochondria from the group fed the 
modified diet than in mitochondria from the group fed the control diet (diet control 
group), namely concerning the respiratory state 3 and RCI when glutamate plus malate 
were used as substrate, and the state 4, state FCCP, RCI and ADO/O ratio, when 
succinate was used. 
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Fig. 42: Oxygen consumption studies with MEN in liver mitochondria from rats fed a 
control diet (black and dark grey bars) or a diet containing 20% rapeseed oil (white and 
light grey bars). Mitochondria were incubated with 20 nmol of MEN per mg of protein (dark 
and light grey bars) or a volume of ethanol equal to that used of MEN solution (black and white 
bars), as controls, for 3 min before the beginning of the assay. Substrates used for the 
respiratory studies were a mixture of glutamate plus malate (Complex I) or succinate (Complex 
II). The parameters represented in the figure are respiratory states 3 and 4 (St. 3 and St. 4, 
respectively), uncoupled respiration (St. FCCP), RCI and the ADP/O ratio (A and B). The 
extent of the action of the drug was evaluated by subtracting from the control value (incubation 
with ethanol) the corresponding value in the presence of MEN (black bars minus dark grey bars; 
white bars minus light grey bars; C and D). Typical oxygen consumption traces for complex II, 
as followed with a Clark type electrode are presented in E (for complex I similar tendencies 
were obtained). Values depicted are means ± standard deviation for 8 animals after 33 days of 
dietary treatment. Comparisons were performed using one-way ANOVA, with the Student-
Newman-Keuls as a post-test for control (without drug) versus determinations with the addition 
of drug (***, P <0.001; **, P <0.01; *, P <0.05) and diet control rats versus rats fed the 
modified diet, for the same parameter (ººº, P <0.001; ºº, P <0.01; º, P <0.05) in A and B. In C 
and D, comparisons were made for diet control rats versus rats fed the modified diet (***, P 
<0.001; **, P <0.01; *, P <0.05). 
 
The effects induced by NIM in liver mitochondria from control rats (Fig. 43A) were 
also consistent with those previously reported in literature [604, 605]. As MEN, NIM 
also promoted a significant increase of respiratory state 4 and a decrease in uncoupled 
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respiration, RCI and ADP/O ratio (Fig. 43A and B). Regarding the assessment of NIM 
effects in both experimental groups, significant differences were only found when 
glutamate plus malate were used as substrate. Similarly to MEN, mitochondria from rats 
fed the alternative diet were less susceptible to the toxic action of NIM regarding the 
effects on respiratory state 3, uncoupled respiration, RCI and ADP/O ratio (Fig. 43). 
 
Fig. 43: Oxygen consumption studies with NIM in liver mitochondria from rats fed a 
control diet (black and dark grey bars) or a diet containing 20% rapeseed oil (white and 
light grey bars). Mitochondria were incubated with 40 nmol of NIM per mg of protein (dark 
and light grey bars) or a volume of DMF equal to that used of NIM solution (black and white 
bars), for 3 min before the start of the assay. Substrates used for the respiratory studies were a 
mixture of glutamate plus malate (Complex I) or succinate (Complex II). The parameters 
represented are respiratory states 3 and 4 (St. 3 and St. 4), uncoupled respiration (St. FCCP), 
RCI and the ADP/O ratio (A and B). The extent of the action of the drug was evaluated by 
subtracting from the control value (incubation with DMF) the corresponding value in the 
presence of NIM (black bars minus dark grey bars; white bars minus light grey bars; C and D). 
Typical oxygen consumption traces for complex II, as followed with a Clark type electrode are 
presented in E (for complex I similar tendencies were obtained). Values depicted are means ± 
standard deviation for 8 animals after 33 days of dietary treatment. Comparisons were 
performed using one-way ANOVA, with the Student-Newman-Keuls as a post-test for control 
(without drug) versus determinations with the addition of drug (***, P <0.001; **, P <0.01; *, P 
<0.05) and diet control rats versus rats fed the modified diet, for the same parameter (ººº, P 
<0.001; ºº, P <0.01; º, P <0.05) in A and B. In C and D, comparisons were made for diet control 
rats versus rats fed the modified diet (***, P <0.001; **, P <0.01; *, P <0.05). 
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2.2.4.2.2. Modified diet modulated menadione, nimesulide and FCCP effects on 
mitochondrial transmembrane electric potential 
 
Fig. 44: Mitochondrial transmembrane potential (∆Ψ) studies with MEN in liver 
mitochondria from rats fed a control diet (black and dark grey bars) or a diet containing 
20% rapeseed oil (white and light grey bars). Mitochondria were incubated with 20 nmol of 
MEN per mg of protein (dark and light grey bars) or a volume of ethanol equal to that used of 
MEN solution (black and white bars), for 3 min before ADP addition. Substrates used for the 
respiratory studies were glutamate plus malate (Complex I) or succinate (Complex II). The 
parameters represented in A and B are initial potential (∆Ψi) developed in the presence of the 
substrate and drug (ethanol for controls), depolarization induced by ADP (-∆ΨADP), potential 
after repolarization (∆Ψrep) and phosphorylative lag phase. The extent of the action of the drug 
was evaluated by subtracting from the control value (with ethanol) the corresponding value in 
the presence of MEN (black bars minus dark grey bars; white bars minus light grey bars; C and 
D). Typical transmembrane potential traces for control rat mitochondrial preparations, as 
followed by a TPP+ electrode are represented in E (for mitochondrial preparations from rats fed 
the modified diet, similar tendencies were obtained). Values depicted are means ± standard 
deviation for 8 animals after 33 days of dietary treatment. Comparisons were performed using 
one-way ANOVA, with the Student-Newman-Keuls as a post-test for control (without drug) 
versus determinations with the addition of drug (***, P <0.001; **, P <0.01; *, P <0.05) and 
diet control rats versus rats fed the modified diet, for the same parameter (ººº, P <0.001; ºº, P 
<0.01; º, P <0.05) in A and B. In C and D, comparisons were made for diet control rats versus 
rats fed the modified diet (***, P <0.001; **, P <0.01; *, P <0.05). 
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As reported in the previous section (2.2.3), dietary effects of rapeseed oil on the 
transmembrane potential (∆Ψ) of liver mitochondria included a decrease in the maximal 
∆Ψ developed upon substrate addition, decreased ADP-induced depolarization and 
repolarization as well as an increase of the phosphorylative lag phase. These effects 
were confirmed during these studies, investigating putative dietary modulation of 
mitochondrial drug toxicity (Fig. 44A and B). 
In rats from the diet control group, MEN decreased the initial transmembrane electric 
potential, ADP-induced depolarization and the final potential after repolarization of 
mitochondria, while only the first parameter was found to be significantly decreased in 
glutamate-malate-energized mitochondria of modified diet-fed animals (Fig. 44A). 
MEN effects were much less evident when succinate was used as substrate, only the 
repolarization potential after ADP phosphorylation being significantly decreased in rats 
fed the control diet (Fig. 44B). By comparing the extent of MEN effects in the two 
experimental groups, it seems that mitochondria from rats fed the rapeseed oil-
containing diet showed again less susceptibility to MEN adverse effects, but only when 
glutamate plus malate were used as substrate (Fig. 44C). When succinate was used as 
substrate apparent differences were not noticeable (Fig. 44D). 
Also NIM caused an initial dissipation of the ∆Ψ, as previously reported [605]. Besides 
affecting the initially developed ∆Ψi, NIM decreased ADP depolarization and 
repolarization potential post-ADP phosphorylation in mitochondria from rats fed the 
control diet, using glutamate plus malate as substrate (Fig. 45A). Using succinate as 
substrate, ADP-induced depolarization was not significantly affected (Fig. 45B). For 
rats fed the alternative diet, ∆Ψi was decreased using both substrates, and post-ADP 
repolarization was also decreased using succinate. Concerning the differences in the 
action of NIM between the two experimental groups, the less severe effects were once 
more observed on mitochondria from rats fed the rapeseed oil-containing diet, and like 
for MEN, significant differences were only registered when complex I substrates were 
used (Fig. 45C and D). Therefore, in the case of the mitochondrial transmembrane 
potential determinations (as for NIM in the respiratory parameters before, Fig. 43), 
dietary modulation of mitochondrial drug toxicity seems to be more perceived at the 
complex I level.  
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Fig. 45: Mitochondrial transmembrane potential (∆Ψ) studies with NIM in liver 
mitochondria from rats fed a control diet (black and dark grey bars) or a diet containing 
20% rapeseed oil (white and light grey bars). Mitochondria were incubated with 40 nmol of 
NIM per mg of protein (dark and light grey bars) or a volume of DMF equal to that used of 
NIM solution (black and white bars), as controls, for 3 min before ADP addition. Substrates 
used for the respiratory studies were a mixture of glutamate plus malate (Complex I) or 
succinate (Complex II). The parameters represented in the figure (A and B) are initial potential 
(∆Ψi) developed in the presence of the substrate and drug (or DMF in the case of controls), 
depolarization induced by ADP (-∆ΨADP), potential after repolarization (∆Ψrep) and 
phosphorylative lag phase. The extent of the action of the drug was evaluated by subtracting 
from the control value (incubation with DMF) the corresponding value in the presence of NIM 
(black bars minus dark grey bars; white bars minus light grey bars; C and D). Typical 
transmembrane potential traces for control rat mitochondrial preparations, as followed by a 
TPP+ electrode are represented in E (for mitochondrial preparations from rats fed the modified 
diet, similar tendencies were obtained). Values depicted are means ± standard deviation for 8 
animals after 33 days of dietary treatment. Comparisons were performed using one-way 
ANOVA, with the Student-Newman-Keuls as a post-test for control (without drug) versus 
determinations with the addition of drug (***, P <0.001; **, P <0.01; *, P <0.05) and diet 
control rats versus rats fed the modified diet, for the same parameter (ººº, P <0.001; ºº, P <0.01; 
º, P <0.05) in A and B. In C and D, comparisons were made for diet control rats versus rats fed 
the modified diet (***, P <0.001; **, P <0.01; *, P <0.05). 
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Fig. 46: Mitochondrial transmembrane potential (∆Ψ) studies with FCCP in liver 
mitochondria from rats fed a control diet (black bars) or a diet containing 20% rapeseed 
oil (white bars). A sequence of three consecutive additions of small pulses of FCCP (10 pmol 
FCCP/mg of protein) was performed into the energized mitochondrial preparations (using either 
a mixture of glutamate plus malate – complex I, or succinate – complex II, as respiratory 
substrate) and the severity of the effects was compared between groups. Assays with ethanol 
(FCCP solvent) were performed for control purposes, but they are not represented since ethanol, 
in the volumes assayed, had no noticeable effects on ∆Ψ. Typical transmembrane potential 
traces for control rat mitochondrial preparations, as followed by a TPP+ electrode are 
represented in C (for complex I, using the mixture of glutamate plus malate as substrate, similar 
tendencies were obtained). Values depicted are means ± standard deviation for 8 animals after 
33 days of dietary treatment. Comparisons were performed using one-way ANOVA, with the 
Student-Newman-Keuls as a post-test for diet control rats versus rats fed the modified diet. ***, 
P <0.001; **, P <0.01; *, P <0.05. 
 
Finally, efforts were made in order to investigate also whether FCCP, a classic 
protonophore [393], would differently act in mitochondria from the two experimental 
groups. With this purpose, a sequential addition of small aliquots of FCCP was 
performed to evaluate effects in ∆Ψ of hepatic mitochondria from both groups. The 
results revealed that mitochondria from the rats fed the diet containing 20% rapeseed oil 
were less depolarized by the same amount of the uncoupler as compared to 
mitochondria from rats from the control group (Fig. 46). This finding revealed to be 
consistent using both respiratory substrates. 
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2.2.4.2.3. Modified diet modulated menadione and nimesulide effects on induction 
of the permeability transition pore 
 
Fig. 47: Effect of MEN and NIM on Ca
2+
-induced MPT in rat liver mitochondria from rats 
fed a control (black bars; full lines) or a rapeseed oil-enriched diet (white bars; dashed 
lines). The rates of absorbance decrease as result of mitochondrial swelling are represented in 
A. The extent of the action of the drugs, as determined by subtracting the rates of the controls 
(incubation with solvent) to the corresponding values in the presence of drugs, is represented in 
B. Mitochondria were incubated with 200 nmol of MEN per mg of protein or 50 nmol of NIM 
per mg of protein for 3 min before the addition of Ca2+ (66,7 nmol/mg protein), in the presence 
of substrate (succinate). Typical traces for the mitochondrial swelling experiments are 
represented in C. Cyclosporin A, a classic MPTP inhibitor, completely inhibited calcium-
induced mitochondrial swelling, as shown in C. Values depicted are means ± standard deviation 
for 7 independent experiments (provided by 7 different mitochondrial preparations from 7 
different animals). Comparisons were performed using one-way ANOVA, with the Student-
Newman-Keuls as a post-test for diet control rats versus rats fed the modified diet. ***, P 
<0.001; **, P <0.01; *, P <0.05. 
 
The effects of MEN and NIM as promoters of the MPTP have been reported [519, 606]. 
As shown in the previous section, mitochondria from rats fed the rapeseed oil diet 
displayed increased susceptibility to Ca2+-induced MPT. Comparing the extent of the 
effects of both NIM and MEN in the two experimental rat groups, it becomes evident 
that NIM ability to promote Ca2+-induced MPT was potentiated in mitochondria from 
rats fed the modified diet (Fig. 47A and B). Regarding MEN promotion of MPT, 
differences to the respective controls were not statistically significant between groups 
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(Fig. 47B). Moreover, MEN seems to attenuate the differences initially taking place 
between groups (Fig. 47A). 
 
Table XVI: Quantification of adenine nucleotides in hepatic mitochondrial samples from rats 
fed a control or a modified diet containing 20% rapeseed oil, in the presence of FCCP, MEN 
and NIM, or absence of these compounds, in the case of the controls (to which a volume of 
solvent equal to that used for the drug solution was added), in the conditions described for 
transmembrane potential determinations. A mixture of glutamate plus malate (Complex I) or 
succinate (Complex II) was used as substrate. ATP/ADP ratios, total energetic contents 
(ATP+ADP+AMP) and energy charges (ADP+2ATP)/ ATP+ADP+AMP) are represented. 
 Complex I Complex II 
 Normal Modified Normal Modified 
Control      
ATP
a)
 33.0±14.92 47.0±20.60 22.7±12.87 27.9±14.21 
ADP
 a)
  61.6±16.37 76.7±17.99 55.8±10.03 66.9±11.90 
AMP
a)
  75.8±23.77 94.4±19.83 131.2±18.92 145.0±10.54 
ATP/ADP 0.46±0.11 0.55±0.14 0.36±0.15 0.36±0.12 
Total energetic 
content 
a)
  
170.3±53.78 218.0±56.47 209.6±17.11 239.7±17.61 
Energy charge 0.73±0.07 0.74±0.08 0.47±0.14 0.49±0.12 
FCCP      
ATP
a)
  13.0±3.45 9.4±4.70 10.4±2.41 10.0±1.56 
ADP
a)
 4.1±1.68* 4.6±1.07* 3.0±1.74* 1.3±1.25** 
AMP
a)
  36.8±7.86 23.8±6.89 21.5±4.48* 20.8±2.10** 
ATP/ADP 2.24±0.80 2.36±0.98 2.45±0.19 2.80±0.00 
Total energetic 
content 
a)
 
53.8±9.58 37.8±11.72* 34.8±7.26** 32.0±2.95*** 
Energy charge 0.56±0.03 0.62±0.14 0.66±0.10 0.66±0.10 
Menadione     
ATP
a)
  13.6±1.40 12.1±1.04 23.6±13.52 21.9±11.32 
ADP
a)
 43.9±16.63 66.3±14.33 52.8±8.59 60.8±9.16 
AMP
a)
  111.0±9.15 107.1±14.90 115.6±19.33 113.9±8.35 
ATP/ADP 0.45±0.19 0.21±0.06 0.38±0.17 0.33±0.12 
Total energetic 
content 
a)
 
168.54±22.08 185.5±12.94 192.0±9.41 196.5±16.77* 
Energy charge 0.41±0.05* 0.49±0.08 0.51±0.18 0.51±0.10 
Nimesulide     
ATP
a)
  39.1±25.40 42.0±27.96 25.0±8.75 16.0±5.96 
ADP
a)
 80.6±17.38** 80.6±17.38 46.5±17.49 55.5±9.31 
AMP
a)
  122.6±9.27 119.4±37.54 140.7±4.79 138.8±5.59 
ATP/ADP 0.39±0.18 0.36±0.13 0.64±0.17 0.27±0.08 
Total energetic 
content 
a)
 
242.2±46.25* 255.1±93.97 212.2±22.74 210.2±9.54 
Energy charge 0.59±0.13 0.63±0.07 0.42±0.11 0.41±008 
a) Values are presented in nmol/mg of protein and are means ± standard deviation for 4 rats from each diet 
group (normal or modified diet). Comparisons were performed using one-way ANOVA, with the Student-
Newman-Keuls as a post-test for liver mitochondria of control diet rats versus liver mitochondria of rats 
fed the modified diet (all results were not significant), and for measurements where drugs were added 
versus the respective controls; ***, P <0.001; **, P <0.01; *, P <0.05. 
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2.2.4.2.4. Modified diet modulated effects of nimesulide and menadione on intra-
mitochondrial adenine nucleotides 
 
As shown in the previous section, modified diet did not alter the intramitochondrial 
content in adenine nucleotides (Table XVI). MEN decreased the energy charge when 
glutamate plus malate was used as respiratory substrate in the diet control group, while 
NIM increased the total content in adenine nucleotides in the same conditions, 
particularly ADP. FCCP, caused a profound depletion of the total content in adenine 
nucleotides.  The modified diet did not alter the effects of FCCP, MEN or NIM on 
adenine nucleotide content. 
 
2.2.4.3. Discussion 
 
Several clinically used drugs have specific mechanisms of action against target 
membrane proteins at certain concentrations, although some have also been shown to 
hold a “secondary pharmacology” at higher concentrations [455]. These non-specific 
effects on embedded membrane proteins may arise from drug-induced changes in the 
physical properties of the membrane, since membrane proteins are energetically coupled 
to the membrane bilayer [225, 455-457]. In fact, the intimate relationship between lipids 
and membrane protein structure and function should imply that bilayer lipids may 
influence drug action at membrane protein targets. Several lipophilic drugs have been 
proposed to influence membrane protein activity by interfering with lipid bilayer 
biophysical properties, and this mechanism is suspected of being responsible for the 
unwanted non-specific side effects for many compounds [226, 455, 607-609]. 
Disruption of lipid rafts, with redistribution of proteins between raft and non-raft 
domains, alterations of membrane curvature stress or bilayer thickness, are some of the 
consequences of the incorporation of amphiphiles into the lipid bilayer with predictable 
repercussions to membrane protein activity [458]. Therefore, since more than 50% of all 
drug targets are membrane proteins [610], drug action as influenced by lipid bilayer 
structure and composition should represent a very valid issue to investigate in a 
pharmacological context. 
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Since mitochondria display a complex physiology resulting from their involvement in 
numerous determinant cell processes, these organelles are very susceptible targets for 
drug-induced hepatotoxicity [335]. It is well known that a large number of natural, 
commercial, pharmaceutical, and environmental chemicals exert their toxicity by 
interfering with mitochondrial bioenergetics [335, 611]. On the other hand, the 
influence that diet fat content exerts on mitochondria functional performance has been 
also reported. Zsigmond and Clandinin [454] showed that the ATPase of heart 
mitochondria from animals fed diets enriched in fatty acids with extended chain length 
exhibited increased oligomycin sensitivity and lower 2,4-dinitrophenol-induced 
stimulation. The authors suggested that in vivo changes in the thickness of the lipid 
bilayer might alter mitochondrial ATPase functioning. 
With this background in mind, the objective of the present study was to investigate 
whether a modified diet enriched in rapeseed oil, which we previously showed to 
negatively alter hepatic mitochondrial function, could modulate the susceptibility of 
liver mitochondria to MEN, NIM and FCCP. 
The use of hepatic mitochondria in this study is justified by the fact that the liver is an 
important organ involved in drug detoxification [612] and the drugs used in this study, 
namely MEN and NIM, were shown to hold hepatotoxic effects [515, 613]. In fact, liver 
mitochondria permeabilization and impairment has been proposed as an unsafe event 
potentially evoked by hepatotoxic drugs, representing an effective risk to human health 
[606]. 
MEN, as a typical quinone, can undergo redox cycling, generating intracellular ROS at 
multiple cellular sites through futile redox cycling, eliciting rapid oxidation in both the 
mitochondrial matrix and cytosol, and being often used to simulate in vitro oxidative 
stress in mitochondrial preparations [614, 615]. In the present study, MEN showed to 
affect respiratory parameters (Fig 42A and B) in a way that was consistent with the data 
reported in literature [521]. Comparing the extent of the effects of MEN in the 
respiratory parameters of mitochondria from rats fed a standard rodent diet and from 
rats fed a diet containing 20% rapeseed oil, significant differences were noticed. 
Mitochondria from rats fed the alternative diet were generally more resistant to MEN-
induced alterations taking into account the different parameters analysed (Fig. 42C and 
D). Regarding transmembrane potential data, mitochondria from rats fed the alternative 
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diet showed to be less affected by MEN than mitochondria from rats from the control 
group when glutamate plus malate was used as respiratory substrate, with the 
respiratory chain working in its full length. When succinate was used, bypassing 
complex I, differences between mitochondria incubated with MEN or ethanol (drug 
solvent) were attenuated. This fact suggests that diet-induced changes in the extent of 
MEN effects should be exerted mostly at the complex I level, not excluding other 
membrane non-specific effects. The rapeseed oil containing diet induces significant 
changes in liver mitochondrial membrane lipid composition, as previously described. 
These changes affected the relative percentages of the three major phospholipid classes 
(increase in PC and decrease in PE and CL) and the fatty acid content (the 
saturated/unsaturated index being decreased). However, DPH and DPH-PA 
fluorescence polarization studies showed that lipid composition alterations did not 
affect membrane fluidity at physiologic temperatures. Therefore, a change in membrane 
order should not account for alterations in the mitochondrial susceptibility to MEN and 
to any of the other studied drugs.  However, the phospholipids PE and CL, whose 
content decreased in mitochondria from animals fed the rapeseed oil diet, were pointed 
as being essential lipid components for the optimal functioning of complex I 
(NADH:ubiquinone oxidoreductase) [267]. Evidences have been accumulated showing 
that tightly bound CL is required for the structural integrity of the complex I and PC and 
PE were found to be bound to this complex too, although more weakly than CL, 
determining its catalytic activity [267]. Therefore, one could speculate that the decrease 
in CL and PE in the mitochondrial membranes of rats fed the modified diet may lead to 
a deficit in the association of these lipids with complex I, resulting in a decrease of 
mitochondria performance. Therefore, MEN effects on mitochondria parameters, which 
follow the same trend of diet-induced changes (increase in state 4 respiration, decrease 
in ∆Ψ, RCI and ADP/O) may have a lower impact in mitochondria from rats fed the 
modified diet than in more efficient mitochondria from rats fed the control diet. Another 
way by which diet-induced lipid composition changes may influence MEN effects could 
be related with disturbances in the lateral pressure profile across the membrane lipid 
bilayer, affecting the conformational dynamics of proteins, namely complex I. In fact, it 
has been reported that the activity of some membrane enzymes is influenced by the 
proneness of the surrounding lipids to form HII structures [251]. This eventually 
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beneficial influence could be affected in mitochondria from rats fed the modified diet 
due to the decrease of PE content, a phospholipid that promotes such non-lamellar 
arrangements. Since MEN was previously shown to increase the proneness of an IMM-
mimicking model membrane to adopt HII arrangements, it is possible that MEN could 
compensate the loss of non-bilayer phospholipids (PE and CL) occurring in 
mitochondria from rats fed the modified diet. Therefore, MEN would exert less toxic 
effects on these mitochondria, to which the decrease in PE content might be detrimental 
for their function. 
MEN also promoted Ca2+-induced mitochondrial swelling according to the available 
literature [519] but no significant differences in the action of the drug were found 
between mitochondria obtained from both dietary groups (Fig. 47). MEN-induced MPT 
was described as depending on the direct oxidation of mitochondrial pyridine 
nucleotides and the modification of critical thiols of MPTP components [520], resulting 
from MEN oxidant activity. Such events should not be significantly affected by diet 
manipulation. Since MPT was suggested as being essential for MEN-elicited apoptosis, 
promoting efflux of cyt c into the cytoplasm and subsequent activation of caspases 9 
and 3 [518], differences in the induction of cell death caused by MEN should not be 
expected between the two experimental groups of rats.  
NIM, an NSAID that acts by preferential inhibition of cycloxygenase-2 [616], also 
affected bioenergetic parameters (Figs. 43A,B, and 45A,B) as expected from the 
available literature [399]. With NIM, it seems even more obvious than with MEN that 
diet-induced modulation of drug effects takes place at the complex I level. In fact, when 
comparing the severity of NIM effects on mitochondria from control rats and rats fed 
the rapeseed oil diet, differences are only significant when glutamate plus malate was 
used as respiratory substrate (Fig. 43C,D and Fig. 45C,D). The same mechanisms we 
proposed for dietary modulation of MEN toxicity may be applicable here. Biophysical 
studies reported previously that NIM, unlike MEN, stabilized lamellar arrangements in 
IMM-mimicking model membranes. Assuming that depressed mitochondrial function in 
the presence of NIM resulted from a decrease of curvature stress in the surroundings of 
critical membrane proteins, the mitochondrial membranes from rats fed the 20% 
rapeseed oil diet, with a lower content of PE and CL, would probably be less susceptible 
to the influence of this drug, since their lipid composition by itself would promote 
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bilayer stability. This could be the explanation for the less severe effects of NIM on 
mitochondria from rats fed the rapeseed oil diet, as compared to mitochondria from 
control rats. 
Regarding NIM activity towards Ca2+-induced MPT, which is also extensively reported 
in literature [349, 400], differences were observed between the two experimental groups 
(Fig. 47A and B), with mitochondria from rats treated with the 20% rapeseed oil diet 
being more affected by the drug. Knowing that NIM is a cationic drug probably 
establishing electrostatic interactions with negatively charged groups of membrane 
lipids such as CL, it is predictable that NIM may interfere with MPTP, preferentially 
localized in CL-enriched domains. As liver mitochondria seem to be particularly 
sensitive to MPT compared to mitochondria from other organs [617], the promotion of 
this process by NIM is thought to play a role in the idiosyncratic hepatic toxicity of 
NIM, as well as other NSAIDs [605]. Mitochondrial uncoupling induced by NIM [349], 
besides triggering induction of the MPT, may lead to the generation of oxidative stress 
in isolated liver mitochondria [605]. Therefore, mitochondria from the rapeseed oil diet 
rats are more susceptible to the effect of NIM on Ca2+-induced MPT probably due to 
their increased basal permeability to protons. State 4 respiration is higher in 
mitochondria from rats fed the rapeseed oil diet (Fig. 43A and B), therefore the 
uncoupling effect of NIM that reportedly leads to MPT, may be potentiated or concur 
with the uncoupling effect of the diet treatment itself. It would also be of great interest 
to study how dietary treatment may modulate NIM action at the level of cycloxygenase-
2 activity. The potency of this anti-inflammatory drug might be influenced by diet-
induced modification of membrane lipid composition, since NSAID-induced 
biophysical changes in membranes have been pointed to contribute to their 
toxic/pharmacologic activity [538]. 
FCCP a classical uncoupler of oxidative phosphorylation [475, 603] that acts at the 
IMM disrupting ∆Ψ, displayed a diminished effect on mitochondria from rats fed the 
rapeseed oil diet as compared to those of rats fed the control diet, regardless of the 
respiratory substrate used (Fig. 46). The extent of the uncoupling promoted by FCCP in 
mitochondria from these two control groups of rats might be correlated with their 
different lipid composition since this was proposed to modulate FCCP-induced proton 
translocation across the IMM [395]. The biophysical effects of FCCP on membrane 
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models, described before, showed that FCCP, besides increasing membrane fluidity and 
promoting lateral phase separation in membranes consisting of CL and PE (3:7), 
increased the proneness of membranes composed of PC, PE and CL (1:1:1) to form HII 
arrangements. Some of these effects were suggested to account for FCCP uncoupling 
activity and, then, they should be considered when appraising pharmacological uses of 
FCCP, as neuroprotection resulting from a “mild” uncoupling [474] or cardioprotection 
[475]. Hence, it is reasonable to assume that diet may modulate the pharmacological 
activity of FCCP by modulating FCCP-induced uncoupling. 
Altogether, the collected data illustrate the complex interplay between membrane lipid 
composition and drug action at the mitochondrial level. Diet, besides affecting drug 
metabolism [618], may also affect drug action at membrane protein targets due to an 
indirect interaction with the membrane lipid environment. Diet-induced changes in lipid 
composition may influence the access of lipophilic drugs to membrane protein sites by 
altering the partitioning of drugs into the lipid bilayer, while interfering with membrane 
biophysical properties. Lipid composition and membrane physical properties may also 
influence protein conformational dynamics and therefore protein responsiveness to 
drugs. This hypothesis may also explain, at least to certain extent, the non-specific 
action of lipophilic drugs on non-target membrane proteins, which may constitute a 
significant problem in novel drug design [225, 455-457]. 
In conclusion, diet may modulate the pharmacological activity of membrane-active 
drugs by modifying membrane lipid-drug interactions from which may result either 
non-specific toxicity or potentiation of drug activity in a therapeutic context. On the 
other hand, we should be aware that changes in lipid composition do occur during 
development and/or disease states, which can alter drug action in vivo [619]. The 
membrane-lipid therapy, a novel therapeutic approach in which membrane lipids 
constitute the main molecular pharmacological targets [235], evidences the importance 
that membrane lipid composition and dietary interventions may hold in a therapeutic 
context. Our work is positioned in the path to a new therapeutic paradigm in which, 
besides taking into account drug-membrane lipid interactions, a strategy is implemented 
to manipulate membrane lipid composition by diet, in order to modulate drug effects. 
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2.3. Cytochrome c-membrane interactions modulated by 
lipid composition 
 
2.3.1. Introduction 
 
Cyt c is a soluble 12 kDa protein usually located in the mitochondrial IMS, although 
significantly bound to the IMM, notorious by its role in the mitochondrial electron 
transport system. In fact, cyt c acts as an electron shuttle from complex III (ubiquinol 
cyt c oxidoreductase) to complex IV (cyt c oxidase) [9]. In addition to this important 
function in mitochondrial bioenergetics, an antioxidant role has also been proposed for 
cyt c, since it can catalyze the oxidation of superoxide radicals to molecular oxygen, 
acting as a superoxide scavenger [620]. On the other hand, extramitochondrial cyt c has 
been proposed as being an active participant in programmed cell death (apoptosis). 
After its release from mitochondria, cyt c interacts with Apaf-1, leading to the formation 
of apoptosomal complexes and activation of proteolytic caspase cascades [621, 622]. 
Moreover, a peroxidase activity has been assigned to cyt c [173, 623]. The interaction 
with CL converts cyt c into a CL-specific peroxidase, with catalytic selectivity towards 
polyunsaturated CL molecular species [173], resulting in the accumulation of CL 
oxidation products, mainly CL–OOH and their reduction products, CL–OH. Whereas 
cyt c loosely bound to CL participates in the transfer of electrons from complex III to 
complex IV, and performs the aforementioned antioxidant action, inhibiting ROS 
production [624, 625], cyt c tightly bound to CL peroxidizes this phospholipid using the 
H2O2 generated in the mitochondria [173]. 
A substantial portion of cyt c (about 85%) is trapped within the cristae of mitochondria, 
while the remaining is free in the IMS [626-629]. Cyt c confined within the 
mitochondrial cristae has been shown to interact with CL at the outer leaflet of the IMM 
[300]. Only a limited amount of CL should be available to interact with cyt c, given that 
most of it lies in the inner leaflet of the IMM (about 60%) and is associated with many 
of the proteins in the IMM [630]. Studies have approximated that less than 15% of the 
total cyt c is bound to CL and less than 5% of the total mitochondrial CL is bound to cyt 
c [173, 299, 300]. 
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Two CL binding sites have been proposed in the structure of cyt c [631]: the A-site, 
most likely involving weak electrostatic interactions between the phosphate groups of 
CL and lysine residues of cyt c [299] and the C-site, allowing a more stable interaction, 
which involves the invariant aminoacid residue Asn52 forming two hydrogen bonds 
with the protonated phosphate of CL [632]. The hydrophobic interaction between cyt c 
and CL may include the insertion of one of the CL acyl chains into a pocket of cyt c 
composed by hydrophobic residues, meaning that this CL acyl chain abandons the 
membrane bilayer to physically interact with cyt c [633, 634]. 
The interaction of cyt c with CL was proposed to result in loss of the tertiary structure 
of the protein [635-637], inducing the protein to adopt an intermediate conformation 
between the native and the fully unfolded states, with a secondary structure comparable 
to that of the native state [119]. 
In this study, the three major lipid components of the IMM in eukaryotic cells (PC, 
40%; PE, 40%; and CL, 20% in weight) [487] were combined in different proportions 
to investigate the effect of membrane composition on cyt c-CL binding. The initial 
hypothesis in this study is that the lipid composition of membrane domains where cyt c 
is localized may alter its binding to the membrane and particularly to CL. Although the 
interaction between cyt c and CL and other anionic phospholipids is well characterized 
by now, there is still room to scrutinize the influence that the presence of certain 
membrane phospholipid species may hold for the establishment of a propitious 
environment for cyt c-membrane binding. Moreover, efforts were made to produce lipid 
systems mimicking the lipid changes described before for liver mitochondria of rats fed 
a rapeseed oil-enriched diet, and to investigate if/how such changes may reverberate in 
protein-membrane interactions, in this case cyt c-membrane binding in particular. 
Finally, since GD3 has also an important role in apoptosis and in the regulation and 
opening of the MPTP [638], which is thought to be formed at the MCS’s [254], its 
influence on cyt c binding to membranes was also evaluated using model systems 
mimicking MCS’s. As previously referred (see Introduction) GD3 is present in 
mitochondrial raft-like microdomains, which represent membrane domains where key 
reactions preferentially take place [123] and to which apoptotic proteins are recruited 
[638]. 
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2.3.2. Materials and Methods 
 
2.3.2.1. Materials 
 
The lipids DPPC, POPC, DOPC, DPPE, DOPE, TOCL and GD3 (at least 98% pure) 
were obtained from Avanti Polar Lipids, Inc. (Murcia, Spain). Cholesterol (chol) and 
horse heart cyt c was purchased from Sigma Chemical Co. (St. Louis, MO, USA). 
 
2.3.2.2. Preparation of unilamellar vesicles 
 
MLVs were prepared by dissolving adequate portions of lipids in chloroform and 
hydrating the dry residues under N2 atmosphere by gentle shaking with an adequate 
volume of phosphate buffer (pH 7.0). MLVs were then submitted to 10 freeze-thaw 
cycles and sonicated for at least 3 h (until the liposome preparations become clear) in 
order to obtain unilamellar vesicles. Different mixtures of lipids were prepared: a) 
DOPC, DOPE and TOCL in different proportions; b) POPC, DPPE and TOCL 1:1:1 for 
studies concerning the effect of fatty acid saturation; c) 41% DOPC, 22% DOPE, 8% 
GD3, 9% chol and 20% TOCL to mimic the MCS’s, and d) the same mixture without 
GD3 or CL, compensated by increases in the other lipids, thus maintaining their relative 
proportions. A concentration of 10 µM cyt c was used for fluorescence determinations 
and 20 µM for circular dichroism (CD) and attenuated total reflection Fourier transform 
infrared spectroscopy (ATR FTIR) studies. For binding experiments, several lipid:cyt c 
molar ratios (from 50:1 to 1000:1) were assayed. For CD determinations, a lipid:cyt c 
molar ratio of 500:1 was used. 
 
2.3.2.3. Fluorescence determinations 
 
Fluorescence spectra of samples containing 10 µM cyt c in phosphate buffer (pH 7.0) 
and HCl solution (pH 2.0) were obtained at room temperature (about 22ºC) on a Perkin-
Elmer LS50 spectrometer. Native-folded cyt c (in phosphate buffer, pH 7.0) was then 
combined with liposome suspensions prepared from a number of different lipid 
mixtures. Lipid:cyt c molar ratios from 50:1 to 1000:1 were used. The ex
168 
João P. Monteiro, 2012 
 
wavelength was set at 295 nm (2 nm bandpass), and emission spectra were recorded 
from 300 to 450 nm (2 nm bandpass). Each spectrum was an average of four scans. 
Spectra were corrected for backgrounds, recording the corresponding samples without 
protein (buffer for spectra of only-protein solutions, and lipid mixtures in buffer for 
spectra of lipid plus protein samples). 
 
2.3.2.4. Circular dichroism 
 
CD spectra at far-UV (200–260 nm) were recorded on a JASCO J-715 
spectropolarimeter with a bandwidth of 1.0 nm and a scanning rate of 100 nm/min. 
Spectra were obtained for samples containing 20 µM cyt c in phosphate buffer (pH 7.0) 
and HCl solution (pH 2.0). Native-folded cyt c (in phosphate buffer, pH 7.0) was then 
studied in the absence and in the presence of a 10 mM lipid mixture of varying 
composition. All spectra were corrected for their corresponding backgrounds (buffer or 
liposomes in buffer, without cyt c). Spectral resolution was 0.5 nm/min, and 16 scans 
were averaged per spectrum. The cell holder was thermostated with a circulating water 
bath, and all spectra were recorded at 20±0.2ºC. 
 
2.3.2.5. Attenuated total reflection Fourier transform infrared spectroscopy 
 
Thin films of oriented multilayers, containing cyt c 20 µM and liposomes of varying 
composition (10 mM in lipid) were deposited on the germanium plate and dried under a 
stream of nitrogen. The ATR plate was then sealed in an universal sample holder and 
placed in a Bruker IFS-55 infrared spectrometer equipped with a liquid-nitrogen-cooled 
MCT (mercury cadmium tellurium) detector. The spectrometer was continuously 
purged with air dried through a silica gel column. Typically, 128 scans were averaged 
per spectrum. All spectra were recorded at a nominal resolution of 2 cm-1, and 
measurements were performed at room temperature (about 20ºC inside the sample 
chamber). The contribution from atmospheric water was subtracted from all spectra, as 
previously described [639]. Spectra were further corrected using a weighted coefficient 
based on the integrated area of the lipid carbonyl peak between 1562 and 1555 cm-1. 
Weighted lipid spectra were subtracted from the spectra of protein plus lipid samples (or 
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buffer spectrum subtracted from the spectrum of cyt c in solution). Final spectra were 
smoothed by apodization with a 4-cm-1 full width at half height Gaussian line shape. 
Protein secondary structure was determined by self-deconvolution of spectra [640, 641] 
and band assignments in deconvoluted spectra were made as previously described 
[642]. 
 
2.3.2.6. Statistical analysis of data 
 
Values were expressed as means ± standard deviation of 3-4 independent experiments. 
Multiple comparisons were performed using one-way ANOVA with the Student-
Newman-Keuls as a post-test. A value of p<0.05 was considered statistically significant. 
 
2.3.3. Results 
 
2.3.3.1. Cytochrome c-membrane binding depended on membrane lipid 
composition 
 
The fluorescence emission of the single tryptophan at position 59 in the polypeptide 
chain of cyt c (Trp59) was used to monitor conformational changes in the protein upon 
interaction with different model membrane lipid systems, mimicking the normal 
composition of IMM and diet- [128-130] or disease- [181] mediated alterations in its 
lipid composition. In cyt c native conformation, Trp59 is located near the heme group 
[643], which results in efficient quenching of the Trp59 fluorescence. Under strong 
denaturing conditions (pH 2.0) or low ionic strength, the fluorescence spectrum 
exhibited an emission maximum near 340 nm (Fig. 48), which reflects a highly 
expanded conformation of the polypeptide chain [644]. Binding of native-folded cyt c to 
the membrane lipid systems assayed promoted a conformational alteration reflected by a 
decrease in Trp59 quenching (Fig. 48) and, hence, an increase in fluorescence emission 
at 340 nm (Fig. 49). Liposome preparations containing DOPC, DOPE and TOCL (1:1:1 
molar ratio), promoted the highest values of fluorescence emission, which means that 
highest cyt c binding was achieved with this membrane lipid system (Fig. 49A). With 
all liposome preparations assayed the highest binding of cyt c was attained at a lipid to 
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cyt c molar ratio of 750:1. Interestingly, at this ratio, the absence of DOPE from the 
lipid mixture caused a decrease of the fluorescence measured. A decrease in binding, 
although not as pronounced, was also obtained with an increase of the saturation degree 
of PC and PE. The only CL species used in these studies contained four oleoyl chains 
(TOCL), therefore, differences in its degree saturation were not considered. Finally, as 
expected, cyt c did not bind to membrane preparations lacking the anionic phospholipid 
CL (Fig. 49B). 
 
 
 
 
Fig. 48: Fluorescence emission spectra of cyt c (10mM) in neutral aqueous solution (native 
protein; solid line), in acid solution (unfolded protein; dashed line) or in the presence of 
liposomes consisting of a mixture of 1 DOPC: 1 DOPE: 1 TOCL (750:1 lipid to protein 
ratio; grey line). The spectra were recorded at room temperature (about 22ºC) with excitation 
at 295 nm. Represented spectra are typical of at least three independent experiments. 
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Fig. 49: Tryptophan intrinsic fluorescence (emission at 340 nm) of cyt c (10 mM) upon 
titration with increasing concentration of lipid. Liposome suspensions had the following 
composition: A) 1 DOPC: 1 DOPE: 1 TOCL (circles); 1.5 DOPC: 0.5 DOPE; 1 TOCL 
(squares); 2 DOPC: 1 TOCL (triangles); 1 POPC: 1 DPPE: 1 TOCL (inverted triangles). B) 
Liposome suspension lacking CL with the following compositions: POPC (circles); 1 DOPC: 1 
DOPE (triangles); 1 POPC: 1 DPPE (squares). The spectra were recorded at room temperature 
(about 22ºC) with excitation at 295 nm. Values depicted correspond to means ± standard 
deviation of at least three independent determinations. 
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2.3.3.2. Cytochrome c conformation was influenced by membrane lipid 
composition 
 
Fig. 50: A) Far-UV CD spectra of native cyt c (10 mM) in neutral aqueous solution (native 
protein; solid line) and acid solution (unfolded protein; dashed line). B) Far-UV CD 
spectra of cyt c (10 mM) in aqueous solution (solid line) or in the presence of liposome 
suspensions (at a 500:1 lipid to cyt c ratio). Lipid suspensions had the following composition: 
1 DOPC: 1 DOPE: 1 TOCL (long dash line); 1.5 DOPC: 0.5 DOPE; 1 TOCL (dashed line); 2 
DOPC: 1 TOCL (dash-dot-dash line); 1 POPC: 1 DPPE: 1 TOCL (dotted line). All spectra were 
acquired at 20ºC and represented spectra are typical of at least three separate experiments. C) 
Molar ellipticity (θ) at 222 nm registered for cyt c in neutral aqueous solution (black bar) or in 
acid solution (white bar), or in the presence of the lipid preparations indicated in the figure. 
Values depicted are means ± standard deviation for at least three different determinations. 
Comparisons were performed using one-way ANOVA, with the Student-Newman-Keuls as a 
post-test for cyt c in neutral aqueous solution versus cyt c in all the other conditions; ***, P 
<0.001; * P <0.05. 
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Circular dichroism was used to monitor structural changes in cyt c upon interaction with 
the same liposome preparations used in the previous binding experiments. The far-UV 
CD spectrum of cyt c in aqueous solution is typical of proteins containing a mainly α-
helical structure, with a characteristic band near 222 nm. Acid-unfolded cyt c shows a 
decrease in this band (Fig. 50A and C), as previously described [645]. The presence of 
liposomes of several compositions made the spectra shift to an intermediate position 
between that of cyt c in neutral buffer (pH 7.0) and that of acid-unfolded cyt c (in acid 
solution). The differences found between the spectra position for the different liposome 
compositions tested correlated with those observed in the binding studies, meaning that 
the preparations promoting stronger interactions with cyt c caused more pronounced 
deviation from the spectrum obtained for cyt c in aqueous solution (Fig. 50B). The 
liposome-induced decrease in the ellipticity (θ) at 222 nm (Fig. 50C), which reflects a 
reduction of α-helical content [646], although slight as compared to that observed with 
acid-unfolded cyt c, evidenced a denaturation trend. Consistently, the preparations 
promoting increased binding introduced higher divergence in the ellipticity at that 
wavelength (Fig. 50C). 
Complementary data were gathered from ATR FTIR, another well established, non-
destructive experimental technique allowing the analysis of the secondary structure of 
polypeptides and proteins. The ATR FTIR measurements showed subtle differences in 
the protein amide I band (at about 1654 cm-1), whose exact position is determined by 
the backbone conformation and the hydrogen bonding pattern, between the spectrum of 
cyt c alone (at physiologic pH) and those of the liposome-bound protein (Fig. 51). 
These differences are less evident, however, than those seen in the CD experiments. 
This should be related to the fact that different techniques may hold different 
sensitivities for the different types of protein secondary structure elements, ATR FTIR 
being much more sensitive to β-structure than CD [647]. A slight decrease at the peak 
of the amide I band in the presence of liposome preparations allows foreseeing a 
decrease in α-helix content, but no significant differences are seen at the onset of the 
band (primarily governed by β-sheet structure). Therefore, the loss of α-helix suggested 
in the CD studies did not translate in evident increase in β-sheet content. 
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Fig. 51: FTIR spectra of the amide I region of cyt c (10 mM) in the absence (thick solid 
line) or presence of different liposome preparations at a 500:1 lipid to cyt c ratio. 
Suspensions with the following molar proportions were assayed: 1 DOPC: 1 DOPE: 1 TOCL 
(solid line); 1.5 DOPC: 0.5 DOPE; 1 TOCL (dashed line); 2 DOPC: 1 TOCL (grey dashed line); 
1 POPC: 1 DPPE: 1 TOCL (grey solid line). All spectra were acquired at 20ºC. Represented 
spectra are typical of at least three independent experiments. 
 
2.3.3.3. Cytochrome c-membrane binding and conformation were not 
affected by the presence of GD3 
 
As expected, cyt c binding to liposomes mimicking MCS’s also depended on the 
presence of CL. In the preparations lacking CL, cyt c displayed residual tryptophan 
fluorescence (Fig. 52) and its CD spectrum almost overlapped that of cyt c in neutral 
aqueous solution (Fig. 53). The protein should therefore remain in solution in those 
preparations, further proving that CL presence is critical for cyt c membrane binding. 
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Fig. 52: Tryptophan intrinsic fluorescence (emission at 340 nm) of cyt c (10 mM) upon 
titration with increasing portions of liposome suspensions mimicking the composition of 
MCS’s. Lipid suspension mimicking MCS’s (circles), MCS’s without GD3 (triangles) and 
MCS’s without CL (squares) were assayed. The spectra were recorded at room temperature 
(about 22ºC) with excitation at 295 nm. Values depicted correspond to means ± standard 
deviation of at least three independent determinations. 
 
Fig. 53: Far-UV CD spectra of cyt c (10 mM) in neutral aqueous solution (solid line) or in 
liposome suspensions (500:1 lipid to cyt c ratio) mimicking the composition of MCS’s. 
Lipid suspension mimicking MCS’s (long dash line), MCS’s without GD3 (dashed line) and 
MCS’s without CL (dash-dot-dash line) were assayed. All spectra were acquired at 20ºC and 
represented spectra are typical of at least three independent experiments. 
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A model mimicking the MCS’s containing GD3 was also used, given the physiological 
relevance of this lipid in mitochondrial raft-like microdomains and for the opening of 
the MPTP [638], which anticipates a putative action on protein convergence and 
docking in mitochondria. Tryptophan intrinsic fluorescence was not altered by the 
presence of GD3, meaning that this lipid did not affect protein interactions with the 
membrane systems assayed (Fig. 52). Also CD studies showed that GD3 did not 
influence cyt c conformation (Fig. 53). 
 
2.3.4. Discussion 
 
A key function of cyt c as a messenger on the verge of cell death was recently added to 
its most familiar function in the life scope, serving as a carrier of electrons in the 
mitochondrial respiratory system. Interactions with CL mediate the role of cyt c in both 
scenarios. Cyt c interactions with CL and other anionic phospholipids are well 
characterized, but in this study it was shown that membrane composition in terms of 
phospholipid species and the unsaturation of their hydrocarbon chains are also relevant 
for protein-membrane relationships, namely in terms of the extent of protein binding to 
the membrane as well as the conformation adopted by the protein upon membrane 
binding. Cyt c binding to models of physiological relevance (MCS’s) was also studied 
to investigate a putative interference of apoptosis-implicated lipids occurring in 
mitochondrial lipid rafts (GD3) on cyt c-membrane interplay. 
CL is a structurally unique phospholipid, containing two phosphate groups and four acyl 
chains [648]. Knowing that part of the cyt c-CL binding is electrostatic in nature, 
attention should be given to the CL state of ionization. As consequence of the presence 
of the two phosphate groups, CL exhibits complex ionization behaviour. In some 
studies, CL is regarded as being fully deprotonated, bearing a charge of -2 at neutral pH. 
This view was based on early findings reporting CL exhibited a single pK below 4.0 
[649]. However, posterior studies revealed that CL exhibits two widely separated pK 
values, pK1=2.8 and pK2 varying between 7.5 and 9.5 [287]. Therefore, in the present 
study (using a phosphate buffer at pH 7.0) we presume CL should be in the 
monocharged form. The strength of the binding between cyt c and CL depends also on 
the molecular structure of the phospholipid. CL species containing saturated acyl chains 
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have been shown to bind cyt c more weakly than species with polyunsaturated acyl 
chains [650]. 
It was earlier proposed that CL and cyt c formed a 4:1 molar complex [651], and 
reported that cyt c binding to CL-containing membranes results in a substantial increase 
of the tryptophan fluorescence emission and considerable perturbations of the circular 
dichroism spectrum in the Soret and in the far-ultraviolet regions. More recent studies 
point that a single CL molecule can be involved in both electrostatic interactions 
(between CL headgroup and the Lys72 residue of cyt c) and hydrophobic interactions, 
leading to the insertion of an acyl chain of CL either in a cyt c pocket surrounded by 
Asn52, Lys72, and Lys73 or between the non-polar polypeptide strands 67–71 and 82–
85 [634, 652]. Upon cyt c binding to CL, the methionine 80 ligand is displaced from the 
heme group, and methionine 65, which is located within a short α-segment, is disturbed 
[653]. The conformational changes taking place upon cyt c binding to CL also lead to 
Trp59 displacement from the heme group, resulting in increased fluorescence emission 
by the tryptophan, when excited [643]. This was the basis for the fluorescence binding 
studies performed in the present study, in which an increase in fluorescence was 
correlated to increased cyt c binding. While membranes without CL (POPC alone, 1 
POPC: 1 DPPE and 1 DOPC: 1 DOPE) showed no significantly cyt c binding (Fig. 
49B), the amount of CL present was revealed to be a critical factor. A relative CL molar 
proportion of 1/8 of total lipid in the model (approximately the same amount that occurs 
in the mitochondrial membrane [85]) showed to be not enough to promote cyt c binding 
in lipid mixtures composed of DOPC, DOPE and TOCL (data not shown). Therefore, it 
can be anticipated that mitochondrial membrane lipid domains enriched in CL should be 
required in vivo to ensure cyt c binding. MSC’s (20% in CL) should represent sites 
where CL is concentrated with physiological purpose, and CL does indeed bind 
significantly to models mimicking these structures (although increased binding was 
demonstrated for liposomes 1/3 in CL). 
On the other hand, it has been suggested that the presence of unsaturated lipids is a 
requirement for an effective membrane interfacing of cyt c and formation of the cyt c-
CL complex, alterations in the saturation of CL lipid acyl chains having been reported 
as promoting a dramatic effect on cyt c binding and unfolding [623]. In fact, it was 
observed that a membrane lipid model exhibiting increased lipid unsaturation (1 DOPC: 
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1 DOPE: 1 TOCL, as opposed to 1 POPC: 1 DPPE: 1 TOCL) bound cyt c more readily 
(Fig. 49A). 
The model composed of DOPC and TOCL showed to significantly bind cyt c, but the 
presence of DOPE seems to be necessary to promote maximal binding (Fig. 49A). Rog 
and colleagues [654] performed an atomic-scale molecular dynamics simulation study 
involving different membrane systems based on the natural composition of the IMM, 
with CL being present in either binary (with PC or PE) or ternary (with PC and PE) 
systems. The authors proposed that the influence of CL on membrane properties 
strongly depends on membrane lipid composition. Interestingly, in systems containing 
PC and PE, these lipids seemed to influence each other’s properties. More importantly 
to our study, among all the lipid systems considered in this simulation work, it was in 
the ternary lipid system that PC headgroup exhibited the slowest rotation, the H-bonds 
were formed in the highest number and the charge pair number was the lowest. These 
findings indicated a stronger interaction between lipids in the PC-PE-CL bilayer as 
compared to the other bilayers (binary systems). Therefore, the requirement of PE for 
maximal binding of cyt c to the membrane lipid models used in the present study may 
have to do with peculiarities of the ternary lipid system. 
Another study [655] reported a spontaneous lateral segregation in POPE:CL (0.8:0.2, 
mol/mol) membranes, leading to the formation of different domains, including CL-
enriched structures. This may also help to explain PE requirement for cyt c binding in 
the present study: PE would facilitate the lateral segregation of CL-rich domains, where 
cyt c would preferentially bind. 
Regarding cyt c effects on membrane biophysical properties, cyt c was reported to 
specifically induce HII phases in CL-containing membrane models [656]. This would be 
favored in the presence of PE, which has been proposed to spontaneously promote these 
arrangements [241]. On the other hand, it has been reported that the activity of some 
membrane enzymes, including mitochondrial respiratory complexes is determined by 
the tendency of the lipid moiety to form HII structures [251]. If curvature stress also 
influenced cyt c binding to membranes, this could also contribute to explain the 
requirement for PE.  
The models used in this series of experiments were designed to somehow mimic the 
alterations undergone by the liver mitochondrial membrane of rats fed the modified diet 
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containing 20% rapeseed oil. With this diet, the PC to PE ratio was significantly 
increased, from 1.27 in the control group to 1.82 after 33 days of treatment with the 
rapeseed oil enriched diet. In fact, this range of alterations is much narrower than that 
used in the models used in this section, but in certain domains of the mitochondrial 
membranes striking changes may locally occur, even with the changes reported in the 
dietary studies. In the light of these considerations, it is fair to foresee a possible dietary 
influence on local membrane-cyt c interactions at the mitochondrial level. 
In terms of conformational changes upon binding, the interaction of cyt c with 
negatively charged lipid membranes was reported to induce considerable disruption of 
the native compact structure of the protein [657]. This state, considered an “alternative 
folding,” is defined as a compact conformation with a secondary structure comparable 
to that of the native state and a fluctuating tertiary conformation due to a high 
enhancement of intramolecular motion [658-661]. Thus, this membrane-bound state of 
cyt c lacks many features of its native tertiary structure but remains highly helical [645]. 
In the present work, differences were observed between the far-UV CD spectra of cyt c 
in solution at physiologic pH and that of cyt c bound to membrane systems containing 
CL (1/3 mol in lipid content; Fig. 50B), which should reflect conformational changes 
upon binding. Interestingly, the lipid preparations that induced more pronounced 
alterations in the CD spectra of cyt c relatively to its spectrum obtained in aqueous 
solution were the same to which cyt c showed to bind preferentially (Fig. 50B). Acid-
unfolded cyt c was shown to acquire a molten globule structure [662], which has been 
characterized as a compact denatured state with significantly defined secondary 
structure but largely disordered tertiary structure. The interaction of cyt c with lipid 
membranes has also been shown to promote the generation of a molten globule-like 
intermediate structure [660, 663]. Consistently, the spectra of cyt c bound to CL-
containing membrane models showed alterations following a trend towards the 
spectrum obtained for the acid-unfolded protein (Fig. 50B). 
Regarding the experiments with models mimicking the composition of MCS’s, the 
binding of cyt c was not as extensive as that obtained with the models firstly assayed (1 
DOPC: 1 DOPE: 1 TOCL and 1.5 DOPC: 0.5 DOPE: 1 TOCL) as inferred by 
comparing Figs. 49 and 52. This may result from the fact that there was less CL 
available for binding in MCS’s models (20%) than in those models (about 33%). The 
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presence of GD3 in the MCS’s models did not show any effect on cyt c binding or 
conformational behaviour. GD3 has been found on raft-like microdomains on 
mitochondrial membranes, which represent sites where some key reactions are 
preferentially catalyzed, and to which apoptotic proteins are recruited [638]. By 
interacting with mitochondrial raft-like microdomains, GD3 was suggested to trigger 
specific events involved in the apoptogenic program, including mitochondria 
hyperpolarization and depolarization, fission-associated changes, MPTP formation and 
release of apoptogenic factors [123]. Further studies would be needed to conclude 
whether GD3 interactions are involved in the process by which GD3 triggers/mediates 
apoptotic outcomes. 
In conclusion, the present study confirmed previous data showing that membrane lipid 
composition is an important factor for cyt c binding to membrane systems, with 
consequences for cyt c-adopted conformation. Alterations in the membrane lipid 
content, such as those reported in mitochondria as a result of dietary manipulations 
[128-130] or physiological/pathological conditions [181] may then reverberate in the 
role of cyt c in cell life and death, which vastly depends on the interplay with the IMM. 
More specifically, binding of cyt c to CL in the IMM leaflet facing the IMS may be 
affected by membrane composition with predictable repercussions to apoptotic 
signaling. 
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3.1 Concluding remarks 
 
The present work, involving a comprehensive study comprising extensive 
characterization of diet-manipulated mitochondrial membrane lipid and protein 
composition, and the resulting effects on mitochondrial physiology, consolidated and 
extended previous data sparsely reported in the literature. This work also demonstrated 
that membrane lipid composition modulates membrane binding and conformational 
dynamics of proteins, with predictable repercussions in their activity, as illustrated by 
cyt c. 
Regarding to repercussions of the present work in a pharmacological/toxicological 
context, we emphasize three main conclusive aspects:  
 
 Lipophilic drugs exhibiting different physico-chemical properties (e.g. size, 
charge, lipophilicity, molecular geometry, among others) and, hence, exerting 
different kinds of membrane perturbation (as observed in this study for FCCP, 
MEN and NIM; see Table XVII) may cause similar effects at cellular or 
subcellular levels using different molecular mechanisms. This was observed in 
the present work for FCCP and nimesulide, both promoting mitochondrial 
uncoupling, although exerting distinct actions at the membrane level. Several 
inferences may be drawn from these findings in a pharmacological/toxicological 
context. One regards the possibility to modulate drug side effects by 
manipulation of its structural design, hence modifying its impact on membrane 
dynamics without loosing its pharmacological activity. 
 
Table XVII: Summary of the results from the biophysical studies carried out with 
mitochondriotoxic compounds in model membranes (section 2.1). 
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 The effects exerted by mitochondria-active drugs (e.g. FCCP, nimesulide and 
menadione) can be modulated by dietary manipulation exclusively as a 
consequence of alterations in the lipid content of the membrane (since in this 
work no alterations were found in mitochondrial protein expression). 
Therefore, dietary interventions should be considered in a therapeutic context, 
namely in combination with chemotherapies, by assisting drug 
pharmacological action or attenuating its side effects. 
 
 
 
 
 
Fig. 54: Summary of the procedures and main conclusions of the dietary manipulation 
studies (section 2.2). 
 
 
 
 Membrane composition may modulate binding and conformation of proteins, 
with predictable repercussions in activity. In particular, changes in 
mitochondrial membrane composition mimicking the ones we obtained in vivo, 
lead to changes in cyt c binding. Changes like those reported here may be 
translated physiologically in membrane domains with functional relevance, with 
implications to protein binding and conformation, and therefore to protein 
activity. 
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3.2 Future perspectives 
 
 Aiming at extending the range of applications of dietary interventions targeting 
mitochondrial membrane composition and function, other feeding protocols 
using diets of different composition will be developed. Employing this strategy, 
we expect to obtain different alterations of mitochondrial membrane lipid 
composition with different outcomes for mitochondria physiology.   
 
 The studies addressed here will be extended to other clinically-relevant drugs, in 
order to ascertain the dietary manipulation of membrane lipid composition with 
higher ability to potentiate the pharmacological activity or to mitigate the side 
effects of a diversity of drugs used for the treatment of different diseases. 
 
 Dietary outcomes will be studied in other native membranes (e.g. plasma 
membranes from different tissues and organs) in order to extend the range of 
dietary manipulation interventions with physiological impact, and potential for, 
by themselves, being used with specific therapeutic intentions. 
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